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Abstract 
The primary objective of this series of experiments was to explore some of the reasons 
which lead to equivocal outcomes in the literature on dietary recommendations and to 
demonstrate the need for evidence-based data on well-trained and elite athletes.  Therefore, 
the previous mentioned groups of athletes were recruited to participate in four research 
studies, each entailing a series of experimental trials.  The data obtained were compared to 
previous research and/or to the established dietary recommendations.   
The aim of the first research study presented in this thesis (Chapter 2) was to examine the 
effects of Glycine-arginine-α-ketoisocaproic acid (GAKIC) supplementation on fatigue 
during high intensity, repeated cycle sprints in trained cyclists.  It should be noted that 
despite the fact that studies on GAKIC supplementation involving well-trained subjects are 
lacking, athletes regularly use this commercially available supplement.  This is is also the 
case for a vast range of other supplements whose suitability has been assessed in normal 
healthy subjects or recreationally active individuals.  In the study presented in Chapter 2, 
10 well-trained male cyclists completed two supra-maximal sprint tests each involving 10 
sprints of 10 s separated by 50 s rest intervals on an electrically braked cycle ergometer.  
Participants ingested 11.2 g of GAKIC (according to protocols previously established in 
the literature) or Placebo (Pl) during a period of 45 min prior to the experimental trials.  
Peak power, mean power, fatigue index as well as heart rate (HR) and ratings of perceived 
exertion did not differ between conditions (GAKIC vs. Pl).  Peak power declined from the 
1st sprint (mean  SD) (Pl: 1332  307 W, GAKIC: 1367  342 W) to the 10th sprint (Pl: 
1091  229 W, GAKIC: 1061  272 W) and did not differ between conditions (P = 0.88).  
Mean power declined from the 1st sprint (Pl: 892  151 W, GAKIC: 892  153 W) to the 
10th sprint (Pl: 766  120 W, GAKIC: 752  138 W) and did not differ between conditions 
(P = 0.96).  Fatigue index remained at ~38% throughout the series of sprints and did not 
differ between conditions (P = 0.99).  HR and ratings of perceived exertion increased from 
the 1st sprint to the 10th sprint and did not differ between conditions (P = 0.11 and P = 0.83, 
respectively).  The data reported, suggest that GAKIC has no ergogenic effect on repeated 
bouts of high intensity exercise in trained individuals.  The reported data further 
contradicts previous performance studies where GAKIC was found to attenuate the decline 
in power output, improve muscle performance and delay muscle fatigue resulting in the 
improvement of total work during high intensity exercise.  Notably, none of the previous 
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confounding factors that could have adversely affected the results.  For instance, utilization 
of untrained individuals and failure to include baseline trials to establish the repeatability 
of performance trials leaves the reliability of the data open to question.  Furthermore, the 
results in Chapter 2 highlight the importance of extrapolating decisions concerning the 
effectiveness of a marketed nutritional supplement from the best available research 
conducted on well-trained subjects.  
The aim of Chapter 3 was to assess the food and macronutrient intake of elite Ethiopian 
distance runners; a group of athletes that dominates endurance running.  The results of the 
research allowed further examination and direct comparison of the nutrient intake to the 
established guidelines and previous studies conducted on African runners.  The dietary 
intake of 10 highly-trained Ethiopian long distance runners, living and training at high 
altitude was assessed during a 7-day period of intense training prior to competition using 
the standard weighed intake method.  Training was also assessed using an activity/training 
diary.  Body mass (BM) was stable (i.e., was well maintained) over the assessment period 
(pre: 56.7 ± 4.3 kg vs. post: 56.6 ± 4.2 kg, P = 0.54).  The diet comprised of 13375 ± 1378 
kJ and was high in carbohydrate (64.3 ± 2.6% of total energy intake (TEI), 545 ± 49 g, 9.7 
± 0.9 g.kg-1).  Fat and protein intake was 23.3 ± 2.1% TEI (83 ± 14 g) and 12.4 ± 0.6% TEI 
(99 ± 13 g, 1.8 ± 0.2 g.kg-1), respectively.  Fluid intake comprised mainly of water (1751 ± 
583 mL.day-1), while no fluids were consumed before or during training with only modest 
amounts being consumed following training.  It was concluded that, as found in previous 
studies on elite Kenyan distance runners, the diet of these elite Ethiopian distance runners 
met most recommendations for endurance athletes in regard to macronutrient intake but not 
in regard to fluid intake.  Nevertheless, it remains unclear in what way these differences in 
fluid consumption, before major competitions, have an impact on their performance.  
Therefore, Chapter 3 highlights the fact that more studies involving truly world-class 
athletes are required in order to assess and possibly improve the applicability of current 
recommendations to elite athletes.  Chapter 3 also highlights the potential role of the 
commercial industry in the application of the science of exercise nutrition. 
Chapter 4 aimed to describe the drinking behaviours of elite male marathon runners during 
major city marathons.  Retrospective video analysis of 10 male marathon runners during 13 
major city marathons was undertaken.  Total drinking durations during the marathons were 
determined by estimating the time spent ingesting fluid at each drinking station from video 
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(ambient temperature) and 59 ± 17% relative humidity; average marathon competition time 
was 02:06:31 ± 00:01:08 (h:min:s).  Total drinking duration during these races was 25.5 ± 
15.0 s (range: 1.6 - 50.7 s) equating to an extrapolated fluid intake rate of 0.55 ± 0.34 L.h-1 
(range: 0.03 - 1.09 L.h-1).  No significant correlations were found between total drink 
duration, fluid intake (rate and total), running speed and ambient temperature.  Estimated 
BM loss based on calculated sweat rates and rates of fluid ingestion was 8.8 ± 2.1% (range: 
6.6 - 11.7%).  Measurements of the winner in the 2009 Dubai marathon revealed a BM loss 
of -9.8%.  It was concluded that the most successful runners during major city marathons, 
drink fluids ad libitum (i.e., at one's pleasure) for less than ~60 s at an extrapolated fluid 
ingestion rate and is in accordance with the current recommendations by the American 
College of Sports Medicine of 0.4 - 0.8 L.h-1.  Nevertheless, these elite runners do not seem 
to maintain their BM within the current recommended ranges of 2 – 3%.  On the other 
hand, this apparently widely adopted ad libitum strategy during marathon racing seems to 
produce optimal/winning performances.  This evidence and the finding that the runner, 
who set the previous world record (2008), finished a competitive race (Dubai, 2009) with a 
BM loss of 9.8%, suggest that a tolerable range for dehydration may exist.  It is possible, 
that this tolerable limit of dehydration may not have a negative impact on running 
performance in elite runners and may even confer an advantage by preventing a significant 
increase in BM due to “over - consumption” of large volumes of fluid.   
Given the data extrapolated from “real world” studies (Chapters 3 and 4) and the 
established guidelines for fluid ingestion, the investigation in Chapter 5 aimed to examine 
a possible method that could bring together the established guidelines and the data 
extracted from “real world” studies.  Therefore, the effects of a hyper-hydration method 
combining creatine (Cr) and glycerol (Gly) supplementation on thermoregulatory 
responses and running economy (RE) in hot and cool conditions were investigated.  
Cr·H2O (11.4 g), Gly (1 g·kg-1 BM) and glucose polymer (75 g) were administered twice 
daily to 15 male endurance runners during a 7-day period.  Exercise trials were conducted 
pre- and post-supplementation at 10 and 35 °C and 70% relative humidity.  Combined Cr 
and Gly supplementation increased BM and total body water by 0.90 kg and 0.71 L, 
respectively following supplementation.  Despite the significant increase in BM, 
supplementation had no effect on oxygen uptake (V̇O2) and thus RE.  Both HR and core 
temperature were attenuated significantly after supplementation.  Combining Cr and Gly is 
effective in reducing thermal and cardiovascular strain during exercise in the heat without 
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The potential influence of the commercial industry on scientific objectivity, as well as the 
lack of properly evaluated, controlled and randomized studies are the two main weaknesses 
that prevent the establishment of well accepted guidelines for food and fluid intake of well-
trained and elite athletes.  The development of novel guidelines needs to be solely 
evidence-based.  Therefore, in order to reach conclusions regarding specific categories of 
athletes, research should be conducted on homogeneous groups (i.e., either well-trained, or 
elite, or world-class).  Furthermore, research must be conducted under environmental and 
other conditions that are equivalent to those met during ‘‘outdoor’’ exercise, in order to 
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When you set out on your journey to Ithaca, 
pray that the road is long, 
full of adventure, full of knowledge. 
The Lestrygonians and the Cyclops, 
the angry Poseidon - do not fear them: 
You will never find such as these on your path, 
if your thoughts remain lofty, if a fine 
emotion touches your spirit and your body. 
The Lestrygonians and the Cyclops, 
the fierce Poseidon you will never encounter, 
if you do not carry them within your soul, 
if your soul does not set them up before you. 
 
Pray that the road is long. 
That the summer mornings are many, when, 
with such pleasure, with such joy 
you will enter ports seen for the first time; 
stop at Phoenician markets, 
and purchase fine merchandise, 
mother-of-pearl and coral, amber and ebony, 
and sensual perfumes of all kinds, 
as many sensual perfumes as you can; 
visit many Egyptian cities, 
to learn and learn from scholars. 
 
Always keep Ithaca in your mind. 
To arrive there is your ultimate goal. 
But do not hurry the voyage at all. 
It is better to let it last for many years; 
and to anchor at the island when you are old, 
rich with all you have gained on the way, 
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Ithaca has given you the beautiful voyage. 
Without her you would have never set out on the road. 
She has nothing more to give you. 
 
And if you find her poor, Ithaca has not deceived you. 
Wise as you have become, with so much experience, 




Although the English version seems to lack the melodic pace that characterises the original 
Greek version, I still find it amazing and I have always used it as a guiding compass for my 
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1. General Introduction 
 
1.1 Factors affecting exercise performance  
Elite athletes (i.e., athletes with potential for competing in the Olympics) and world-class 
athletes (i.e., athletes who are amongst the best in the world) are constantly looking for 
“the edge” to optimise exercise performance in order to reach their maximal performance 
level.  In fact, the international standard in sports is typically on an upward trend.  As a 
result athletes constantly endeavour to find new strategies in order to maintain and/or 
improve their competitive edge.  Therefore, training and competition preparation for 
athletes should focus on the improvement of factors, which have in the past shown to 
positively affect exercise performance.  Talent is undoubtedly the most important attribute 
of the elite performer, but it is difficult to define (Maughan, King, & Lea, 2004).  Although 
there are a variety of factors essential to world-class exercise performance, the principle of 
optimal training and recovery appears to be an inviolable rule for optimal performance 
(Myburgh, 2003).  According to Myburgh (2003), the formation of research on 
performance contributors can be represented by a pyramid model (Figure 1.1) where 
optimal training and recovery are always found at the base of this multidisciplinary 
approach (Figure 1.1).  Myburgh’s model (2003) proposes that conventional methods (i.e., 
physiology, biochemistry and histology) may be insufficient for assessing and 
distinguishing between elite and truly world-class athletes.  Hence, a multidisciplinary 
approach that also includes molecular biology and genetics must be embraced.  The study 
by Williams and Folland (2008) is also in agreement with the aforementioned evidence.  
These authors (Williams & Folland, 2008) mention that human physical performance is 
multi-factorial and is determined by a range of genetic and environmental factors (physical 
training, nutrition and technological aids).  When viewing Olympic and world records in 
athletic events as indicators of the limits of human physical potential, it should be 
recognised that a performance record is a function of economic and social opportunities in 
addition to genetic potential and physical environment (i.e., nutrition, economics and 
culture) (Williams & Folland, 2008). 
1.1.1 Genetics factors affecting performance 
A defining factor affecting exercise performance is genetics (Hamilton, 2000; Scott et al., 
2009).  Undoubtedly, there are many interacting genes involved in exercise-related traits, 
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including sporting performance (Pitsiladis & Wang, 2011).  Nevertheless, there has been 
limited progress in determining genetic contribution to  fitness phenotypes due to few 
coordinated research efforts and the use primarily of the candidate gene approach 
(Pitsiladis & Wang, 2011).  For example, despite a growing number of candidate genes, 
only two nuclear candidate genes have been investigated in elite Kenyan runners, the ACE 
and ACTN3 genes (Scott et al., 2005; Yang et al., 2007).  It should be noted that East 
African middle and long distance runners are currently the dominant force in athletics.  
Notably, Scott et al. (Scott et al., 2009) compared DNA samples obtained from Kenyan 
athletes who compete either on a national or international level with samples obtained from 
the general Kenyan population.  The authors (Scott et al., 2009) found that the international 
level athletes showed a significantly different distribution of mtDNA haplogroups relative 
to control subjects (general Kenyan population) and national standard athletes.  The 
implication however, is that there is undiscovered potential for a further understanding of 
the capacity of endurance by researching the human genome extensively (Klissouras, 1971; 
Pitsiladis & Wang, 2011).  The genetic factor is also related to training (since realisation of 
genetic potential requires interaction with environmental stimuli, which in the case of 
athletic performance is training) (Myburgh, 2003).  This may also be corroborated by the 
aforementioned investigation (Williams & Folland, 2008), which attributes the success of 
East African endurance runners as likely to be the interplay of complex genetic factors and 
their surrounding environment (Williams & Folland, 2008).  Without the interaction 
between each genetic element and the environment, world-class performance will never be 
achieved (Myburgh, 2003; Williams & Folland, 2008).  Hence, the model of Myburgh et 
al. (2003) does not make genetic analysis the basis of elite endurance performance, as this 
would not be sufficient in assessing and distinguishing between elite and truly world-class 
athletes.  A multidisciplinary approach is necessary in order to obtain a clear understanding 
of the performance of athletes and the examination of other factors including biochemistry, 
molecular biology and physiology, must also be considered (Myburgh, 2003; Williams & 
Folland, 2008). 
1.1.2 Physiological factors affecting exercise performance 
To become an elite and/or world class athlete, it is necessary to have the correct physiology 
since there are key physiological factors which seem to be fundamental in order to win at 
the highest level.  For example, elite endurance performance is a complex, multi-factorial 
phenotype characterized by several physiological adaptations.  Firstly, high maximal 
oxygen uptake values (V̇O2max), defined as the highest rate at which oxygen can be taken 
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up and utilized by the body during severe exercise, are undoubtedly necessary for 
successful performance in elite endurance running (Bassett & Howley, 2000; Sjodin & 
Svedenhag, 1985).  For instance, to complete a 02:15:00 (h:min:s) marathon, a V̇O2max of 
about 60 mL·kg-1·min-1 must be maintained throughout the run.  Since the marathon is 
typically ran at about 80–85% of V̇O2max, the V̇O2max values needed for that 
performance would be 70.5-75 mL·kg-1·min-1 (Bassett & Howley, 2000).  Furthermore, 
running economy (RE) (i.e., the sub-maximal V̇O2 at a given running velocity) is also a 
major contributor for successful running (Bassett & Howley, 2000; Saunders, Pyne, 
Telford, & Hawley, 2004b).  Di Prampero et al. (1993) stated that a 5% increase in RE 
induced an approximately 3.8% increase in distance running performance (Di Prampero et 
al., 1993).  Early research comparing elite runners with V̇O2max values at 79 mL·kg-1·min-
1 with good distance runners (V̇O2max values at 69.2 mL·kg-1·min-1) indicated that elite 
runners had better RE than good runners.  When expressed as a percentage of V̇O2max, 
this difference in RE was magnified, with the elite runners working at a lower percentage 
of their V̇O2max (Saunders, Pyne, Telford, & Hawley, 2004).  The RE of athletes with 
similar V̇O2max values can vary up to 30% (Daniels, 1985).  The relationship between RE 
and performance is well documented.  However, data on the extent to which RE can 
improve with continued training are limited to a few case reports that have followed 
athletes over a number of years.  A study by Jones (Jones, 2006) reported a 15% 
improvement in RE in a longitudinal (over 7 years) laboratory physiological study 
conducted on Paula Radcliffe (the current women’s marathon world record holder), while 
no changes were observed in V̇O2max during the same period.  The study by Jones is also 
in agreement with the data extracted from Lance Armstrong (seven times Tour de France 
winner) (Coyle, 2005) whose muscular efficiency when cycling improved by 8% over a 7 
year period.  A case study of the American mile record holder Steve Scott (Conley, 
Krahenbuhl, Burkett, & Millar, 1984) is a further example of the relationship between RE 
and performance.  Conley, et al. (1984) reported that during a 6-month period of training, 
Scott improved his V̇O2max by 3.8% (74.4 to 77.2 mL·kg-1·min-1) with a greater 
improvement of 6.6% in RE (48.5 to 45.3 mL·kg-1·min-1) at a running velocity of 16 km·h-
1.  The combined improvement of an increased V̇O2max and a better RE reduced the 
relative intensity of running at 16 km·h-1 by 10.0% (65.1% to 58.6% of V̇O2max) and was 
associated with improved performance during this period (Conley, et al., 1984; Coyle, 
2007; Daniels, 1985; Saunders, et al., 2004).  Hence, it can be concluded that a high 
V̇O2max level is required for elite performance, but major improvements in RE, that may 
take years of training to achieve, may enable world-class performance.  Additionally, the 
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blood lactate thresholds (i.e., the lactate threshold, the anaerobic threshold, the onset of 
blood lactate accumulation and the individual anaerobic threshold) (Coyle et al., 1991), the 
relative exercise intensity (i.e., the fraction of V̇O2max used while running (%V̇O2max) 
(Kozlowski et al., 1985), and the histological factors (e.g., muscle capillarity and cross-
sectional area determinations), are all key physiological principles for successful 
endurance running/exercise performance.  
 
 
Figure 1.1 A multidisciplinary approach to research on elite athletes. Adapted from Myburgh 
(2003). 
 
1.1.3 Multi-disciplinary approach and limitations 
By way of explanation, it seems that several factors characterise the elite athlete and 
include: sustained effective training, a recovery program with effective nutritional support, 
a range of heritable and acquired characteristics, optimal competition strategies, while 
resistance to injury also appears to be important (Maughan, et al., 2004).  The preceding 
factors have been discussed in scientific literature and are all currently being applied to 
questions relating to exercise capacity and the adaptation to exercise.  However, the 
interactions between the aforementioned factors do not seem to be fully understood 
(Myburgh, 2003).  Additionally, the lack of well accepted guidelines is a further limitation 
in understanding the factors affecting exercise performance (in order to achieve world-
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class performance).  The equivocal outcomes of the established recommendations on well-
trained and elite athletes are due to two major limitations in the scientific research process.  
The first is the role of the commercial industry in scientific research process and the 
second one, concerns the design limitations of each study (e.g., the type and homogeneity 
of subjects, limited “real world” data).  The following sections will address each of these 
issues in sequence.   
1.2 The role of commercial industry in establishing 
guidelines  
The formulation of guidelines entails collection of all relevant evidence.  These pieces of 
evidence are then passed on to a group of experts who, through their knowledge and 
expertise, determine what needs to be done and the best way to do it (Moore, Derry, & 
Aldington, 2011).  However, in many instances, established guidelines are not widely 
accepted for a variety of reasons (Bellis, 2011; Noakes, 2007a; Taylor & Giles, 2005).  The 
aforementioned studies (Bellis, 2011; Noakes, 2007a; Taylor & Giles, 2005) expose two 
main concerns regarding established guidelines.  In general, it appears that many 
guidelines lack an adequate, scientifically proven evidence base and have not been 
properly evaluated in appropriately controlled and randomized trials.  This and the 
potential influence of commercial interests on scientific independence and objectivity seem 
to be limiting factors in establishing well accepted guidelines.  For instance, Taylor and 
Giles (Taylor & Giles, 2005) exposed close ties between scientists and manufacturers and 
the findings are surprising (Figure 1.2).  According to their study, more than one-third of 
authors who participate in the panels which publish the guidelines, declared financial links 
to affiliated pharmaceutical companies, with around 70% of panels being affected.  In one 
case, every member of the panel had received payment by the company responsible for the 
drug that was ultimately recommended.  Moreover, in the same survey (Taylor & Giles, 
2005) more than 200 guidelines from around the world which were deposited with the US 
National Guideline Clearinghouse in 2004, were studied.  Only 90 guidelines contained 
details concerning individual authors and their conflicts of interest, and of those, just 31 
were free of commercial industry influence.  These pieces of evidence above, clearly 
establish that guidelines should not be determined by individuals with financial conflicts of 
interest (Taylor & Giles, 2005).  According to Noakes (2007a) the concerns discussed 
above are clearly applicable to the prevailing drinking guidelines (Sawka et al., 2007) 
drawn up by the American College of Sports Medicine (ACSM) as advocated by the 
Gatorade Sports Science Institute (GSSI).  Gatorade and the GSSI are the only two 
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‘‘platinum’’ sponsors of the ACSM (Noakes, 2007a).  The ACSM drinking guidelines 
promote the double recommendation that sports drinks containing salt (and glucose) are 
more beneficial during exercise than water and that drinking ‘‘as much as tolerable’’ is the 
preferred option during exercise.  Both these conclusions favour the promotion of sports 
drinks, including Gatorade, over water for all who participate in physical activity (Noakes, 
2007a).  However the ACSM drinking guidelines contain no warnings of potential 
conflicts of interest, nor of receipt by either the ACSM or any of the authors of the 
guidelines, of financial or other ‘‘rewards’’ from the sports drinks industry. 
 
Figure 1.2 Conflicts of Interest.  In 685 disclosures examined in survey of authors of 
prescription guidelines.  Adapted from Taylor and Giles (2005). 
 
Pharmaceutical research is not the only area influenced by industry.  The other area of 
concern also influenced by the commercial industry, involves dietary supplements, which 
have become a popular item in the nutrition-related market.  A dietary supplement is a 
product taken by mouth that contains a "dietary ingredient" intended to supplement the 
diet.  The "dietary ingredients" in these products may include: vitamins, minerals, herbs or 
other botanicals, amino acids, and substances such as enzymes, organ tissues, glandulars, 
and metabolites.  Dietary supplements can also be extracts or concentrates, and can be 
found in a variety of forms such as tablets, capsules, soft-gels, gel-caps, liquids, or 
powders.  They may also come in the form of a bar, but in such a case, the information on 
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their label must not represent the product as a conventional food or a sole item of a meal or 
diet.  Whatever their form may be, the Dietary Supplement Health and Education Act 
(DSHEA) places dietary supplements into a special category under the general umbrella of 
"foods" not drugs, and requires that every supplement be labelled a dietary supplement 
(FDA, 2011).  
For decades, the Food and Drug Administration (FDA), an agency of the United States 
Department of Health and Human Services, has protected the public from mislabelled and 
unsafe products.  The FDA used to regulate the dietary supplements that contained only 
those essential nutrients listed in The Nutrition Labelling and Education Act of 1990.  The 
new law (DSHEA, 1994), amended the Federal Food, Drug and Cosmetic Act, creating a 
new regulatory framework for the safety and labelling of dietary supplements.  The 
DSHEA expanded the definition of dietary supplements so as to include other substances, 
not only essential nutrients.  Dietary supplements are no longer considered food additives, 
which makes them exempt from pre-screening or from any safety and efficacy studies 
before they are released to the public.  Unlike drug products that must be proven safe and 
effective for their intended use before being marketed, there are no provisions for FDA to 
“approve” dietary supplements for safety or effectiveness before they reach the consumer.  
Under DSHEA, it is the manufacturer who is responsible for determining that the dietary 
supplements manufactured or distributed are safe.  When the DSHEA was approved, the 
FDA lost its regulatory power.  According to industry data, the market for dietary 
supplements (vitamins, minerals, botanicals such as herbal products and other specialty 
products) in the USA was valued at $8.8 billion in 1994, then grew to $11.8 in 1997 
(Ahrendt, 2001; Nesheim, 1999) to more than $15.7 in 2000 (Giunta, Basile, & Tibuzzi, 
2010; Maughan, et al., 2004) and to $27 billion in 2009 (Figure 1.3) with more than 55600 
products on the market (Abdel-Rahman et al., 2011).  This growth has been attributed to a 
number of factors, including the DSHEA legislation of 1994, which made it easier to 
market dietary supplements with attractive properties, and the growth of the self-care 
movement (Giunta, Basile, & Tibuzzi, 2010).  Indeed, the media may have contributed to 
the increase in the use of dietary supplements by spreading the myth of “the ideal body” as 
a way of convincing potential consumers to buy sports enhancement products (Alves & 
Lima, 2009; Maughan, et al., 2004).  Notably, the global market for supplements in 2001 
was estimated at $46 billion (Maughan, et al., 2004) while more than 50% of the general 
population and more than 76% of athletes in the US use nutritional supplements (Ahrendt, 
2001).  Therefore it is imperative to make a connection between the marketing of 
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supplements by the commercial industry and their consumption by athletes.  As indicated 
previously, surveys show that the prevalence of supplement use is widespread among 
sportsmen and women, however only in few cases is the use of these products scientifically 
supported and some may even be harmful to the athlete (Maughan, et al., 2004).  With 
broader use of a wide variety of supplements, greater concerns have arisen regarding the 
safety and quality of these products, since many may not have any scientific basis 
(Ahrendt, 2001).  Some dietary supplement ingredients are unsafe for all consumers, while 
others should not be taken by certain segments of the population (e.g., children, elderly 
people) (Abdel-Rahman, et al., 2011).  Additionally, poor manufacturing practices can 
result in products being contaminated with toxins, metal, or pesticides and in products 
containing too little or too much of the key ingredients (Abdel-Rahman, et al., 2011; 
Giunta, et al., 2010). 
 
Figure 1.3 Sales of dietary supplements in USA 
 
Many supplements are often referred to as ergogenic aids; specifically substances that 
enhance energy production and provide athletes with a competitive advantage (Ahrendt, 
2001).  As described previously, the marketing of ergogenic supplements is an 
international, billion dollar business that targets athletes’ endeavour for excellence 
(ACSM, 2000).  A published survey on random supplement costs is presented in Table 1.1.  
In general, an athlete may choose to consume a supplement for a number of reasons: in 
order to prevent or to resolve a specific nutritional deficiency (Alves & Lima, 2009) 
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especially when requirements for a nutrient are increased by the existing exercise 
programme, in order to provide a more convenient form of nutrients in situations where 
everyday foods are not practical, in order to provide a direct ergogenic (performance - 
enhancing) effect, or because of the belief that every top athlete is consuming the 
supplement, and consequently the athlete cannot afford to miss out (Burke, Castell, & 
Stear, 2009; Maughan, et al., 2004).  
Table 1.1 Supplement costs based on a sampling of popular nutrition stores in January 2000 
for one month’s therapy at lowest usual dose. 
Product Cost ($) 
Creatine powder  26 





Protein powder (50 g daily) 85 
Antioxidant formulations 30 
Energizing/diet capsules 35 
Multivitamins 5 to 20 
*Note. DHEA, dehydroepiandrosteron. HMB, calcium beta-hydroxy beta-methylbutyrate. 
*Adapted from Ahrendt 2001. 
 
New products with ergogenic claims appear on the market almost daily.  The need to 
produce novel supplements induces the industry to market “cocktails” made up of mixed 
ingredients in an attempt to maximize the potential effect of the product making it more 
attractive to athletes (Green, Catlin, & Starcevic, 2001).  Although these new products 
claim to enhance sports performance, and are used by amateur and professional athletes 
(Ahrendt, 2001), many of them do not have the desired effect (Ahrendt, 2001).  Therefore, 
before deciding to use a supplement, athletes should always consider the issues of efficacy, 
safety and legality/ethical issues associated with the product (Burke, et al., 2009).  More 
specifically, athletes can evaluate these products by examining the following four factors;  
The method of action, the available research, the adverse effects, and the legality of the 
substance (Ahrendt, 2001).  According to Ahrendt et al. (2001) and Kreider et al. (2004) 
the following questions can help athletes determine whether a product should be taken or 
not: 1. What is the physiological basis or theory for this product’s action? 2. Are there any 
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scientific studies published in peer-reviewed journals that support or refute the claims 
made by the product? 3. Are there any side effects, especially any potentially serious 
adverse effects? 4. Is the product legal?  Based on the above criteria, nutritional 
supplements can be placed into the following categories: apparently effective; possibly 
effective; too early to tell; and apparently ineffective (Kreider et al., 2004).  Alternatively, 
the ACSM (ACSM, 2000) classifies dietary supplements into the following categories: 
those that perform as claimed; those that may perform as claimed but for which there is 
insufficient evidence of efficacy at this time; those that do not perform as claimed; and 
those which are dangerous, banned, or illegal, and consequently should not be used 
(ACSM, 2000).  In any case, it is obvious that not all supplements have the effects they 
claim to have and in most cases there is opportunity for further scientific research in order 
to evaluate the potential effectiveness of the supplements (Table 1.2).  Therefore, decisions 
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Table 1.2 Categorization of the Ergogenic Value of Performance Enhancement, Muscle 













• Weight gain powders • Low-calorie foods, MRPs and RTDs 
that help individuals maintain a 
hypocaloric diet 
• Water and sports drinks 
• Creatine • CHO 
• HMB (untrained individuals 
initiating training) 
• Creatine 
• Ephedra, caffeine, and salicin-
containing thermogenic supplements 
taken at recommended doses in 
appropriate populations (now banned 
by FDA) 
• Sodium phosphate 
 • Sodium bicarbonate 
 • Caffeine 
    
II. Possibly 
effective 
• Postexercise CHO and protein 
• High-fiber diets • Postexercise CHO/PRO 
• Calcium • Glutamine 
• BCAA • Phosphate • EAA 
• Essential amino acids (EAA) • Green tea extract • BCAA 
• Glutamine • Pyruvate/DHAP (at high doses) • HMB (trained subjects) 
• Protein  • Glycerol 
• HMB (trained subjects)  • Low doses of 
ephedrine/caffeine (now 
banned by FDA) 
    
III. Too early to 
tell 
• α-Ketoglutarate • Appetite suppressants and fat 
blockers (Gymnema sylvestre, 
chitosan) 
• Medium chain 
triglycerides 
• α-Ketoisocaproate (KIC) • Ribose 
• Ecdysterones 
• Thermogenics (synephrine, thyroid 
stimulators, cayenne pepper, black 
pepper, ginger root) 
 
• Growth hormone releasing 




• HMB (trained athletes) • Lipolytic nutrients (phosphatidyl 
choline, betaine, Coleus forskohlii, 7- 
keto DHEA) 
 




• Psychotropic Nutrients/Herbs  
• Zinc/magnesium aspartate (ZMA)   





• Chromium • CLA 
• High doses of 
ephedrine/caffeine 
• Conjugated linoleic acids 
(CLA) 
• HCA 
• Gamma oryzanol (ferulic acid) • L-Carnitine  
• Prohormones • Pyruvate (at low doses)  
• Tribulus terrestris • Herbal diuretics  
• Vanadyl sulfate (vanadium) • High doses of ephedrine/caffeine  
• Yohimbe (Yohimbine)     
*Note. Adapted from Kreider 2004.  
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While little scientific data is available to support the potential role of dietary supplements 
in training/performance enhancement a number of nutrients/dietary supplements have been 
confirmed to help in improving performance/recovery (Maughan, et al., 2004).  For 
example, the effects of amino acid supplementation on physical performance have been 
widely investigated, with some studies showing positive effects on strength (Crowe, 
Weatherson, & Bowden, 2006; Schena, Guerrini, Tregnaghi, & Kayser, 1992) and 
endurance performance (Blomstrand, Hassmen, Ekblom, & Newsholme, 1991), while 
other studies report no ergogenic effect (Madsen, MacLean, Kiens, & Christensen, 1996; 
Pitkanen et al., 2003; van Hall, Raaymakers, Saris, & Wagenmakers, 1995).  Despite 
conflicting results, amino acid supplementation amongst athletes is widespread (Ahrendt, 
2001; Maughan, et al., 2004), with most of them believing that exercise performance will 
be enhanced.  Given the lack of well-controlled studies on nutritional supplements 
conducted on well-trained subjects, opportunity for further research is available.  A good 
example is GAKIC; a specific combination of amino acids, namely glycine, arginine and 
α-ketoisocaproic acid (a breakdown product of leucine).  GAKIC is marketed as “the 
world’s first and only muscle fatigue toxic neutralizer” (GAKIC, 2010).  There are only 
two available scientific studies that have examined the effects of GAKIC supplementation 
on human performance during high intensity and short duration exercise (Buford & Koch, 
2004; Stevens, Godfrey, Kaminski, & Braith, 2000).  Both studies employed untrained 
individuals as subjects.  Although these are the only two studies that had examined the 
effects of GAKIC on exercise performance, both investigations showed ergogenic effects 
but not any clear mechanism(s), a fact that suggests that neither study is definitive.  Given 
the scientific limitations in the design of both existing studies (Buford & Koch, 2004; 
Stevens, et al., 2000) this commercial product could be categorized in the “too early to tell” 
class of supplements (Table 1.2) thus allowing for this potential sport enhancing aid to 
warrant further investigation.  
1.3 Properly evaluated and controlled studies in 
guidelines establishment  
1.3.1 Limited scientific evidence based data conducted on food 
and fluid intake on a homogeneous group of athletes 
The potential influence of commercial interests on scientific subjectivity is described in 
section 1.2.  The other consideration and possible source of conflict is the means by which 
proper guidelines are established do not serve conflicting objectives.  On examination there 
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are approximately 33600 scientific publications in Pub Med that include the term 
‘guidelines’ in the title, and almost 1000 with the addition of ‘evidence-based’.  However, 
when a guideline claims to be evidence-based it does not necessarily mean that it offers the 
correct advice (Moore, et al., 2011).  To expand the Pub Med search, keywords such as 
“world-class athletes”, “world-class performance”, “elite athletes’ nutrition”, “elite 
athletes’ hydration”, and “highly trained athletes” were used.  The literature found in the 
search included consensuses, editorials, original articles, and review articles written in 
English.  The search revealed a word combination of no more than 300 studies (i.e., highly 
trained athletes-346) while, a vast number of the titles were not directly related to the 
objectives of the current thesis.  For example, the majority of peer-reviewed articles cited 
in the guidelines did not investigate a homogeneous group of athletes (e.g., either well-
trained, or elite, or world-class), rendering their conclusions somewhat generalised for the 
current conundrum.  Therefore, studies examining “real world” data, which indicate what 
the best athletes eat and drink, are imperative in order to assess and possibly improve the 
applicability of the current recommendations for dietary intake. 
The American Dietetic Association, Dieticians of Canada, and the ACSM state that 
physical activity, athletic performance, and recovery from exercise are enhanced by 
optimal nutrition (Rodriguez, Di Marco, & Langley, 2009).  These organizations 
recommend appropriate selection of food and fluids, timing of intake, and supplement 
choices for optimal health and exercise performance (Rodriguez, et al., 2009).  
Furthermore, to maximize training effects and maintain body mass (BM) and health, 
athletes need to consume adequate energy during periods of high-intensity and/or long-
duration training.  Meeting energy needs should be a nutritional priority for optimum 
athletic performance (Rodriguez, et al., 2009).  Restricting energy intake (EI) or adopting 
severe weight loss practices, results in the elimination of one or more food groups from the 
diet or in the risk of micronutrient deficiencies due to consumption of high or low 
carbohydrate (CHO) diets of low micronutrient density.  Another consensus statement on 
Nutrition for athletics published by the International Association of Athletic Federations 
(IAAF) in 2007 states: “Well chosen foods will help athletes train hard, reduce risk of 
illness and injury, and achieve performance goals, regardless of the diversity of events, 
environments, nationality and level of competitors.” (IAAF, 2007).  Such consensus has 
emerged by taking into account over a century of diet/metabolic research where nutrition 
has been clearly documented to have beneficial effects on exercise performance.  It is 
evident that the foods chosen can make the difference between success and failure 
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(Maughan, et al., 2004).  This of course does not imply that a non-talented or non-
motivated athlete will become a champion, but signifies that a talented athlete may be 
prevented from making it to the top by following an inadequate diet (Maughan, et al., 
2004).  The athlete who wants to optimize exercise performance needs to follow correct 
nutrition and hydration practices, use supplements and ergogenic aids with care, and 
consume a variety of foods in adequate amounts (ACSM, 2000; Below, Mora-Rodriguez, 
Gonzalez-Alonso, & Coyle, 1995; Brooks & Mercier, 1994; Calders, Matthys, Derave, & 
Pannier, 1999; Coggan & Coyle, 1991; Jeukendrup, Brouns, Wagenmakers, & Saris, 
1997).  Thus, making considerate choices about the type, timing, and quantity of food to be 
consumed as well as considering the competition schedule, can all play a role in optimizing 
exercise performance. 
There is no doubt that what an athlete eats and drinks can affect health, body weight and 
composition, substrate availability during exercise, recovery time after exercise, and 
ultimately exercise performance (ACSM, 2000).  Nevertheless, the “real world” evidence 
data regarding the nutritional needs of world-class athletes for endurance running are 
limited.  Therefore, the establishment of specific nutritional recommendations requires 
further investigation.  The nutritional guidelines should be practical and direct in order to 
be followed correctly by athletes.  Hence, more research involving world-class athletes is 
required in order to improve existing guidelines.  Certainly, elite East African runners are 
an appropriate target group for investigating this area, as they are a major dominant force 
in endurance running (IAAF, 2007).  Therefore, the East African running phenomenon is 
unequivocal in the world’s competitive athletics.  It should be noted that there have been 
periods in history when other countries or groups of athletes have also had great success in 
distance running.  However, these were the accomplishments of individual athletes and do 
not constitute a general phenomenon as do East African runners.  Nevertheless, there are 
only five studies that have assessed the dietary practices of elite East African runners and 
all studies have involved Kenyan athletes (Christensen, Van Hall, & Hambraeus, 2002; 
Fudge et al., 2008; Fudge et al., 2006b; Mukeshi & Thairu, 1993; Onywera, Kiplamai, 
Boit, & Pitsiladis, 2004).  Since historically there has been very little cultural or biological 
exchange between Kenyans and Ethiopians (Scott et al., 2009), it is hypothesized that there 
may be distinct dietary habits adopted in the two countries.  Therefore, there is a need for 
novel data that can be obtained from some of the best athletes in Ethiopia in order to assess 
and possibly improve the applicability of the current recommendations to elite athletes, in 
particular endurance runners.  
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1.3.2 Concerning the transfer of data from lab to field and the 
establishment of reasonable debates  
A rationale for debate is data transference from laboratory-based investigations to the field 
setting (Saunders, Dugas, Tucker, Lambert, & Noakes, 2005).  The tremendous debate 
regarding the most effective fluid intake strategy for endurance athletes is a good example 
(Convertino et al., 1996; Noakes, 2001).  Based on laboratory experiments (Costill, 
Kammer, & Fisher, 1970; Gisolfi & Copping, 1974; Montain & Coyle, 1992) the ACSM 
(Convertino, et al., 1996) adopted the previous fluid replacement guidelines that advocate 
ingesting large amounts of fluid in order to prevent any weight loss during exercise.  In 
contrast to the aforementioned conclusion by the ACSM (Convertino, et al., 1996), 
Saunders et al. (2005) proposed that the three laboratory studies (Costill, et al., 1970; 
Gisolfi & Copping, 1974; Montain & Coyle, 1992) which report a relationship between 
increased levels of heat storage and dehydration, are performed in conditions of low wind-
speed which negatively affect the rate of heat loss in the previously mentioned studies.  
More specifically, convective and evaporative cooling was likely to be less than that 
encountered in outdoor competition.  Therefore, reduction in the heat dissipation potential 
is associated with convective and evaporative heat transfer coefficients (Cheuvront, Carter, 
Montain, Stephenson, & Sawka, 2004).  In general, Saunders et al. (2005) support that 
laboratory studies in cycling and running, which employ wind speeds that are substantially 
lower than an athlete’s estimated cycling or running speed should not be used as a basis for 
establishing fluid replacement guidelines, since they underestimate the body’s ability to 
adapt to mild dehydration and overestimate the beneficial effects of high rates of fluid 
ingestion (Saunders, et al., 2005).  For instance, Adams et al. (1992) found that the subjects 
studied had higher body temperatures (rectal and oesophageal) in wind-still conditions of 
0.75 km·h-1 compared to a facing wind velocity of 11.25 km·h-1; consequently the cooling 
rate may be different outdoor than in a laboratory.  In general, laboratory studies 
examining the biophysical consequences of hypo-hydration when working in a hot 
environment provide less airflow than what is naturally generated when running or cycling 
over ground (Saunders, et al., 2005).  Empirical observations support the notion of the 
failure of laboratory experiments to simulate “outdoor” conditions (for a review see 
reference (Cheuvront & Haymes, 2001a).  Consequently, data for establishing universal 
guidelines must be extracted from studies that are properly evaluated in appropriately 
controlled, randomized trials conducted under environmental and other conditions that 
match those found in ‘‘outdoor’’ exercise (Noakes, 2007a). 
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One of the most scientifically equivocal research areas is the “science of hydration”.  A 
further example is the lively debate concerning dehydration (i.e., the loss of body water or 
the process of reducing body water) and its effects on exercise performance (Sawka & 
Noakes, 2007).  Nevertheless, the recommended guidelines for specific fluid intake of the 
ASCM in 1987 are considered to be the prevailing ones (Binkley, Beckett, Casa, Kleiner, 
& Plummer, 2002; Convertino, et al., 1996; Montain, Latzka, & Sawka, 1999).  These 
guidelines are regularly revised and adjusted accordingly.  Analytically, fluid intake 
recommendations for long-distance events such as the marathon have changed 
substantially over the last half century.  During the first half of the twentieth century until 
the early 1970s, runners were typically advised to avoid ingesting fluid during competitive 
marathon running (Noakes, 2003b).  However, since the publication of the 1987 ACSM 
position stand on fluid intake, recommendations have typically advocated that all sweat 
loss during exercise should be replaced by drinking the maximum amounts that can be 
tolerated (Binkley, et al., 2002; Convertino, et al., 1996; Montain, et al., 1999).  More 
recently, the ACSM has replaced the 1996 Position Stand (Convertino, et al., 1996) with an 
updated version (Sawka, et al., 2007) that promotes drinking ad libitum (i.e., at one's 
pleasure) from 0.4 to 0.8 L·h-1 of fluid during exercise.  The most recent guideline advises 
the prevention of a weight loss of more than 2-3% BM due to dehydration, and 
recommends this specific range of fluid ingestion (i.e., 0.4 to 0.8 L·h-1) depending on BM 
and running speed (Sawka, et al., 2007).  The efficacy of proposing a specific fluid intake 
range during exercise has been investigated in a study that modelled parameters that 
influence sweating rate (Montain, Cheuvront, & Sawka, 2006).  Montain et al. (2006) 
estimated that this rate (i.e., 0.4 – 0.8 L·h-1) of fluid intake was sufficient to maintain BM 
loss within 3% and to prevent BM gain in 50 – 90 kg subjects running a marathon at 8.5 – 
15 km·h-1 in cool and warm ambient conditions (i.e., 18 ºC and 28 ºC, respectively).  
However, in their calculations, these authors did not consider the fluid requirements of 
elite marathon runners (Montain, et al., 2006), making the existing debate reasonable 
(Sawka & Noakes, 2007).  For example, maximum running speed calculated was 15 km·h-
1, whereas to win a major city marathon a male athlete must run faster than 19 km·h-1.  
Furthermore, the environmental temperatures (i.e., 18 ºC and 28 ºC) on the basis of which 
sweat rates and resultant BM loss were estimated do not adequately reflect the lower 
environmental temperatures typically experienced in most major city marathons 
(Cheuvront & Haymes, 2001b) or indeed the ambient conditions encountered when the 
fastest marathons are run (Fudge, Pitsiladis, Kingsmore, Noakes & Kayser, 2006a).  This 
observation is not unexpected given the laboratory results of (Galloway & Maughan, 1997) 
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that found the longest exercise duration at 10.5 ºC (93.5 ± 6.2 min) vs. 3.6 °C (81.4 ± 9.6 
min) vs. 20.6 °C (81.2 ± 5.7 min) vs. 30.5 ºC (51.6 ± 3.7 min).  The progress of the 
guidelines on hydration over the years is presented in Figure 1.4. 
 
Figure 1.4 The progress of the guidelines of hydration over the years. 
 
Athletes are advised to drink enough so as to ensure that they do not lose more than 2% of 
BM, based on the premise that BM loss greater than 2-3% impairs exercise performance 
(Sawka & Noakes, 2007).  Indeed, there are many studies supporting that correct fluid 
replacement practices are especially crucial in endurance events and water seems to be the 
most important nutritional ergogenic aid for athletes as a body water deficit in excess of 2-
3% BM marks the level of dehydration that can adversely affect performance (Cheuvront, 
Carter, & Sawka, 2003; Sawka, 1992).  Thus, adequate fluid intake before, during, and 
after exercise is important for health and optimal performance (Rodriguez, et al., 2009).  
Additionally, many other studies support that mental performance (Hancock & 
Vasmatzidis, 2003) as well as the subjective perception of the exercise difficulty (Montain 
& Coyle, 1992) are affected negatively by a body water deficit of more than 2-3% of BM.  
On the other hand, there is data to support that there is no real evidence that drinking more 
than ad libitum improves exercise performance regardless of the extent of the BM loss.  A 
meta-analysis of all laboratory studies of fluid ingestion during self-paced exercise 
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concludes that “exercise-induced dehydration does not alter cycling performance under 
“real world” or “outdoors” exercise conditions (Goulet, 2011).  Additionally, as far as 
hyperthermia is concerned; it seems unlikely to occur in prolonged competitive events held 
in mild environmental conditions, and that exercise intensity rather than the level of 
dehydration is probably the most important factor determining post-exercise rectal 
temperature (Noakes et al., 1988).  The lack of evidence on what the best endurance 
runners drink during running competition seems to be a major limitation in establishing the 
guidelines since currently there exist limited data on the drinking behaviours of the fastest 
marathon runners during competition (Cheuvront & Haymes, 2001b; Van Rooyen, Hew-
Butler, & Noakes, 2010; Zouhal, et al., 2010).  If these data concerning drinking 
behaviours of the best endurance runners during running competition existed, this would 
allow for the adequacy of current fluid intake recommendations (Sawka & Noakes, 2007) 
to be assessed. 
1.4 Hydration in hot and humid environment: An example 
of bringing together “real world” and guidelines 
It has been shown that athletes who lose the most BM during marathon and ultra-marathon 
races and ironman triathlons are usually the most successful (Cheuvront & Haymes, 
2001b; Muir, Percy-Robb, Davidson, Walsh, & Passmore, 1970; Pugh, Corbett, & 
Johnson, 1967; Sharwood, Collins, Goedecke, Wilson, & Noakes, 2004; Wharam et al., 
2006; Wyndham & Strydom, 1969; Zouhal, et al., 2010; Zouhal et al., 2009).  However, 
the prevailing guidelines propose a water deficit of no more than 3% of BM in order to 
preserve cardiovascular and thermoregulatory function during exercise (Sawka, et al., 
2007).  This limit is often exceeded since the proposed recommendations for fluid 
consumption during a race (Sawka & Noakes, 2007) are not always practical for various 
reasons (e.g., difficulties of providing drinks during a race, athletes’ difficulty to drink 
while running), preventing the athlete from consuming the recommended amounts of 
fluids.  Additionally, sweat loss has been shown to be higher than fluid intake leading to 
dehydration.  Although, lively debate exists in the literature on whether dehydration 
negatively affects performance or not (Sawka & Noakes, 2007), the rationale for fluid 
ingestion during exercise seems the most appropriate practice so as to achieve the 
minimum water deficit (i.e., < 3%).  This level of dehydration seems to compromise 
cardiac output and the capacity of the cardiovascular system to transport metabolic heat to 
the body surface (Casa et al., 2000; Montain & Coyle, 1992) and to increase the risk of 
heat exhaustion during and immediately after activity (Montain & Coyle, 1993).  
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Therefore, maintaining hydration at less than a 3% of BM during exercise helps preserve 
heart rate (HR), stroke volume, cardiac output, skin blood flow, and normal core 
temperature (Tcore) (Armstrong et al., 1997).  Therefore given the fact that athletes do not 
consume enough liquids during a race, a better hydrating strategy prior to the race would 
potentially be more advantageous.  The implementation of a well regulated water loading 
strategy with the use of hydrating agents, prior to exercise, in order to expand the water 
compartments and consequently maintain cardiovascular and thermoregulatory responses 
is imperative.  In this way, the recommended guidelines could find practical application 
since one may argue that even the fastest marathon runners can improve their exercise 
performance achievement by following the guidelines. 
Hydrating agents such as glycerol (Gly; 1,2,3-propanetriol) and creatine (Cr) have shown 
to have significant hydrating effects, although the exact mechanisms remain to be 
elucidated.  Gly is a 3-carbon sugar alcohol that provides the backbone of triglycerides and 
is naturally found in foods as a component of dietary fats.  When consumed simultaneously 
with a substantial volume of fluid, there is a temporary retention of this fluid and 
expansion of body fluid compartments.  Rosendal et al. (2010) have recently reviewed the 
literature regarding Gly use.  Effective protocols for gly hyper-hydration are 1–1.5 g·kg-1 
BM with an intake of 1.4 - 2.0 L of fluid 2.5 - 4 h before exercise (Anderson, Cotter, 
Garnham, Casley, & Febbraio, 2001; Lyons, Riedesel, Meuli, & Chick, 1990).  Such a 
protocol typically achieves a fluid expansion or retention of approximately 400–800 mL 
(Kern, Podewils, Vukovich, & M.J., 2001; Magal et al., 2003; Riedesel, Allen, Peake, & 
Al-Qattan, 1987; Volek et al., 2001) above a matched fluid dose via a reduction in urinary 
volume (Poortmans, Rawson, Burke, Stear, & Castell, 2011).  This results in reduced 
thermal and cardiovascular strain during exercise in the heat (Easton, Turner, & Pitsiladis, 
2007).  It should be noted that Gly properties are also related to plasma expansion (Murray, 
Eddy, Paul, Seifert, & Halaby, 1991; van Rosendal, Osborne, Fassett, & Coombes, 2010).  
For this reason, the World Anti-Doping Agency (WADA) has added Gly to the group of 
‘masking agents’ in the 2010 Prohibited List (WADA, 2010).  However, the scientific 
basis of the inclusion of Gly as a ‘masking agent’ remains to be conclusively determined as 
several published studies have indicated that no changes in haemoglobin (Hb), 
haematocrite (Hct) or serum electrolyte concentrations are elicited by Gly ingestion 
(Lyons, et al., 1990).   
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Unlike the overall-body-hydrating effects of Gly, ingestion of 20 g·day-1 of Cr dissolved in 
500 mL of water for 7 days has been shown to be effective in retaining fluid predominantly 
in the intracellular fluid compartments (Easton, et al., 2007; Kern, et al., 2001; Kilduff et 
al., 2004) resulting in an increased specific heat capacity of the body (Kern, et al., 2001; 
Kilduff et al., 2004) and consequently attenuating the rise in HR and Tcore during exercise 
in the heat.  Easton et al. (2007) were the first to add Gly to a Cr containing solution and 
demonstrated a combination of the two hyper-hydrating agents has an additive effect, as 
the addition of Gly to Cr significantly increased total body water (TBW) more than Cr 
alone.  This novel water-loading strategy that combines Cr and Gly resulted in a mean 
TBW increase of approximately 0.9 ± 0.2 L, a significantly larger volume than either Cr or 
Gly alone.  In addition, the retained water was dispersed equally between the intracellular 
water (ICW) and extracellular water (ECW) compartments resulting in the reduction of 
cardiovascular and thermoregulatory responses during exercise.  Despite the physiological 
benefits accompanied by the TBW increase, this rise in the body water compartments leads 
to a subsequent rise in BM.  This, in turn, may have a negative impact on RE and thus on 
performance (Easton, et al., 2007).  As described in section 1.1, exercise performance is 
influenced by several factors such as RE which may be affected by BM which in turn is 
closely related to hydration status.  The more water in the body the higher the BM is.  
Presumably during running, the greater the BM is, the greater the oxygen demand of the 
skeletal muscle is since more weight has to be moved when running.  If this sequence 
holds true, hydration status may have an impact on performance.  Therefore, a need to 
investigate the effects of hyper-hydration induced by a combined Cr and Gly 
supplementation on RE measures should be investigated further.  
1.5 Aims and Objectives 
Given the potential role of the commercial industry and the limited properly evaluated and 
controlled data derived in “real world” conditions concerning the dietary (foods and 
liquids) recommendations and nutritional supplementation (as factors for optimal training 
and recovery) for elite athletes, the main objectives of the following research were: 
1. To compare data extracted from a well-controlled study to previous investigations that 
did not control for primary confounding factors that could have adversely affected the 
results.  This will be investigated by examining the effects of a nutritional supplementation 
(GAKIC) on fatigue during high-intensity, repeated cycle sprints in trained cyclists.   
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2. To examine the application of established guidelines for food and fluid intake on an elite 
group of endurance runners.  This will be achieved by assessing the food and 
macronutrient intake of elite Ethiopian distance runners during a period of high-intensity 
exercise training at altitude and prior to major competition.  The data will also be 
compared to previous studies conducted on East African runners. 
3. To describe the drinking behaviours of elite male marathon runners during major city 
marathons.  The results from the current study will allow direct comparison to established 
guidelines on optimal hydration during long distance running. 
4. To investigate the effects of a hyper-hydration strategy that combines Cr and Gly 
supplementation, on thermoregulatory responses in hot and cool conditions.  The data will 
allow examination of a possible method that will bring together the established guidelines 
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2.  Failure of Glycine-arginine-alpha-ketoisocaproic 
to improve high intensity exercise performance 
in trained cyclists 
 
2.1 Introduction 
The effects of amino acid supplementation on physical performance have been widely 
investigated with some studies showing positive effects on strength (Crowe, Weatherson, 
& Bowden, 2006; Schena, Guerrini, Tregnaghi, & Kayser, 1992) and endurance 
performance (Blomstrand, et al., 1991), while other studies report no ergogenic effect 
(Madsen, MacLean, Kiens, & Christensen, 1996; Pitkanen et al., 2003; Van Hall, 
Raaymakers, Saris, & Wagenmakers, 1995).  Despite conflicting results, amino acid 
supplementation amongst athletes is widespread (Ahrendt, 2001; Maughan, et al., 2004) in 
the belief that exercise performance will be enhanced.  Two studies have examined the 
effects of GAKIC on human performance during high intensity short duration exercise 
(Buford & Koch, 2004; Stevens, Godfrey, Kaminski, & Braith, 2000).  In the first study, 
Stevens, et al. (2000) measured peak torque and work values in the quadriceps femoris of 
13 subjects using a computer-controlled isokinetic dynamometer, over a 23-days interval.  
These authors (Stevens, et al., 2000) found that GAKIC supplementation increased muscle 
torque and work sustained during intense acute anaerobic dynamic exercise and increased 
overall muscle performance by delaying muscle fatigue during the early phases of 
anaerobic dynamic exercise.  A subsequent study by Buford & Koch (2004), appeared to 
support the previous findings (Stevens, et al., 2000).  In the latter study (Buford & Koch, 
2004) 10 men completed a randomized, double-blinded, placebo-controlled exercise 
protocol of two sessions separated by 7 days.  Subjects consumed either 11.2 g GAKIC or 
Pl during a 45-min period prior the exercise trials.  Mean power, peak power, and fatigue 
values were assessed from 5 supra-maximal, 10-s cycle ergometer sprints, separated by 1-
min rest intervals.  It was found, that GAKIC supplementation attenuated the decline in 
mean power output during repeated cycling sprints.  Both studies employed untrained 
individuals as subjects.  Although these are the only two studies to have examined the 
effects of GAKIC on exercise performance, both report ergogenic effects yet neither seem 
to provide a clear mechanism(s) by which the components of GAKIC act (individually or 
synergistically).  The amino acids making up GAKIC appear to be active in the metabolic 
pathways associated with the biosynthesis of Cr, protein, and nitric oxide (Campbell, La 
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Bounty, & Roberts, 2004; Minuskin, Lavine, Ulman, & Fisher, 1981; Nair, Schwartz, & 
Welle, 1992).  The effects of GAKIC may be to stabilize muscle pH and/or attenuate the 
rise in ammonia concentration (Greenstein, Birnbaum, Gullino, Otey, & Winitz, 1956) 
released from the purine nucleotide cycle (Meyer & Terjung, 1979; Terjung, Dudley, & 
Meyer, 1985) possibly through alterations in the enzymatic pathways of nitrogen 
metabolism (Jeevanandam, Ali, Holaday, Weis, & Petersen, 1993; Sitren & Fisher, 1977).  
As such, GAKIC could enhance high intensity exercise performance as ammonia 
accumulation has been implicated in fatigue (Wilkinson, Smeeton, & Watt, 2010).  GAKIC 
is marketed as “Muscle Fatigue Toxin Neutralizer” (GAKIC, 2010) and appears to render 
an ergogenic effect within minutes of consumption.  This presents an obvious advantage 
for GAKIC supplementation (Buford & Koch, 2004). 
Although previous research indicates GAKIC supplementation improves high intensity 
exercise performance (Buford & Koch, 2004; Stevens, et al., 2000), the paucity of data 
warrants further investigation.  Furthermore, both previous studies (Buford & Koch, 2004; 
Stevens, et al., 2000) used untrained subjects and failed to incorporate more than one 
baseline trial leaving the reliability of the data open to question.  The subjects in the study 
by Buford & Koch (2004) completed a modified Wingate test consisting of 5 sprints of 10 
s.  Although there were no statistical differences in peak power output following GAKIC 
supplementation, an increased power output was reported in the last of the 5 sprints.  
Conceivably, had the experiment been continued to include further sprints, an attenuation 
in the decline in peak power output may have been observed following GAKIC 
supplementation.  Therefore, the aim of this Chapter was to investigate the effects of 
GAKIC on fatigue during a series of 10 sprints in trained cyclists using near identical 
experimental design as the study by Buford & Koch (2004).  It was hypothesized that 
GAKIC supplementation would enhance peak power output and attenuate the decline in 
power output during repeated sprints in trained cyclists concurrent with previous research. 
2.2 Methods 
2.2.1 Subjects 
Ten trained male cyclists (age 33 ± 6 years, weight 72.4 ± 8.9 kg, height 176 ± 1 cm) gave 
their written informed consent to take part in the present study which was approved by the 
local Ethics Committee and was performed according to the code of ethics of the World 
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Medical Association (Declaration of Helsinki).  The sample size of the present study was 
in accordance with the subject numbers used in the two previous studies involving GAKIC 
(Buford & Koch (2004); Stevens, et al., 2001) as well as the majority of previous relevant 
studies (see Hopkins, Schabort, & Hawley, 2001 for review).  Subjects were in good health 
at the time of testing, trained almost daily and participated regularly in local and national 
races. 
The overall design was a randomized, cross-over scheme conducted in a double-blind 
fashion, with trained cyclists completing two performance trials consisting of 10 repeated 
supra-maximal sprints of 10 s.  All tests were conducted on an electrically braked cycle 
ergometer (Lode Excalibur, Lode BV, Groningen, The Netherlands) at standard room 
temperature (19 – 21 oC) with one week separating each test.  Prior to these performance 
trials, familiarization trials were completed until the variability of peak power output was 
within 5% difference between the two consecutive trials.  No subject had to complete a 
third familiarization trial to achieve less than 5% variability in line with our previous 
experience of trained cyclists. Subsequently, all subjects completed two performance trials 
prior to which they ingested either GAKIC or placebo (Pl) in a double-blinded crossover 
fashion and in accordance with previous studies (Buford & Koch, 2004; Stevens, et al., 
2000).  
2.2.2 Experimental Procedures 
Subjects reported to the laboratory on the day of testing following a 3 h fast and having 
refrained from alcohol and strenuous exercise the day before.  Upon arrival at the 
laboratory, BM (Avery Weight-Tronix 3302, ABN, Birmingham, U.K.) and height (Invicta 
Plastics Ltd., Leicester, U.K.) were measured.  Additionally, a HR monitor (Polar Sports 
Tester, Polar Electro Oy, Kempele, Finland) was attached prior to each test. Subjects were 
also required to complete a 24-h dietary record and reproduce this diet the day prior to each 
trial in an attempt to standardize the diet in terms of total energy intake (TEI), 
macronutrient intake and quantity of specific amino acids (glycine, arginine and leucine).  
Each subject ingested either 11.2 g of commercially available GAKIC (2.0 g glycine, 6.0 g 
L-arginine monohydrochloride, 3.2 g α-ketoisocaproic acid calcium salt; Iovate Health 
Sciences Research Inc., Mississauga, ON, Canada) or Pl (9.46 g sucrose, 3.2 g calcium 
carbonate) prior to the experimental performance trials.  No attempt was made to verify the 
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presence of the active ingredients.  Supplements were dissolved in 450 mL of sugar free 
fruit juice and subjects were required to wear a nose clip to prevent differentiating between 
beverages as GAKIC has a distinguishable and fairly unpleasant odor.  It was confirmed 
via a simple discussion at the end of each experiment that subjects were not able to identify 
any differences between the treatments.  The supplement was divided into 3 equal aliquots 
of 150 mL and ingested 45, 30 and 10 min prior to exercise.  Timing of ingestion and 
supplementation dosage was in line with those used in the two previous studies (Buford & 
Koch, 2004; Stevens, et al., 2000).  After ingestion of the third and final beverage, subjects 
commenced a warm-up consisting of 5 min of cycling at 100-150 W, followed by a 
familiarization sprint of 5 s.  The warm-up also consisted of stretching exercises depending 
on each individual.  Subsequently, subjects performed a series of ten, maximal effort 10 s 
sprints, each separated by a 50 s rest interval.  Each sprint was a modified 10 s Wingate 
test performed using a resistance of 0.8 N.kg-1.  Power output was analysed using standard 
computer software (Version 1, Lode BV, Groningen, The Netherlands).  This analysis 
enabled calculation of both 10 s mean power (the average power output during each 10 s 
sprint) and peak power output (the highest power during each sprint).  Furthermore, the 
fatigue index was determined as follows: fatigue index % = [(peak power – minimum 
power)/peak power] x 100 where the minimum power is the lowest power output after the 
subject achieved peak power output.  After the 10 sprints, subjects were instructed to 
continue pedalling for at least 6-7 min to allow recovery to occur.  HR was recorded (Polar 
Sports Tester, Polar Electro Oy, Kempele, Finland) and ratings of perceived exertion 
(RPE) determined using the Borg category scale (Borg, 1982) at the end of each sprint. 
Illustrations of the lab work are presented in Figure 2.1.  
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Figure 2.1 Illustration of the lab work data collection. 
 
2.2.4 Data analysis 
All data are expressed as the mean  SD.  Following a test for the normality of distribution 
all repeated measures data (i.e., peak power, mean power, minimum power, fatigue index, 
HR, and RPE were compared between the two treatments using a two-way repeated 
measures analysis of variance (ANOVA).  Other comparisons (i.e., total energy and 
macronutrient) were compared using students paired t-test.  Statistical significance was set 
at P < 0.05.  All statistical analysis was completed using the software package SPSS, 
version 11.0 (SPSS, Inc., Chicago, IL, USA).   
2.3 Results 
There were no significant differences in either macronutrient or micronutrient intake prior 
to either GAKIC or Pl trials.  Detailed diet analysis is presented in Table 2.1.  No 
significant differences were observed between GAKIC and Pl treatments in any of the 
measured performance variables.  Peak power (Figure 2.2) declined from the 1st sprint (Pl: 
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1332  307 W, GAKIC: 1367  342 W) to the 10th sprint (Pl: 1091  229 W, GAKIC: 
1061  272 W) and did not differ significantly between conditions (P = 0.88).  Mean 
power (Figure 2.3) declined from the 1st sprint (Pl: 892  151 W, GAKIC: 892  153 W) to 
the 10th sprint (Pl: 766  120 W, GAKIC: 752  138 W) and did not differ between 
conditions (P=0.96); the average coefficient of variation (C.V.) for the 10 sprints taking 
into account both trials was 2.1% and 2.2% for peak and mean power output, respectively 
(calculated as indicated in Hopkins, et al., 2001).  In general, the fatigue index (Figure 2.4) 














Figure 2.2 Peak power outputs over ten repeated cycling sprints with GAKIC and Pl 
treatments (N = 10, mean ± SD). 
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Figure 2.3 Mean power outputs over ten repeated cycling sprints with GAKIC and Pl 
treatments (N = 10, mean ± SD). 
 
 
Figure 2.4 Fatigue index over ten repeated cycling sprints with GAKIC and Pl treatments (N 
= 10, mean ± SD). 
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Table 2.1 Comparison of Total Energy Intake, Macronutrients and Specific Amino Acids 
(mean ± SD). 
Variable GAKIC Placebo P 
Energy (KJ) 11246 ± 3084 10629 ± 3808 0.5 
CHO (g) 392 ± 110 406 ± 143 0.7 
Protein (g) 98 ± 38 90 ± 39 0.3 
Fat (g) 86 ± 44 66 ± 44 0.6 
Arginine (mg) 1727 ± 1158 1400 ± 585 0.3 
Leucine (mg) 2358 ± 1755 2496 ± 1602 0.8 
Glycine (mg) 1393 ± 925 1360 ± 1023 0.9 
 
The RPE increased from the 1st sprint (Pl: 13  3, GAKIC: 13  3) to the 10th sprint (Pl: 19 
 1, GAKIC: 20  1) and did not differ between treatments (P = 0.11).  Additionally, HR 
increased from the first 1st (Pl: 151  10, GAKIC 152   12 beats·min-1) to the 10th sprint 
(Pl: 166  11, GAKIC: 164  12 beats·min-1) and did not differ between conditions (P = 
0.83). 
2.3.1 Side Effects 
Generally, all subjects tolerated the supplementation protocol well, with no reports of 
gastrointestinal distress.  
2.4 Discussion 
The findings of the present study suggest that GAKIC supplementation does not have an 
ergogenic effect on muscle power output or attenuation of fatigue during repeated sprints 
in trained cyclists when administrated during a 45-min period prior the exercise.  These 
results are in contrast to our initial hypothesis developed from previous literature which 
suggested that supplementation with GAKIC would enhance peak power output and 
attenuate the decline in power output during repeated high intensity sprints.  In the present 
Chapter 2. Failure of Glycine-arginine-alpha-ketoisocaproic to improve high intensity exercise 




© Lukas Y. Beis (2012) 
study (Chapter 2), GAKIC had no effect on peak power, mean power, minimum power or 
fatigue index.  Additionally, no differences were found in HR or RPE between the two 
experimental conditions.  
The data reported in the present study contradicts both previous performance studies where 
GAKIC was found to attenuate the decline in power output, improve muscle performance 
(Buford & Koch, 2004) and delay muscle fatigue resulting in improving total work 
(Stevens, et al., 2000) during high intensity exercise.  In the initial study, (Stevens, et al., 
2000), demonstrated that GAKIC supplementation increased muscle force production by 
up to 28%, increased total muscle work by at least 12% and improved overall performance 
compared to Pl.  The high intensity experimental protocol of Stevens, et al., (2000), 
consisted of 35 maximal, isokinetic repetitions at a rate of 90°·s-1 knee extensions.  In the 
later study, Buford & Koch (2004) reported a significant difference in mean power output 
during high intensity exercise consisting of 5 repeated sprints of 10 s on a cycle ergometer.  
On the other hand, a more recent study (Yarrow, Parr, White, Borsa, & Stevens, 2007), 
failed to find any ergogenic effect during moderate or high intensity exercise when the -α-
ketoisocaproic acid (KIC) component of GAKIC was examined in isolation. 
In both previous studies (Buford & Koch, 2004; Stevens, et al., 2000), it was hypothesised 
that the specific combination of amino- and keto-acids contained in GAKIC could work 
synergistically to improve high intensity exercise performance through their relevant 
metabolic pathway(s).  In theory this hypothesis could be proposed as the individual 
components of GAKIC have been shown to contribute to the detoxification of ammonia 
(Greenstein, et al., 1956; Meneguello, Mendonca, Lancha, & Costa Rosa, 2003) which is 
released from the purine nucleotide cycle (Meyer & Terjung, 1979; Terjung, et al., 1985) 
during high intensity exercise or from the catabolism of protein and deamination of amino 
acids (Sitren & Fisher, 1977; van Hall, van der Vusse, Soderlund, & Wagenmakers, 1995).  
The detoxification of ammonia could theoretically enhance high intensity exercise 
performance as ammonia accumulation has been shown to be linked to muscular fatigue 
(Wilkinson et al., 2010), although the precise mechanisms remain to be determined.  
However, when the effect of each GAKIC component on exercise performance was 
examined (Bower et al., 1995; Daly et al., 1988; Jeevanandam, et al., 1993; Nair, et al., 
1992; Weimann et al., 1998) there was little evidence to support an ergogenic effect. 
Chapter 2. Failure of Glycine-arginine-alpha-ketoisocaproic to improve high intensity exercise 




© Lukas Y. Beis (2012) 
Arginine appears to be essential for human metabolism only under specific circumstances 
such us burns, trauma, cancer (Bower, et al., 1995; Daly, et al., 1988; Weimann, et al., 
1998) and other conditions of rapid growth apparently via the production of a number of 
hormones such as growth hormone (Besset, Bonardet, Rondouin, Descomps, & Passouant, 
1982).  However, the majority of studies using a variety of doses of L-arginine have failed 
to show any effect on altering nitric oxide production (Liu et al., 2009) or influencing 
hormone levels (e.g., growth hormone) or indeed exercise performance (Liu, et al., 2009; 
Marcell et al., 1999; McConell, Huynh, Lee-Young, Canny, & Wadley, 2006).  
Additionally, large doses of arginine have been shown to cause gastrointestinal discomfort 
(unpublished data cited in (Wagenmakers, 1999).  On the other hand, glycine has an active 
role in the formation of Cr phosphate (as one of the three amino acids involved in synthesis 
of Cr), which is the main source of energy during intense exercise, such as employed in the 
present study.  The synthesis of Cr from arginine and glycine is dependant on the 
formation of guanidinoacetate which is formed by the enzyme arginine:glycine amino-
transferase (AGAT) (Walker, 1979).  Excess Cr leads to downregulation of AGAT and in 
doing so inhibits the formation of guanidinoacetate (Stead, Au, Jacobs, Brosnan, & 
Brosnan, 2001).  Therefore, the rate limiting step in the formation of Cr is not the 
concentration of arginine but the formation of guanidinoacetate from AGAT (Campbell, et 
al., 2004).  Consequently, supplementation with arginine would not necessarily lead to a 
higher intramuscular Cr concentration.  Previous studies involving KIC or Leucine 
supplementation (individually or in conjunction with other amino acids such as the 
branched-chain amino acids) have also failed to find any effect on aerobic or indeed 
anaerobic performance (Madsen, et al., 1996; Pitkanen, et al., 2003; van Hall, Raaymakers, 
et al., 1995; Yarrow, et al., 2007).  Leucine supplementation seems ineffective in altering 
nitrogen balance (Sandstedt, Jorfeldt, & Larsson, 1992), protein degradation (Sandstedt, et 
al., 1992) or reducing the concentration of ammonia (MacLean, Graham, & Saltin, 1996; 
Madsen, et al., 1996).  Therefore, the underlying mechanism behind the performance 
enhancing effects of GAKIC supplementation reported in the two aforementioned studies 
(Buford & Koch, 2004; Stevens, et al., 2000) remains elusive.  
Alternatively and possibly most likely, the findings in the previous studies (Buford & 
Koch, 2004; Stevens, et al., 2000) could be due to the experimental design and 
methodology employed.  For example, (Stevens, et al., 2000), utilizing untrained subjects 
failed to include baseline trials to establish the repeatability of the performance trials.  It 
remains a distinct possibility that the differences in power output observed in the previous 
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studies (Buford & Koch, 2004; Stevens, et al., 2000) were due to a lack of reliability 
between performance trials, especially since non-trained subjects were utilized (Hopkins, 
et al., 2001; Coleman, Wiles, Nunn, & Smith, 2005; Hebestreit, Dunstheimer, Staschen, & 
Strassburg, 1999).  Although V̇O2max of the subjects presented in this Chapter was not 
measured, peak power output is an established good predictor of V̇O2max (Hawley & 
Noakes, 1992).  As such, peak power output of the first sprint in the present study was 
1297  263 W for the Pl trial and 1353  283 W for the GAKIC trial as compared to 
approximately 750 W in the study by Buford & Koch (2004) reflecting the clear difference 
is training status of the subjects between studies.  Therefore, there are several possible 
explanations for the difference in reliability between athletes (used in the present study) 
and non-athletes (used in the previous studies by Stevens, et al., 2001 and Buford, et al., 
2004).  Firstly, the frequent exposure to high-intensity exercise on an almost daily basis 
may eliminate performance variability (Hopkins, et al., 2001).  Secondly, physical 
conditioning during the course of a study should not change to the same extent in trained as 
in non-trained individuals.  Thirdly and possibly the most likely explanation is the custom 
to detail approach typically associated with trained cyclists (e.g., using customised cycling 
shoes and pedals, fixed cycling position etc.).  Finally, assuming a constant random error 
contributed by equipment or examiners, this error will have less impact on overall outcome 
when expressed as a percent of the higher power output of trained individuals (Hopkins, et 
al., 2001).  In the present study, variability in performance trials between familiarization 
trials was small (i.e., less than 5%) as would be expected from subjects who are well 
accustomed to the exercise protocols employed (Hopkins, et al., 2001; Coleman, et al., 
2005; Hebestreit, et al., 1999).  The more stringent methodology used in the present study 
ensured that a number of possible confounding factors were minimised.  However, it 
should be noted that no attempt was made to verify the presence of the supplement active 
ingredients which is clearly a limitation of the present study (Chapter 2).  Furthermore, the 
study design was not focussed on the null hypothesis and as a consequence it is lacking 
power to eliminate it.  Future studies should be designed to ensure that the null hypothesis 
can be rejected with confidence. 
2.5 Conclusion 
The data presented in this Chapter do not support the findings of previous studies (Buford 
& Koch, 2004; Stevens, et al., 2000) that GAKIC supplementation will enhance high 
intensity exercise performance.  After controlling for all possible confounding factors that 
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could have adversely affected the results, GAKIC supplementation had no effect on peak 
power, mean power or fatigue index.  On the basis of this finding and those of previous 
studies involving the individual components of GAKIC, there appears little evidence to 
support the ergogenic effects of GAKIC during high intensity exercise performance when 
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The IAAF Consensus Statement on Nutrition for athletics published in 2007 states: “Well 
chosen foods will help athletes train hard, reduce risk of illness and injury, and achieve 
performance goals, regardless of the diversity of events, environments, nationality and 
level of competitors.” (IAAF, 2007).  Specific nutritional recommendations for optimal 
performance, particularly for endurance athletes, include a daily CHO intake ranging from 6 
to 10 g·kg-1 BM considered essential for replacing liver and muscle glycogen stores 
(Rodriguez, et al., 2009).  A significant protein intake ranging between 1.2 to 1.7 g·kg-1 BM 
per day is required for optimal health and performance of endurance athletes (Rodriguez, et 
al., 2009).  Studies examining protein intake in athletes have shown an increased 
requirement for protein in endurance trained athletes (Friedman & Lemon, 1989; Gaine et 
al., 2006; Meredith, Zackin, Frontera, & Evans, 1989) as opposed to healthy adult males 
(i.e., 0.8 g·kg-1) due to increased amino acid oxidation during exercise and for growth and 
repair of muscle tissue (Genton, 2011).  Maintenance of normal body water during 
strenuous training and minimising the level of dehydration (i.e., preventing a BM loss of > 2-
3%) during endurance exercise achieved by consuming fluids at a rate of 0.4 to 0.8 L·h-1 ad 
libitum is now recommended (Sawka, et al., 2007).  More studies that employ truly world 
class athletes are required in order to assess and possibly improve the applicability of the 
current recommendations to elite athletes.  Therefore, there is an urgent need for novel data 
that can be obtained from some of the best athletes in the world.  
Ever since Abebe Bekele became the first black African gold medallist in winning the 
marathon at the Rome Olympics in 1960, scientists have tried to explain the phenomenal 
success of east African distance runners in international athletics (Fudge et al., 2008; 
Onywera, Kiplamai, Boit, & Pitsiladis, 2004; Scott, et al., 2009; Scott & Pitsiladis, 2007). 
Notably, middle- and long-distance runners from Ethiopia and Kenya hold over 90% of 
both all-time world records as well as the current top-10 positions in world event rankings 
(IAAF, 2008).  Possible explanations have been proposed including genetic factors 
(Hamilton, 2000; Scott et al., 2003), environmental conditions (Onywera, et al., 2004; 
Onywera, Scott, Boit, & Pitsiladis, 2006) and near optimal dietary practices (Christensen, 
Van Hall, & Hambraeus, 2002; Mukeshi & Thairu, 1993; Onywera, et al., 2004).  
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However, the east African running phenomenon still remains largely unexplained.  While a 
significant number of studies have investigated putative factors influencing the east 
African running phenomenon, only five studies have assessed the dietary practices of elite 
east African runners and all have involved Kenyan athletes (Christensen, et al., 2002; 
Fudge, et al., 2008; Fudge et al., 2006b; Mukeshi & Thairu, 1993; Onywera, et al., 2004).  
The first of these studies, Mukeshi and Thairu (Mukeshi & Thairu, 1993) estimated the EI of 
male, long distance Kenyan runners through a combination of questionnaires and direct 
observation.  Remarkably low EI (9790 kJ·day-1 on average) was reported, while the average 
CHO intake was 441 g (8.1 g·kg-1 BM per day) or 75% TEI.  However, in the subsequent 
studies (Christensen, et al., 2002; Fudge, et al., 2008; Fudge, et al., 2006b; Onywera, et al., 
2004), substantially higher estimates of EI were noted in comparison to the initial data.  For 
example, Christensen et al. (2002) reported an average EI of 13210 kJ·day-1, while the 
consumption of CHO was 476 g (8.7 g·kg-1 BM, 71 % of TEI).  Similarly, Onywera et al. 
(2004) reported an average EI of 12486 kJ·day-1 (CHO 607 g, 10.4 g/kg BM and 76.5% 
TEI), while estimated EI in two studies by Fudge and colleagues were 13241 kJ·day-1 (CHO 
552 g, 9.8 g·kg-1 BM and 71% TEI) (Fudge, et al., 2006b) and 12300 kJ·day-1 (CHO 580 g, 
9.8 g·kg-1 BM, 79% TEI) (Fudge, et al., 2008), respectively.  These dietary studies focused 
primarily on athletes from the Kalenjin tribe of Kenya; a fairly distinct Kenyan ethnic group 
living at high altitudes, noted for producing athletes of great endurance.  For example, the 
Kalenjin tribe has less than 0.1% of the world’s population, yet members of this tribe have 
achieved nearly 50 athletic Olympic medals.  
Ethiopian athletes boast a recent success record in international distance running second 
only to Kenya.  As is the case in Kenya, successful Ethiopian athletes come predominantly 
from one localized ethnic group in the Ethiopian region of Arsi (Scott, et al., 2003).  The 
Arsi region of Ethiopia is situated at high altitude and contains roughly 5% of the 
Ethiopian population whilst accounting for 14 of the 23 distance runners selected for the 
country’s 2008 Olympic team.  Historically there has been very little cultural exchange or 
indeed biological intermingling between Kenyans (Scott, et al., 2009) and Ethiopians, 
therefore very distinct dietary habits can be found in the two countries, even between tribes 
within each country.  Consequently and given the absence of dietary data for Ethiopian 
athletes, the main aim of the investigation presented in Chapter 3 was to assess the dietary 
practices of elite Ethiopian endurance runners to elite Kenyan athletes during an important 
training period, as well as to the current recommendations for endurance athletes.  This 
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investigation also aimed to provide a rare insight into the lifestyle and training practices of 
some of the most successful endurance runners in the world prior to major competitions. 
3.2 Methods 
3.2.1 Subjects 
Ten highly-trained (8 male, 2 female) Ethiopian distance runners gave their written 
informed consent to take part in the present study which was approved by the local ethics 
committee (Research Ethics Committee, Department of Physical Education and Sport 
Science, Addis Ababa University, Addis Ababa, Ethiopia) and was performed according to 
the code of ethics of the World Medical Association (Declaration of Helsinki).  Subjects 
were highly trained (best marathon time: 2:13:55 ± 0:01:42; mean ± SD; Table 3.1) and in 
excellent condition (trained twice daily) while preparing for major competitions (e.g., 2008 
Beijing Olympic Games, 2008 Berlin marathon).  Athletes recruited were managed by 
Global Sports Communication (http://www.globalsportscommunication.nl/); arguably the 
most accomplished of all the track and field athlete management organizations specializing 
in middle- and long-distance running events.  Athletes living and training at the training 
camp under the management of Global Sports Communication all follow very similar 
training practices.  Athletes residing at the Global training camp included world record 
holders, medallists at major championships such as the Olympic Games, World 
Championships and major city marathons like the London Marathon.  The present study 
was conducted during the period when some of the athletes were preparing for the 2008 
Beijing Olympics.  The physical characteristics of the athletes included in the present study 
were measured according to the 2006 ISAK procedures (Marfell, 2006) and are presented 
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BM (kg) BT (M) BT (F)
1 23 1.72 58.7 58.7 0.0 0.0 2:12:00  
2 21 1.78 62.4 61.5 1.4 -0.9 2:12:00  
3 22 1.72 59.8 59.9 -0.1 0.1 2:13:15  
4(F) 19 1.75 57.3 57.4 -0.2 0.1  2:35:03
5(F) 19 1.61 48.8 48.3 1.0 -0.5        2:30:15
6 23 1.73 57.7 58.5 -1.4 0.8 2:15:15  
7 27 1.81 53.5 53.3 0.4 -0.2 2:14:10  
8 20 1.76 61.7 61.0 1.1 -0.7 2:12:35  
9 23 1.73 53.4 53.6 -0.4 0.2 2:15:45  
10 23 1.65 53.3 53.4 -0.2 0.1 2:16:17  
         
Average 22 1.73 56.7 56.6 0.2 -0.1 2:13:56  
SD 2 0.06 4.3 4.2 0.8 0.5 0:01:42  
 * Note: M, male; F, female; BM, body mass; BT, best marathon time.  
 
3.2.2. Experimental Procedures 
The dietary intake of the athletes was assessed in the month of July (ambient temperature: 
12 to 21 oC) during a period of intense training prior to major competition using 7-day 
weighed dietary records (Lissner, Heitmann, & Lindroos, 1998).  The dietary intake of the 
athletes was directly observed, weighted and recorded.  All athletes competed in endurance 
running events ranging from 10 km to the marathon and lived in a single training camp 
(Global Sports training camp Addis Ababa - Kotebe, 8° 58' 0 N, 38° 49' 60 E) which was 
based at high altitude (~2400 m above sea level).  During the 7 days, subjects followed 
their habitual eating/drinking pattern, as was confirmed by the manager/coach of the 
training camp.  Training was assessed using a training diary which included the type, 
intensity and duration of exercise training.  The training diary, in combination with direct 
observation, was used to estimate energy expenditure (EE) (Table 3.2).  Briefly, total EE 
was estimated from the duration and intensity of each activity, using physical activity 
ratios (PAR) (Ainsworth et al., 2000).  The energy cost was expressed as a multiple of 
basal metabolic rate (BMR).  In the current study, BMR was estimated using the Schofield 
equations (Schofield, 1985).  It should be noted that the training intensity and EE data has 
been generated in the present study using indirect methods (Ainsworth, et al., 2000).  
Nevertheless, the results of these indirect methods are reported in order for the results of 
the current study to be directly comparable to the data generated in previous studies using 
similar methods (Onywera, et al., 2004). 
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Table 3.2 Estimated daily energy expenditure according to Physical Activity Ratio. 
      Duration (h) Energy cost (PAR) 
    PARa MEAN SD MEAN  SD 
Sleeping 0.9 9.0 0.8 8.1 0.7 
Relaxingb 1.0 5.7 0.5 5.7 0.5 
Miscellaneous activityc  1.5 6.7 0.0 10.1 0.0 
Light exercised (home activities) 3.0 0.5 0.1 1.4 0.2 
Slow pace running 10.0 0.1 0.2 1.5 1.6 
Moderate pace running 14.0 0.9 0.3 13.1 3.7 
Fast pace running 18.0 0.7 0.2 12.2 4.0 
Total  24 0.6 52.1 3.3 
*Note: SD, standard deviation; aPhysical activity ratio (PAR) is the energy expenditure expressed in relation to basal 
metabolic rate (BMR) (i.e., BMR × 1.0); bWatching TV, sitting quietly; cEating, socializing; dHome activities. 
 
 
The subjects weighed and recorded all food and drink consumed using individual kitchen 
weighing scales accurate to 1 g (Salter Housewares LTD, England).  All food was weighed 
before and after cooking.  The cooking method was also described and recorded.  Athletes 
self-selected their portion sizes from the food provided ad libitum.  The remaining food 
(leftover) was also weighed and deducted from the initial weight of portion. The 
participants were also required to use the weighing scales when they were away from the 
training camp and to disclose any extra food intake during the hours when direct 
observation was not possible.  Details on how to report food and fluids consumed were 
given to each subject in English and in their local dialect (i.e., Oromo or Amharic).  Total 
water intake was assessed by combining the reported dietary intake of water with the 
estimated metabolic water value as previously described and conducted in elite Kenyan 
athletes (Fudge, et al., 2008; Fudge, et al., 2006b).  Metabolic water was determined by 
multiplying the measured EE by the fraction of energy in the diet obtained from CHO, 
protein and fat (data derived from the 7-day nutritional records).  This value was then 
multiplied by water obtained from CHO, protein and fat oxidation (0.60, 0.41 and 1.07 mL 
water·g-1, respectively) (Fjeld, Brown, & Schoeller, 1988).  To improve the quality of the 
collected data and to avoid any problems or under reporting of food or fluids consumed, 
one of the researchers resided at the camp for the entire assessment/observational period.  
Meals were prepared whilst athletes trained and served at the same times every day: 
Breakfast was at 09:30, after the morning training session, lunch at 13:30 and dinner at 
19:30.  On some occasions, athletes also had an afternoon snack which was served at 
16:00.  Nude BM was measured on the first day of the assessment period (as well as for 
two days prior to the start of the assessment period to ensure a representative baseline) and 
at the end of the 7-day period, before the consumption of any food or drink.  The weighed 
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dietary intake data were used to determine EI and diet composition using a computerised 
version of the food composition tables of McCance and Widdowson as revised by Holland 
et al. (1991).  However, for foods more specifically consumed by Ethiopians, food tables 
published by the Ethiopian Ministry of Health of Ethiopia were used (Ethiopian Health and 
Nutrition Research Institute, 1998).  No samples were retained for further analysis due to 
local regulations.  Food labels were also collected where possible, mainly for imported 
foods.  Illustrations of the lab work are presented in Figure 3.1. 
 
Figure 3.1 Illustrations of the field work data collection. 
 
3.2.3 Data Analysis 
Data were expressed as the mean ± SD, as appropriate following a test for the normality of 
distribution.  Paired t-tests were used to compare EI vs. EE and starting BM vs. final BM. 
Statistical significance was declared when P <0.05.  All statistical analysis was completed 
using the software package SPSS, version 15.0 (SPSS, Inc., Chicago, IL, USA). 
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3.3 Results 
Training typically consisted of two sessions per day.  The morning run (normally at 07.00) 
took place before breakfast and included a session at moderate or fast pace (16-20 km·h-1) 
for 10 to 20 km depending on the instructions given by the coach and/or weather 
conditions.  The afternoon session, prior to dinner (17.00), was typically an easy run over 6 
to 10 km at a slower pace (10-15 km·h-1), unless morning weather conditions had been 
adverse.  If this was the case, athletes reversed their sessions.  Warming up periods were 
15 min and cooling down periods were more than 20 min. Warm up and cool down 
consisted of standard stretching exercises and athletes carried out most of their sessions as 
a group.  In some instances, some athletes trained alone.  Athletes completed high intensity 
interval training sessions 2-3 times per week and one 20-25 km run at near race speed for 
each athlete.  Recovery time between training sessions was spent at the camp sleeping, 
eating, socialising, watching television or washing their clothes.  Some athletes went home 
on weekends and completed individual training runs as advised by their coach/manager.  
The EE of the athletes as estimated using PAR is shown in Table 3.2. 
Estimated EI over the 7-day assessment period (13375 ± 1378 kJ) was matched by 
estimated EE (13670 ± 862 kJ; P = 0.69).  BMR was estimated at 6292 ± 565 kJ·day-1.  
The BM remained stable over the 3 days prior the assessment period (pre: 56.6 ± 4.1 kg vs. 
post: 56.7 ± 4.3 kg; P = 0.58).  The athletes’ BM (pre: 56.7 ± 4.3 kg vs. post: 56.6 ± 4.2 
kg; P = 0.54) remained stable over the 7 days (Table 3.1).  The diet consisted mainly of 
vegetable sources (approximately 88%) with only a small portion of meat (approximately 
12%; Table 3.3). Breakfast consisted typically of milk, porridge, omelette and bread.  
Lunch comprised mainly of vegetable sources such as pasta, rice and lentils, while meat 
was served only twice a week and dinner was similar to lunch.  Food portions were chosen 
by the subjects themselves (i.e., ad libitum), as no advice or guidelines were given.  
Furthermore, two of the athletes consumed commercially available nutritional supplements 
(i.e., 100 g of the supplement consisted of 95.1 g CHO of which sugars 59.7 g, L-
Glutamine 250 mg, L-Leucine 110 g, L-Valine 100 g, L-Isoleucine 70 mg, and Sodium 0.9 
g).  As for fluid intake, subjects consumed water with modest amounts of tea, milk, orange 
juice and a local drink called Besso, a mixture of barley and water.  The diet was high in 
CHO intake (64.3 ± 2.6% TEI, 545 ± 49 g, 9.7 ± 0.9 g·kg-1 BM per day (Figure 3.2, Figure 
3.3).  The fat intake of the diet was 23.3 ± 2.1% TEI and 83 ± 14 g daily (Figure 3.2, 
Figure 3.3).  Protein intake was 12.4 ± 0.6% TEI, 1.8 ± 0.2 g·kg-1 and 99 ± 13 g per day 
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(Figure 3.2, Figure 3.3) of which 76% was derived from vegetable sources (Table 3.3).  
Daily fluid intake consisted mainly of water (1751 ± 583 mL·day-1; 55.4% of the total 
water intake), while the athletes did not consume any fluids before or during their training 
sessions.  Other sources of daily fluid intake were water consumed as moisture in food 
(950 ± 60 mL; 29.9%) and metabolic water produced as a result of the oxidation of CHO, 
protein, and fat (470 ± 28 mL; 14.8%) which resulted in a mean total daily fluid intake of 
3.2 ±0.6 L·day-1.  
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Porridge 4.5 5.5 2.1 3.0 
Bread 15.2 18.7 4.7 17.5 
Pasta 10.0 12.0 3.1 13.4 
Rice 5.0 6.5 1.8 2.8 
Injera 20.8 27.3 4.8 16.5 
Meat 5.3 0.1 16.1 11.9 
Lentils 2.4 1.8 3.6 3.5 
Sugara 3.5 5.4 0.0 0.0 
Eggs 1.5 0.1 3.9 4.0 
Milk 1.3 0.6 3.1 2.1 
Vegetable Oil 10.2 0.0 43.5 0.0 
Chick Peas 1.0 0.9 0.6 1.9 
Shiro 2.1 1.5 2.4 4.7 
Total 83 85 90 84 
Otherb 17 15 10 16 
     
Animal source 12 1 27 24 
Vegetable source 88 99 73 76 
     
Mean  3194 545 83 99 
SD 329 49 14 13 




The findings of the study present in Chapter 3 indicate that Ethiopian endurance runners 
whilst meeting dietary recommendations for endurance athletes for macronutrient intake 
did not do likewise as far as fluid intake was concerned.  In the present study (Chapter 3), 
the dietary intake data were used to estimate the EI, while the EE and BM data were 
interpreted in the context of energy balance and in order to assess under eating.  Total 
average EI was 13375 ± 1378 kJ and is in agreement with previous studies (Christensen, et 
al., 2002; Fudge, et al., 2008; Fudge, et al., 2006b; Onywera, et al., 2004) (~ 12809 kJ·day-
1 on average).  In the first of these studies conducted in Kenyan athletes, Mukeshi and 
Thairu (Mukeshi & Thairu, 1993) estimated the EI of male, long distance Kenyan runners 
through a combination of questionnaires and direct observation and reported remarkably 
low EI (9790 kJ·day-1 on average).  However, in subsequent studies (Christensen, et al., 
2002; Fudge, et al., 2008; Fudge, et al., 2006b; Onywera, et al., 2004), substantially higher 
estimates of EI were reported in comparison to the initial data.  For example, Christensen 
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et al. (2002) reported an average EI of 13210 kJ·day-1. Similarly, Onywera et al. (2004) 
reported an average EI of 12486 kJ·day-1, while estimated EI in two studies by Fudge and 
colleagues were 13241 kJ·day-1 (Fudge, et al., 2006b) and 12300 kJ·day-1 (Fudge, et al., 
2008).  A finding common to most of the aforementioned studies was the lower EI 
compared to EE and therefore indicative of negative energy balance before major 
competition (Fudge, et al., 2006b; Onywera, et al., 2004).  It is well acknowledged that 
training at high altitude can impact negatively on energy balance (Westerterp-Plantenga, 
Rolland, Wilson, & Westerterp, 1999), most likely due to a reduction in EI brought about 
by a loss of appetite (Ward, 1995).  However, in contrast to previous studies in Kenyan 
runners (Fudge, et al., 2006b; Onywera, et al., 2004), Ethiopian runners recruited in this 
study met their energy needs (EI did not differ from EE) and consequently maintained their 
BM (pre assessment period BM: 56.7 ± 4.3 kg vs. post: 56.6 ± 4.2 kg).  This is consistent 
with recent guidelines by the ACSM that advocate that differences between EI and EE 
could compromise performance and negate the benefits of training (Rodriguez, et al., 
2009). 
 
Macronutrient intake of Ethiopian long distance runners fulfilled recent recommendations 
(Rodriguez, et al., 2009).  CHO intake was 64.3% TEI (9.7 g·kg-1 BM per day) and the 
daily CHO intake was 545 ± 49 g (Figure 3.2), while recommendations for male and 
female athletes range between 6 to 10 g·kg-1 BM per day (Rodriguez, et al., 2009).  These 
results are also in agreement with previous studies (Christensen, et al., 2002; Fudge, et al., 
2008; Fudge, et al., 2006b; Mukeshi & Thairu, 1993; Onywera, et al., 2004) when the daily 
amount of CHO was well above 65% of TEI, ranging from 8.1 to 10.4 g·kg-1 BM and 
within the current recommendations (Rodriguez, et al., 2009).  Protein intake was 12.4% of 
TEI (Figure 3.2) (1.76 g·kg-1 BM per day with a daily intake of 99 ± 13 g) of which 76% 
was delivered from vegetable sources (Table 3.3) and well within the current 
recommendations for endurance athletes (1.2 to 1.7 g·kg-1 BM per day) (Rodriguez, et al., 
2009). This is also in agreement with the literature (Christensen, et al., 2002; Fudge, et al., 
2008; Fudge, et al., 2006b; Onywera, et al., 2004) where daily protein intake ranged from 
1.3 to 2.2 g·kg-1 BM.  Adequate protein and fat intake are also vital for optimal health and 
performance of long distance runners.  Sufficient dietary protein will provide essential 
amino acids and maintain the nitrogen balance for building and repair of muscle tissue 
after intense endurance training (Rodriguez, et al., 2009).  Furthermore, having achieved 
the recommended amounts of CHO and protein, this would have resulted in a sufficiently 
high intake of fat to ensure an important source of fat soluble vitamins and essential fatty 
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acids (Coyle, Jeukendrup, Oseto, Hodgkinson, & Zderic, 2001; Rodriguez, et al., 2009).  
Hence, the fat intake of distance runners especially from developing countries should not 
be restricted further as there would be no performance benefit in consuming less fat than 
that observed in the current study (23.3% TEI).  Rodriguez et al. (2009) reported that there 
are no advantages in consuming a diet with less than 15% of energy from fat compared 
with 20 to 25% of TEI.  Although the values from the present study (23.3% TEI, Figure 
3.2) for fat intake are in agreement with the guidelines (Rodriguez, et al., 2009), they were 
somewhat higher in comparison to values (6.6 to 17.4% of TEI) observed in previous 
studies (Christensen, et al., 2002; Fudge, et al., 2008; Fudge, et al., 2006b; Mukeshi & 
Thairu, 1993; Onywera, et al., 2004).  Moreover, the fact that vegetable sources accounted 
for approximately 88% of TEI (Table 3.3) concurs with other published dietary studies for 
low income countries (Cerqueira, Fry, & Connor, 1979; Christensen, et al., 2002; Mukeshi 
& Thairu, 1993) and contrasts with that for developed countries (Burke, Gollan, & Read, 
1991; Grandjean, 1989; van Erp-Baart, Saris, Binkhorst, Vos, & Elvers, 1989).  For 
example, the CHO intake of elite distance runners in the United States (Grandjean, 1989), 
the Netherlands (van Erp-Baart, et al., 1989) and Australia (Burke, et al., 1991) was 49%, 
50% and 52% of TEI respectively, as a result of  a more varied diet.   
Optimizing fluid replenishment is fundamental during exercise.  Correct fluid replacement 
practices are especially crucial in endurance events lasting longer than an hour where the 
participating athlete might have not consumed adequate food or fluid before exercise or in 
cases where the athlete is exercising in an extreme environment (heat, cold, or high 
altitude) (Rodriguez, et al., 2009).  It is perhaps surprising that in the present study 
(Chapter 3), the Ethiopian endurance athletes taking part in prolonged intense exercise 
and/or extreme conditions, did not fulfil the current recommendations for fluid intake 
(Sawka, et al., 2007).  In fact, the athletes consumed approximately 1.75 L·day-1 of fluids 
which comprised mainly of water and athletes in general did not consume water before or 
during training; on some occasions small amounts of water was consumed following 
training.  This finding is in line with previous findings (Fudge, et al., 2008; Fudge, et al., 
2006b; Onywera, et al., 2004).  Onywera and colleagues (2004) reported a modest fluid 
consumption (2.3 L·day-1).  Additionally, similar fluid intake (1.8 L·day-1) was observed 
by Fudge et al. (2006) and in a subsequent study by the same group (2.3 L·day-1) (Fudge, 
et al., 2008).  These studies collectively show that these elite athletes do not consume any 
fluids before or during training, while modest amounts of fluids are consumed after 
training and only by a small number of runners (Fudge, et al., 2008; Fudge, et al., 2006b; 
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Onywera, et al., 2004).  According to current recommendations, the amounts of fluid 
consumed (as dietary water intake) in the present study would be inadequate to maintain 
athletes’ hydration status (Sawka, et al., 2007).  Nevertheless, when total water intake (i.e., 
dietary water intake and metabolic water) is considered, Ethiopian athletes are found to be 
well hydrated during the day due to the high quantity of water in their staple foods (e.g., 
injera).  Furthermore, although fluid consumption in the present study was less than 
recommended (Sawka, et al., 2007), the daily total ad libitum water intake (0.23 ± 0.04 
L·MJ-1) was consistent with guidelines from the US National Research Council (National 
Research Council, 1989).  These guidelines suggest 1 mL of water per kcal (0.24 L·MJ-1) 
of EE for adults under average conditions of EE and environmental exposure with the rare 
exception of instructing the consumption of 1.5 mL·kcal-1 (0.36 L·MJ-1) in cases of higher 
levels of physical activity, sweating and solute load.  Additionally, the total water intake in 
the current study (3.2 L) is in accordance with optimal kidney function and urine output 
maintenance at high altitude (i.e., 3–4 L·day-1) (Rodriguez, et al., 2009).  This is also in 
agreement with the existing literature (Fudge, et al., 2008; Fudge, et al., 2006b; Onywera, 
et al., 2004) where elite Kenyan distance runners maintained their hydration status due to 
the consumption of foods with a high quantity of water (e.g., ugali) (Onywera, et al., 
2004).  On the other hand, fluid intake recommendations as set by the ACSM guidelines 
indicate that athletes should consume 5-7 mL·kg-1 BM of fluids at least 4-h prior to the 
exercise session aiming to start the physical activity euhydrated with normal plasma 
electrolyte levels (Sawka, et al., 2007).  Nevertheless, evidence to support this 
recommendation is equivocal at this point.  It is important to note that mild dehydration 
may actually be an advantage as, theoretically, it will lower the energy cost of running at 
the same relative intensity (Armstrong, Costill, & Fink, 1985; Coyle, 2004).  
3.5 Conclusions 
As previously found in elite Kenyan endurance runners, elite Ethiopian runners met dietary 
recommendations for endurance athletes for macronutrient intake but not for fluid intake.  
Nevertheless, it remains unclear how these differences in dietary patterns with regard to 
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Fluid intake recommendations for endurance events such as the marathon have changed 
substantially over the last half century.  During the first half of the twentieth century until 
the early 1970s, runners were typically advised to avoid ingesting fluid during competitive 
marathon running (Noakes, 1993).  However, since the publication of the 1987 ACSM 
position stand on fluid intake, recommendations have typically advocated that all the sweat 
lost during exercise should be replaced by drinking the maximum amounts that can be 
tolerated (Binkley, et al., 2002; Convertino, et al., 1996; Montain, et al., 1999).  More 
recently, the ACSM has replaced the 1996 Position Stand (Convertino, et al., 1996) with an 
updated version (Sawka, et al., 2007) that promotes drinking ad libitum (i.e., at one's 
pleasure) from 0.4 to 0.8 L·h-1 of fluid during exercise with lower fluid volumes for slower 
and lighter individuals competing in cooler environments, and higher volumes for faster 
and larger individuals competing in warmer environments.  Athletes are also advised to 
drink enough to ensure that they do not lose more than 2-3% of BM, based on the premise 
that BM loss greater than 2% impairs exercise performance (Cheuvront & Haymes, 2001b; 
Coyle, 2004; Fudge, Pitsiladis, Kingsmore, Noakes, & Kayser, B. 2006; Sawka, et al., 
2007).  This advice also ensures that individuals do not gain BM since large increases in 
BM can cause hyponatraemia (i.e., serum sodium concentration <135 mmol·L-1) (Almond 
et al., 2005; Hew-Butler et al., 2008; Noakes et al., 2005). 
We have previously shown that drinking ad libitum maintained hydration status day - to - 
day in elite Kenyan endurance runners (Fudge, et al., 2008; Fudge, et al., 2006b; Onywera, 
et al., 2004).  The value of proposing specific fluid intake ranges during exercise has been 
investigated by modelling parameters that influence sweat rate (Montain, et al., 2006).  
Montain et al. (Montain, et al., 2006) estimated that a fluid intake rate of 0.4 - 0.8 L·h-1 
would maintain BM loss within 3% and prevent BM gain in 50 – 90 kg subjects running 
marathons at 8.5 – 15.0 km·h-1 in cool and warm ambient conditions (i.e., 18 ºC and 28 ºC, 
respectively).  The authors suggested that factors that influence sweat rate such as BM, 
running speed and ambient conditions should also be considered before the recommended 
fluid intake range is adopted and that individual variation needs to be appropriately 
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considered (Montain, et al., 2006).  However, the authors did not specifically consider the 
fluid requirements of elite marathon runners (Montain, et al., 2006).  For example, 
maximum running speed used in these calculations was only 15 km·h-1, whereas to win a 
major city marathon, a male athlete must generally run faster than 19 km·h-1.  Furthermore, 
the environmental temperatures (i.e., 18 ºC and 28 ºC) on the basis of which sweat rates 
and resultant BM loss were estimated in that analysis, do not adequately reflect the lower 
environmental temperatures typically experienced in many major city marathons 
(Cheuvront & Haymes, 2001b) or indeed the ambient conditions encountered when the 
world’s fastest marathons are run (Fudge, et al., 2006a).  For example, the top ten fastest 
marathons of all time (up to 2004) were performed at a mean ambient temperature of 7.3 
ºC (Fudge, et al., 2006a).  This observation is not unexpected given the strong evidence 
that exercise performance is strongly influenced by the prevailing environmental 
conditions (Galloway & Maughan, 1997). 
Currently there are limited data on the drinking behaviours of the fastest marathon runners 
during competition (Cheuvront & Haymes, 2001b; Van Rooyen, et al., 2010).  Therefore, 
in the present study, retrospective video analysis was used to determine the drinking 
behaviours of elite marathon runners competing in major city marathons.  Determining the 
drinking behaviours of successful elite runners also allowed us to assess (albeit indirectly) 
the efficacy of current fluid intake recommendations (Sawka, et al., 2007) for this group of 
elite athletes.  Furthermore, the sweat rates of 5 elite male distance runners (including 2 of 
the studied 10 marathon runners) were determined during training prior to the 2008 Beijing 
Olympic Games.  According to the current drinking guidelines, a fluid intake rate is 
considered adequate if BM loss in athletes adopting that rate remains between 0 and 2-3% 
for the duration of the race (Cheuvront & Haymes, 2001b; Coyle, 2004; Fudge, et al., 
2006a; Sawka, et al., 2007).  Therefore, the efficacy of current fluid intake 
recommendations (Sawka, et al., 2007) for elite marathon runners is described in the study 
present in Chapter 4 by documenting the fluid intake behaviours of the given population. 
 
4.2 Methods 
4.2.1 Subjects and Experimental Procedures 
A retrospective analysis of the drinking behaviours of 10 male athletes during 13 
successful city marathons was undertaken using available video footage.  Much of the 
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required footage was provided by the British Broadcasting Corporation.  Permission for the 
present investigation was given by the respective race organizers.  Elite runners 
participating in the laboratory/field studies gave their written informed consent to take part, 
approved by the local ethics committee and performed according to the code of ethics of 
the World Medical Association (Declaration of Helsinki).   
Data were collected from the Athens Olympic Marathon 2004 and the Beijing Olympic 
Marathon 2008 as well as for the following city marathon races: Berlin 2006, 2008 and 
2009, Chicago 2008 (1st and 2nd placed athletes), Dubai 2009, Fukuoka 2009, London 2006 
and 2007, New York 2008 and 2009 and Rotterdam 2010.  Only the winners of each race 
were targeted (unless otherwise stated), as the images were recorded from a motorcycle 
that followed the lead group(s).  This methodological constraint resulted in maximum 
possible camera coverage of the race winners.  Inevitably, however, there was no useful 
footage available for some drinking stations for various reasons such as the camera 
focusing on athletes others than those of interest.  The observed duration of fluid 
consumption was measured from the available video footage.  Where data from specific 
drinking tables was missing, the observed data for each athlete was extrapolated to provide 
information for the entire race (Table 4.1).  For example, 6 of the 8 (75%) drinking stations 
were observed in the video footage of the Berlin 2006 marathon, so the data from the 
analysed footage were extrapolated to 100% (Table 4.2).  Furthermore, the athletes 
competing in Beijing 2008, Chicago 2008, Chicago 2009 and New York marathons did not 
only use sport drink bottles (the maximal flow rates of which had been simulated in the 
laboratory), but they also used water bottles or cups from which flow rates are unknown.  
The percentage of the drinking episodes involving alternate container types is 
approximately 23%.  For the runners of this study we had to assume a single flow rate from 
all these fluid dispensers. The video footage was retrospectively analyzed using Virtual 
Dub 1.6.12 Software (Copyright© 1998 - 2005 by Avery Lee) as this software allowed 
viewing of each individual frame.  Drinking stations for elite runners were placed at or 
close to every 5 km of the course (as governing body regulations stipulate) and the time 
spent ingesting fluid (in seconds) was measured from the video images.  It was assumed 
that drinking time occurred when the drinking bottle was raised above 90 º (horizontal) 
whilst in contact with the runner’s lips.  The entire race was also monitored for any 
additional fluid that may have been ingested along the route (e.g., general water and sports 
drink stalls).  If there was no footage of the athlete of interest at a drinking station then an 
entry of no data (ND) was recorded.  Fluid intake (mL) for each athlete was estimated by 
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multiplying the total duration spent ingesting fluid by 45.2 as this was the average flow 
rate (mL.s-1) obtained from a purposely designed laboratory drinking simulation.  For this 
simulation experiment, the maximal flow rate (45.2 ± 13 mL.s-1) of a typical sports drink 
bottle was measured in 7 male volunteers who ingested as much fluid as possible within 3 
s.  This procedure was repeated 10 times whilst data were acquired from video footage 
which accurately measured the time taken to complete fluid ingestion.  This was the same 
method used to determine drinking time from the video footage of the marathon runners.  
The estimated fluid intake rate (i.e., L·h-1) was compared to the current fluid replacement 
recommendations (Sawka, et al., 2007) which suggest that athletes should drink 0.4 – 0.8 
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Table 4.1 The temperature, relative humidity, finishing time, average pace, observed and extrapolated drinking time, estimated volume 
and rate for fluid intake of the athletes during 13 specified marathon races. 





















rate of fluid 
intake 
(L.h-1) 
Athens 2004 1 30 39 2:10:55 19.35 3.7 11.2 506.2 0.23 
Berlin 2006 2 20 ±3 30±13 2:04:26 20.29 21.6 28.8 1299.5 0.63 
Berlin 2008 2 12±2  89±12 2:03:59 20.39 20.2 40.5 1829.7 0.89 
Berlin 2009 2 16±1  72±8 2:06:08 20.00 17.4 24.3 1097.5 0.52 
Dubai 2009 2 16±2  54±14 2:05:29 20.10 24.0 38.4 1735.7 0.83 
Beijing 2008 3 27±2  52 2:06:32 20.00 12.4 19.6 885.9 0.42 
Chicago 2008 1st 4 21±3  59±9 2:06:25 20.00 10.5 14.0 631.0 0.30 
Chicago 2008 2nd 5 21±3 59±9 2:07:37 19.81 45.0 48.8 2204.9 1.04 
Chicago 2009 3 0±1  70±5 2:05:41 20.10 10.5 12.0 542.4 0.26 
London 2006 6 10±1  84±3 2:06:39 20.00 38.0 50.7 2289.8 1.09 
London 2007 7 18±3  55±9 2:07:41 19.72 31.0 31.0 1401.2 0.66 
Fukuoka 2009 8 7±1  63±7 2:06:10 20.00 20.5 32.3 1458.2 0.69 
New York 2008 9 6±1  42 2:08:43 19.63 1.4 1.6 72.8 0.03 
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Table 4.2 The amount of time (s) the athlete was observed drinking at each feeding station during the different races. 











Athens 2004 NS ND ND ND ND ND ND 0.5 ND 0.0 ND ND 0.0 ND 0.0 3.2 3.7 5/15 (33) 11.2 
Berlin 2006 NS 0.6 NS 5.9 NS 2.3 NS ND NS ND NS 5.4 NS 4.8 NS 2.7 21.6 6/8 (75) 28.8 
Berlin 2008 NS 7.2 NS 2.3 NS 8.7 NS ND NS ND NS ND NS ND NS 2.1 20.2 4/8 (50) 40.5 
Berlin 2009 NS 3.6 NS 0.0 NS ND NS 1.8 NS ND NS 7.0 NS 5.0 NS NS 17.4 5/7 (72) 24.3 
Dubai 2009 NS 5.4 NS ND NS 5.8 NS 6.0 NS 0.9 NS ND NS 4.8 NS 1.1 24.0 5/8 (63) 38.4 
Beijing 2008 NS 4.1 0.0 ND 0.0 0.4 0.0 0.0 0.9 1.6 ND 0.0 ND 0.0 5.0 7.4 12.4 12/15(80) 19.6 
Chicago 08 1st NS ND NS 1.5 NS 1.2 NS 1.0 NS 5.0 NS 0.7 NS 1.4 NS ND 10.5 6/8 (75) 14.0 
Chicago 08 2nd NS 4.4 NS 4.9 NS 4.7 NS 2.1 NS 18.6 NS 2.9 NS 4.2 NS 3.2 45.0 7/8 (88) 48.8 
Chicago 2009 NS 0.5 NS 1.0 NS 2.3 NS 1.9 NS ND NS 1.0 NS 3.7 NS 0.0 10.5 7/8 (88) 12.0 
London 2006 NS ND NS 7.0 NS 7.0 NS 5.0 NS 6.0 NS ND NS 11.0 NS 2.0 38.0 6/8 (75) 50.6 
London 2007 3.0 3.0 5.0 0.0 2.0 3.0 2.0 2.0 5.0 1.0 1.0 2.0 2.0 0.0 0.0 0.0 31.0 17/17(100) 31.0 
New York 2008 NS 1.5 NS 0.0 NS 0.0 NS 0.0 NS ND NS 0.0 NS 0.0 NS 0.0 1.5 8/9 (89) 1.6 
Rotterdam 2010  NS NS NS 1.9 NS NS NS ND NS NS NS 0.8 NS NS NS 0.0 2.7 3/4 (75) 3.6 
Marathon NS 5km NS 10km NS 15km NS 20km NS 25km 28km 32km 33.5km 36km 38km 41km Total Stations Extrap 
Fukuoka 2009 NS 4.6 NS 5.0 NS 2.7 NS 4.1 NS 4.2 0.0 ND ND ND ND 0.0 20.5 7 /11(64) 32.3 
* Note: NS, no drinking station; ND, no data collected. 
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To supplement this analysis physical data were collected from the Dubai marathon in 2009.  
Accordingly, BM of the race winner was recorded to the nearest 0.1 kg prior to the start 
(just before the start of the race) as well as at the end of the Dubai 2009 marathon and 
before he consumed any post-race food or drink.  Additionally, 5 elite male middle- and 
long-distance runners (BM: 54.9 ± 3.8 kg; including 2 of the 10 marathon runners 
investigated while the other 3 specialised in the 5 and 10 km events and included 2 of the 
world’s fastest 5 and 10 km athletes; e.g., world record holder for the 5 and 10 km events) 
underwent acclimation training in preparation for the 2008 Beijing Olympics.  This unique 
opportunity allowed the assessment of BM losses and consequently, the estimation of 
sweat rate/losses following 30-60 min of treadmill running at variables speeds ranging 
from 10-20 km.h-1 at 1% gradient to simulate outdoor running (Jones & Doust, 1996). The 
data collected were used to estimate total BM loss during a hypothetical 02:06:31 (h:min:s) 
marathon; the average marathon time of the current 10 elite marathoners.  These 
measurements were collected under hotter and more humid conditions (i.e., 35 °C and 70% 
relative humidity) than typically experienced in major marathon races in which very fast 
performances are achieved.  The hot, humid and wind-still conditions of these experiments 
limit the extent this data can be extrapolated to out-of-doors running where facing air 
velocities are seldom lower than the athlete’s rate of forward progression (Gonzalez, et al., 
2009).  Nevertheless, power output (running speeds ranged from 10-20 km.h-1 but the 
majority of time was spent running at 10-12 km.h-1; ~14 W.kg-1) during these acclimation 
sessions conducted to mimic ambient conditions expected at the 2008 Beijing Olympics 
were estimated to be no greater than 50% of the power output at 20 km.h-1 (average speed 
of the marathons assessed; ~30 W.kg-1) (Fukunaga & Matsuo, 1980).  The higher sweat 
rates elicited during the acclimation sessions were estimated to be twice as high as those 
expected during ambient conditions typical of fast marathon racing (e.g., at 16 oC and 54% 
relative humidity) (Gonzalez, et al., 2009). Consequently, the hot, humid and wind-still 
conditions of the acclimation experiments would have elicited maximal or near maximal 
sweat rates (Nielsen, 1996) and therefore be in line with expected sweat rates during 
intense marathon racing.  Notably, the sweat rate of the winner of the Dubai marathon in 
2009 was estimated at 3.6 L.h-1 and matched reasonably well with the same athlete’s 
estimated sweat rate during the acclimation session (i.e., 3.2 L.h-1).   
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Figure 4.1 Illustration of a snapshot during data collection. 
 
4.2.2 Data Analysis 
Data were expressed as mean ± SD, as appropriate following a test for the normality of 
distribution.  Linear regression analysis was performed to investigate the possible 
association between total drink duration, fluid intake (rate and total), running speed and 
ambient temperature.  Statistical significance was set at P < 0.05.  Test-retest reliability of 
the observed total drink duration for both the marathons and the simulation experiment 
were estimated by the mean of the Spearman-Brown coefficient.  Values ≥ 0.7 were 
considered acceptable reliability.  The test-retest procedure was used to assess stability 
over time after a three-week interval.  All statistical analysis was completed using the 
software package SPSS, version 15.0 (SPSS, Inc., Chicago, IL, USA). 
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4.3 Results 
During the 13 marathon races that we analyzed, the athletes’ running speeds ranged from 
19.4 km.h-1 (Athens 2008) to 20.4 km.h-1 (Berlin 2008) with average race time (h:min:s) of 
02:06:31.   Ambient conditions ranged from 0 ± 1 °C (Chicago 2009) to 30 °C (Athens 
2004) and from 29.5 ± 12.5% (Berlin 2006) to 88.5 ± 11.5% relative humidity (Berlin 
2008).  Invariably, there was no footage available for some drinking stations.  Therefore, 
the obtained data have been extrapolated to provide information for the entire races 
including the stations for which data were not available.  In summary, 72% of all drinking 
stations were observed on the video footage and data from the analysed footage was 
extrapolated to 100% (Table 4.2).  The mean extrapolated duration of fluid consumption 
was 25.5 ± 15.0 s and ranged from 1.6 s (New York 2008) to 50.7 s (London 2006) (Table 
4.2).  Applying a flow rate of 45.2 mL·s-1 to these data (Table 4.2), resulted in estimated 
fluid intakes for the athletes of 1151.3 ± 716.0 mL.  These extrapolated data equated to the 
mean fluid consumption rate (0.55 ± 0.34 L.h-1) which falls within the ACSM guidelines 
(0.4 - 0.8 L.h-1; Figure 4.2).  Test-retest scores of the observed total drink duration for both 
the marathon drinking time and the simulation experiment were highly correlated (r > 0.9). 
No significant correlation was found between running speeds and the total time of 
consuming fluid during the different marathons.  The composition of each athlete’s drink 
was unknown except that ingested by the winner of the 2009 Dubai marathon.  The 
composition of the drink ingested during the race consisted of 160 g CHO and 1.2 g 
Sodium/Natrium per Liter of solution. 
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Figure 4.2 The observed and extrapolated rates of fluid consumption (L.h-1) of the winning 
runners in the different marathon races.  The grey area represents the ACSM guideline fluid 
intake rates of 0.4 - 0.8 L.h-1. 
 
Measured data collected from the 2009 Dubai marathon (16.0 °C and 53.5% relative 
humidity) showed that the race winner finished the marathon with a reduction in BM of 5.7 
kg (58.2 - 52.5 kg) equivalent to a 9.8% BM reduction.  Given the athlete ingested 1.7 L 
during the race, his estimated sweat rate was approximately 3.6 L.h-1.  That is similar to his 
sweat rate (3.2 L.h-1) measured during the laboratory experiments (Table 4.3), which were 
conducted 4 months before the 2009 Dubai marathon.  Finally, based on the observed rates 
of fluid ingestion the estimated BM loss of the 5 elite marathoners, whose sweat rates were 
measured during the laboratory simulation as 2.3 ± 0.7 L.h-1 (range: 1.6 - 3.2 L.h-1, Table 
4.3), was found to be 8.8 ± 2.1% (range: 6.6 - 11.7%; Table 4.3) during a marathon.  
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Table 4.3 Measured body mass changes during ~30 min exercise bout in the heat; estimated changes in 5 athletes and observed changes 
in 1 athlete during 42 km marathon races.   
 Measurements during ~ 30 min exercise bout in 
the heat  
Values estimated for 
a 42km marathon 
Observed values during 
42km marathon race 

















01 59.0 57.6 1.4 30.3 2.7 5.8 9.9   
02 52.6 51.7 0.9 35.4 1.6 3.5 6.6   
02b 52.7 51.7 1.1 39.4 1.6 3.5 6.6   
03* 57.0 53.9 3.2 60.0 3.2 6.7 11.7 5.7 9.8 
04 57.8 56.2 1.5 36.6 3.0 6.3 10.9   
04b 57.1 55.0 2.1 61.1 2.2 4.7 8.2   
05** 48.4 46.8 1.6 56.7 1.7 3.7 7.5   
MEAN 54.9 53.3 1.7 45.6 2.3 4.9 8.8 5.7 9.8 
SD 3.8 3.6 0.8 13.1 0.7 1.4 2.1     
*Note: SD, standard deviation; BM, body mass; BML, body mass loss; * same athlete as subject 02 in Table 4.1; ** same athlete as subject 09 in Table 4.1; b different exercise 
bout. 
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4.4 Discussion  
This investigation (Chapter 4) provides a unique insight into drinking behaviours of elite 
runners during major city marathons.  The first important finding was the wide range of 
individual rates of fluid ingestion.  The mean extrapolated duration spent ingesting fluid 
was 25.5 ± 15 s, ranging from 1.6 s (New York 2008) to 50.7 s (London 2006).  This 
variation may reflect the different ambient conditions which ranged from 0 ± 1 °C 
(Chicago 2009) to 30 °C (Athens 2004) and 29.5 ± 12.5% (Berlin 2006) to 88.5 ± 11.5% 
relative humidity (Berlin 2008).  Notably, the warmer conditions did not always result in 
greater total drinking durations.  For example, during the London 2006 marathon the 
winning athlete consumed more fluid than during the London 2007 marathon (2290 vs. 
1400 mL) even though the 2006 race was run in cooler conditions (10 vs. 18 °C ) (Table 
4.1).  Similarly, the runner in the New York 2008 marathon consumed less fluid (73 mL) 
than did the winner of the Fukuoka 2009 marathon (1458 mL) even though both races were 
run at almost identical conditions (6 vs. 7 °C, respectively).  
The second important finding was that the estimated fluid intakes of the runners during 
these races was 1151 ± 716 mL, which equates to a mean fluid intake rate of 0.55 ± 0.34 
L.h-1, assuming a maximal flow rate of 45.2 ± 13 mL.s-1.  This estimated fluid intake rate is 
within the current ad libitum fluid intake recommendations of 0.4 – 0.8 L.h-1 initially 
proposed by the International Marathon Medical Directors Association (IMMDA) 
(Noakes, 2003a) and subsequently adopted by the ACSM (Sawka, et al., 2007) (Figure 
4.2).  It is recognised, however, that these estimated fluid intake rates (Figure 4.2) 
represent the maximum rates that might have been ingested since these flow rates are 
dependent on the pressure applied to the sport drink bottle.  Currently, this method is the 
best indirect measure of the drinking behaviours of successful elite marathon runners. 
The athletes who won the London 2007, New York 2008 and Rotterdam 2010 races were 
the only athletes who did not drink anything between 35 - 42.2 km; a distance that these 
athletes would have covered in approximately 22 min.  The study of Montain and Coyle 
(Montain & Coyle, 1993) found that the physiological effects of fluid ingestion such as a 
reduced HR and Tcore as well as increased plasma volume (PV) may require 40 - 60 min to 
develop.  Consequently, late fluid ingestion in a marathon race may be of limited but albeit 
unknown psychological value since it may result in retained fluid solely in the 
gastrointestinal tract.  This would simply add unnecessary BM without any clear 
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performance benefit.  Indeed some degree of BM loss may actually be advantageous 
towards the end of a marathon race as theoretically this BM loss will lower the energy cost 
of running at the same relative sub-maximal speed (Armstrong, et al., 1985; Coyle, 2004; 
Fudge, et al., 2006a; Sawka & Montain, 2000).  Indeed the study of Armstrong et al. 
(2006) showed that even though V̇O2 (expressed relative to BM) was not significantly 
influenced by a loss in BM as high as 5.7%, the fractional utilisation of V̇O2max was 3.2% 
(86.0 vs. 89.2% V̇O2max) lower compared to the euhydrated state (Armstrong et al., 2006).  
Whilst this difference was not statistically significant, it may be of significance to an elite 
runner completing the last part of a marathon race, as this difference may influence 
performance (Hopkins, Hawley, & Burke, 1999).  Indeed, it has been shown that athletes 
who lose the most BM during marathon and ultramarathon races and ironman triathlons are 
usually the most successful (Cheuvront & Haymes, 2001a; Muir, et al., 1970; Pugh, et al., 
1967; Sharwood, et al., 2004; Wharam, et al., 2006; Wyndham & Strydom, 1969; Zouhal, 
et al., 2010; Zouhal, et al., 2009).  Furthermore, there is no evidence that fluid intake 
during exercise increases sweat rates, stroke volume or reduces overall cardiovascular 
strain.  Nor does fluid intake during exercise alter skin and muscle blood flow, increase 
oxygen and substrate delivery to the working muscle (Fudge, et al., 2006a). 
The data of Chapter 4 suggest that elite marathon runners ingest fluid within a wide range 
(30 - 1100 mL·h-1) during marathon competition.  Nevertheless, physical data collected 
during the Dubai 2009 marathon showed that such rates of fluid ingestion are not sufficient 
to prevent significant BM losses.  Thus, the BM loss of the winner was 9.8% (5.7 kg), even 
though his rates of fluid intake exceeded the upper limit of the current guidelines (Figure 
4.2).  This estimated sweat rate was approximately 3.6 L.h-1, closely matching his sweat 
rate measured during a laboratory trial in the heat (3.2 L.h-1; Table 4.3).  Most probably the 
laboratory experiments (i.e., acclimation training) which were conducted under fairly 
extreme ambient conditions (35 oC, 70% relative humidity and wind-still conditions) and 
marathon racing at high running speeds (i.e., 20.1 km.h-1) would have elicited near 
maximal sweat rates (Nielsen, 1996).  These sweat rates are approximately two times 
higher in comparison to the highest values of 1.8 L·h-1 previously reported (Godek, 
Bartolozzi, & Godek, 2005; Millard-Stafford et al., 1995).  As a consequence of these very 
high sweat rates, recommended fluid ingestion rates did not prevent significant sweat/BM 
loss and these athletes performed better than their competitors.  
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Elsewhere it has been argued that drinking ad libitum may be the most effective drinking 
behaviour (Sawka & Noakes, 2007).  Drinking ad libitum throughout a marathon appears 
to confer no major disadvantage over drinking to replace all fluid losses or at least up to 
the maximal amount tolerated (Cheuvront & Haymes, 2001a; Daries, Noakes, & Dennis, 
2000; Dugas, Oosthuizen, Tucker, & Noakes, 2009; Kay D & FE, 2003; McConell, Burge, 
Skinner, & Hargreaves, 1997; Noakes, 2007a; Saunders, et al., 2005), and there is no study 
to date demonstrating that full fluid replacement is superior to ad libitum drinking (Noakes, 
2007a).  For example, Daries et al. (Daries, et al., 2000) ran 8 endurance runners twice for 
2-h with subjects ingesting a CHO electrolyte drink either ad libitum or in set volumes that 
approximated full replacement of sweat loss.  These authors found that the higher rates of 
fluid ingestion did not alter PV and osmolality and did not improve 2-h running 
performance.  Furthermore, Dugas et al. (Dugas, et al., 2009) tested 6 cyclists, each 
performing 80 km time trials at 5 different experimental conditions with subjects replacing 
0%, 33%, 66%, and 100% of the BM lost during an ad libitum trial or simply rinsed their 
mouths.  The authors concluded that ad libitum drinking may be the optimal fluid 
replacement strategy, preventing athletes from ingesting too little or too much fluid and 
achieving the best possible result (Dugas, et al., 2009).  More recently, Goulet et al. 
(Goulet & Dugas, 2010) had concluded using a meta - analysis of relevant studies, that 
drinking either more or less than ad libitum impairs exercise performance.   Furthermore, a 
pre - planned strategy to limit BM loss is not easily calculated as sweat rate is dependent 
on ambient conditions and race pace which cannot always be predetermined.  For example, 
ambient conditions during the New York City Marathon has previously changed by as 
much as 17 °C from start to finish in the same race (Cheuvront & Haymes, 2001b) and race 
pace at the elite level can vary throughout the race.  
An important consequence of drinking ad libitum is significant BM loss (Cheuvront & 
Haymes, 2001a; Muir, et al., 1970; Pugh, et al., 1967; Sharwood, et al., 2004; Wharam, et 
al., 2006; Wyndham & Strydom, 1969; Zouhal, et al., 2010; Zouhal, et al., 2009).  The 
winner of the Dubai 2009 marathon finished the race with a BM loss of 9.8 %.  This level 
of dehydration did not appear to have any adverse effects during this race or in others in 
which he drank similar volumes (e.g. Berlin 2006 and 2008).  The evidence collected in the 
present study (Chapter 4), is in accordance with the current literature (Muir, et al., 1970; 
Pugh, et al., 1967).  In general, the world’s best marathoners and cyclists during elite 
competition seem to consume inadequate amounts of fluid in order to prevent more than 2-
3% dehydration (Noakes, 2007a).  In one of the hottest marathons in recent history (Athens 
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2004), the winner Mizuki Noguchi appeared to drink relatively small amounts; a total of 
only approximately 30 s drinking during the race (Van Rooyen, et al., 2010).  Hence, it is 
almost certain that the Olympian had lost a significant volume of body water by the end of 
the marathon, yet she won the race.   
4.5 Conclusions 
This study aimed to describe the drinking behaviours of successful elite marathon runners 
and in the process assess the efficacy of current fluid intake recommendations (albeit 
indirectly), which propose drinking ad libitum 0.4 - 0.8 L·h-1 during exercise for elite 
marathon runners.  Although the estimated fluid intake rates of the winners during the 13 
races (Table 4.2) are broadly within current recommendations (Sawka, et al., 2007), these 
elite runners do not seem to maintain their BM during successful marathon racing within 
current recommended ranges of 2-3%.  On the other hand, this apparently widely adopted 
ad libitum strategy during marathon racing seems to produce optimal/winning 
performances.  This evidence and the finding that the winner of the 2009 Dubai marathon 
finished a competitive race with a BM loss of 9.8% dehydrated, would suggest that there 
exists a tolerable range for dehydration that may not negatively impact on running 
performance, but may even confer an advantage by preventing a significant increase in BM 
due to the “over - consumption” of large volumes of fluid.  This finding is in accordance 
with a recent meta-analysis which suggests that ad libitum drinking produces optimum 
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5. The effects of hyper-hydration on running 
economy in well trained endurance runners 
 
5.1 Introduction  
RE, which is defined as the sub-maximal V̇O2 at a given running velocity, is an important 
physiological parameter as superior RE is essential for successful endurance running 
performance (Bassett & Howley, 2000; Saunders, et al., 2004).  In general, runners with 
good RE use less oxygen than runners with poor RE at the same absolute exercise 
intensity.  RE appears to be influenced by many physiological factors (Saunders, et al., 
2004) including hydration status.  Coyle (2003) proposed that a 4 to 8% BM deficit due to 
dehydration (i.e., the process of reducing body water) may lower the oxygen cost of 
movement (Coyle, 2004), given that athletes who lose the most BM during a race are 
usually the most successful (Zouhal, et al., 2010).  Nevertheless, this theoretical paradigm 
contradicts the prevailing view of a body water deficit in excess of 2-3% BM constituting 
the level of dehydration that can adversely affect performance (Sawka, et al., 2007).  
During exercise, skeletal muscle produces a significant amount of heat.  When this 
metabolic heat production exceeds total heat loss, Tcore rises.  Consequently, endurance 
exercise performance in hot and dry environments can be limited by the increase in Tcore 
(Nielsen et al., 1993).  An increase in Tcore during exercise can be attenuated via the 
secretion and evaporation of sweat through the skin with inevitable body water loss.  This 
decrease in body water is hypothesized to decrease PV and consequently reduce the 
sweating response and therefore thermoregulation capacity, increase HR and reduce skin 
blood flow (Ekelund, 1967).  Improved maintenance of PV is the overriding rationale for 
fluid ingestion during exercise by those supportive of the “cardiovascular model of 
dehydration” (Sawka, et al., 2007).  However, proposed guidelines (Sawka, et al., 2007) 
are not always practical (e.g., difficulties providing adequate drinks during a race, athletes 
difficulties in drinking while running) and athletes typically refrain from consuming 
recommended amounts of fluids.  Other means to expand PV can be by infusion of isotonic 
saline (Fortney, Vroman, Beckett, Permutt, & LaFrance, 1988) with somewhat conflicting 
success (Fortney, et al., 1988; Grant, Green, Phillips, & Sutton, 1997).  More recent 
approaches aimed at expanding body water compartments using hydrating agents such as 
Cr and Gly have successfully attenuated the rise in Tcore and HR during exercise in heat 
(Magal, et al., 2003; Riedesel, et al., 1987).  
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Cr has been shown to have hydrating effects (Kern, et al., 2001; Kilduff, et al., 2004), 
although the exact process has yet to be established.  Ingestion of 20 g·day-1 of Cr 
dissolved in 500 mL of water for 7 days have proved successful in attenuating the rise in 
HR and Tcore during exercise in the heat (Kilduff, et al., 2004).  These effects have been 
attributed to an increase in ICW, resulting in an increased specific heat capacity of the 
body (Kern, et al., 2001; Kilduff, et al., 2004).  Moreover, whole body Cr retention is 60% 
higher when consumed with CHO compared to when Cr was consumed alone (Green, 
Hultman, Macdonald, Sewell, & Greenhaff, 1996).  Although the mechanism by which 
CHO enhances Cr uptake is not completely understood, consumption of 100 g per 5 g of 
Cr has been recommended for the effective improvement of Cr uptake (Steenge, Simpson, 
& Greenhaff, 2000).  Like Cr, Gly has been found to be an effective agent in expanding the 
water compartments within the human body (Murray, et al., 1991; Riedesel, et al., 1987).  
Gly, seems to expand the ICW as well as the ECW (Nelson & Robergs, 2007).  In general, 
doses of 1.0–1.5 g Gly·kg-1 BM dissolved in 1.4 - 2.0 L of fluid 2.5 - 4 h before exercise 
(van Rosendal, et al., 2010) increase TBW compartments and reduce thermal and 
cardiovascular strain during exercise in the heat.       
Supplementation with combined hydrating agents such as Gly or Cr has consistently 
produced modest fluid retention of 400 - 800 mL (Kern, et al., 2001; Magal, et al., 2003; 
Riedesel, et al., 1987).  Easton et al. (2007) were the first to add Gly to a Cr containing 
solution and demonstrate that a combination of the two hyperhydrating agents has an 
additive effect, as the addition of Gly to Cr significantly increased TBW more than Cr 
alone.  Although the combination of the aforementioned hyperhydrating agents results in 
an increase in TBW and a reduction in certain cardiovascular and thermoregulatory 
responses (Easton, et al., 2007), the BM increase due to enhanced hydration status could 
potentially reduce RE.  The reduction of the energy cost of movement at a sub-maximal 
velocity by way of reducing BM to improve running performance is well known (Fudge, et 
al., 2006b).  For instance, it is noted that some marathon runners perform well despite 
dehydration of 4 - 8% BM (Costill, 1972).  Coyle (2004) proposed that this may occur 
because fluid loss (i.e., reduced BM) lowers the oxygen cost of movement.  On the other 
hand, the acute influences of hyper-hydration on RE has not been investigation to date.  
Hence, the aim of the study presented in Chapter 5 was to investigate the effects of hyper-
hydration induced by a combined Cr and Gly supplementation on thermoregulatory and 
cardiovascular responses and RE during 30 min of running at a running speed 
corresponding to 60% V̇O2max in cool (10 °C with a relative humidity of 70%) and hot 
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conditions (35 °C with a relative humidity of 70%) in well-trained male athletes.  In cool 
ambient conditions were intended to minimize heat stress during exercise thus enabling a 
focus on the effects of the altered BM induced by hyper-hydration  on RE at 60% V̇O2max.  
However, effects of hyper-hydration on thermoregulatory and cardiovascular responses are 
also expected during exercise in hot and humid conditions; conditions typical of major 
sporting events (e.g., Olympic Summer Games).  As such, it was hypothesized that an 
increase in BM and TBW induced by hydrating agents such as Gly or Cr would improve 
thermoregulatory and cardiovascular responses in line with previous findings but 
potentially negatively influence RE during running in the heat. 
5.2 Methods 
5.2.1 Subjects 
Fifteen well-trained male runners gave their written informed consent to take part in the 
present observational, non-blinded, non-randomised study (Chapter 5).  The current 
investigation was approved by the University of Glasgow Ethics Committee and was 
performed in the Glasgow University according to the code of ethics of the World Medical 
Association (Declaration of Helsinki).  One subject withdrew from the study before the 
final trial because of gastrointestinal distress during supplementation.  Subjects were 
questioned as to their supplementation and training practices in order to ascertain that they 
had not supplemented with Cr for at least 8 weeks prior to commencing the study.  
Subjects were in good health at the time of testing, ran on a daily basis and participated 
regularly in competitive races.  Athletes were also requested to maintain their typical 
weekly training regime during the course of the study. 
5.2.2 Experimental Procedures  
All subjects completed a V̇O2max test during an initial continuous incremental test at 
standard room temperature (20 - 21 °C) and relative humidity (30 - 40%) on a motorized 
treadmill (PPS Med, Woodway, Germany) at 1% grade.  After a warm-up period 
(depending on the runner), the subjects started running at 8 km·h-1 for 3 min in order to 
reach a steady state.  In the next exercise bout the treadmill speed was set to 10 km·h-1 for 
3 min and this procedure was repeated with 2 km·h-1 increments in running speed until 
volitional exhaustion of the subject.  During the test expired gas samples (30 s collection 
time at the end of each bout) were taken using Douglas bag collection technique as is 
considered the gold standard method (Douglas, 1911) and analyzed for O2% and CO2% 
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(Servopro 4100 Gas Purity Analyzer, Servomex, UK) as well as analyzed for volume using 
a dry gas meter (Harvard, Kent, UK) and temperature of expired gases.  Barometric 
pressure was measured using a standard mercury barometer.  Additionally, a HR monitor 
(Polar Sports Tester, Polar Electro Oy, Kempele, Finland) was attached prior to each test 
and HR was recorded at the end of each bout.  The V̇O2max measurement was used for 
calculating the intensity (60% of V̇O2max) that subjects would perform during the actual 
tests.  Running speed at 60% of V̇O2max (exercise intensity) was calculated using the 
linear relation between treadmill speed and V̇O2.  
Prior to the actual experimental trials, familiarization trials were completed until the 
variability of V̇O2 of two consecutive trials was within 5% difference.  No subject had to 
complete a third familiarization trial to achieve less than 5% variability, an observation 
which is in line with our previous experience of trained athletes (Easton, et al., 2007).  At 
least three days after this familiarization period, subjects reported to the laboratory for the 
first experimental trial (i.e., a pre-supplementation trial).  After this baseline test, all 
subjects commenced the hyper-hydration treatment comprising Cr, Gly and glucose.  For 
this, subjects consumed a solution of 11.4 g of Cr·H2O (equivalent to 10 g Cr), (Reflex 
Creapure Creatine, Reflex Nutrition LTD, UK), 1 g·kg-1 of BM Gly (Glycerin BP/Value 
Health Glycerin BP, Boots Company plc) and 75 g of Glucose polymer (SiS GO 
electrolyte), mixed in hot water (approximately 50 °C) and made up in 1 L of cold water 
twice daily.  This supplementation regimen was followed for 6 days.  This protocol has 
been shown to increase resting muscle-phosphocreatine levels within 5 days (Harris, 
Soderlund, & Hultman, 1992).  On the day of the post-supplementation test (i.e., day 7th) 
subjects began consuming the final supplement 5 h before the exercise-performance trial 
(with instructions to complete ingestion within 1 h).  Hypertonic solutions such as the Cr, 
Gly, Glucose combination (~1556 mOsm·kg-1) cause an initial net secretion of water into 
the intestinal lumen (Gisolfi, Summers, Schedl, Bleiler, & Oppliger, 1990), resulting in an 
effective loss of body water, albeit temporary.  Unpublished work from our laboratory has 
indicated that ingesting Cr/Gly 5 h prior to commencement of exercise results in a larger 
volume of fluid absorbed compared to when the solution is consumed 3 h prior to the 
exercise test.  In order to prevent degradation of Cr to creatinine, each supplement was 
prepared fresh each time before consumption.  The subject was also given a temperature 
pill (HQ Inc., USA) about 8-12 h prior to each test allowing Tcore to be measured (Easton, 
Fudge, & Pitsiladis, 2007).  On each of the experimental test days, subjects ingested 500 
mL of water 1 h before exercise in an attempt to ensure euhydration before all exercise 
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trials (Convertino, et al., 1996).  Subjects otherwise followed their normal diet and 
recorded all food and drink consumed during the supplementation period as well as the 
preceding week using a food diary.  The diet was analyzed for EI and macronutrient 
content using computerized food composition tables (Holland, 1991) (Food Meter U.K., 
Medimatica s.r.l., Benedetto, Italy).  Subjects were asked to minimize caffeine intake to 1 
cup of tea or coffee per day to lessen any possible confounding effects of caffeine on Cr 
(Vandenberghe et al., 1996). 
The subject reported to the lab after a 3 h fast and having refrained from alcohol, caffeine, 
and strenuous exercise at least 24 h prior to the experimental trial.  Firstly, a urine sample 
was collected from the subject prior to taking the pre-test nude BM (Tanita Corporation of 
America, Inc.).  Body water compartments were estimated using a multi frequency 
bioimpedance analyzer while the subject lay comfortably in a supine position for 5 min on 
a nonconductive surface with their arms and legs slightly abducted (Quadscan 4000, 
Bodystat Ltd., Isle of Man).  This method allows TBW and ECW to be estimated.  From 
these measurements ICW can also be deduced.  Bioimpedance has been shown to produce 
valid and reliable TBW estimations in the euhydrated state (O'Brien, Young, & Sawka, 
2002) which has been also verified in the present lab (unpublished measurements; highly 
correlated with deuterium oxide measurements).  To date, several studies have successfully 
used this technique in order to estimate hyper-hydration induced changes in TBW (Kern, et 
al., 2001; Kilduff, et al., 2004).  Changes in BM from pre- to post-supplementation were 
used to supplement the indirect measurement of the fluid volume retained.  Following 
TBW determination, the subject lay in a supine position for 5 min further and a 7 mL blood 
sample was taken from a 21G cannula which was introduced into a superficial vein of the 
anticubital fossa of the right arm.  The venous cannula was kept patent by flushing it with 7 
mL of isotonic saline solution between samples.  Prior to entering the environmental 
chamber a HR monitor (Polar Sports Tester, Polar Electro Oy, Kempele, Finland) was 
attached to the subject.  Then, the subject was transferred to the climatic chamber (ambient 
temperature 10.0 ± 1.0 °C with a relative humidity of 68.5 ± 3.6%).  Subjects were then 
instructed to begin running to their predetermined 60% V̇O2max for 30 min at 1% 
inclination of the treadmill.  HR and Tcore were recorded every 5 min throughout the 30-
min exercise period.  1 min gas measurements were collected at 5 min intervals of exercise 
for the purpose of V̇O2, carbon-dioxide production (V̇CO2), temperature and expired gas 
volume determination.  RPE and thermal comfort (TC) were recorded every 5 min of the 
exercise using the Borg category scale (Borg, 1982) for RPE and a modified scale (from -
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10 to + 10).  Following the first exercise bout, the subject was removed from the chamber 
and nude BM was measured immediately.  The difference in BM before and after exercise 
was calculated and subsequently used to estimate sweat rate and sweat loss.  Subsequent to 
BM determination, the subject lay in a supine position for 10 min and a final blood sample 
was retrieved.  The fluid loss was then replaced by giving the subject the equivalent 
amount of water to that calculated between pre- and post-exercise.  Subjects were then 
instructed to re-enter the climatic chamber and complete a second bout of run at the same 
speed (60% V̇O2max), at 35.1 ± 0.1 °C and 69.4 ± 4.0% relative humidity.  The protocol 
for data collection was identical to the one used in the first bout of exercise.  Once the 
second bout was completed, subjects’ nude BM and a final blood sample were taken as 
described above.  The analytical procedure is shown in Figure 5.1.  Illustrations also from 
the lab work are presented in Figure 5.2. 
 
Figure 5.1 Schematic representation of the experimental protocol. 
 
 
5.2.3 Blood Analysis  
Blood was drawn into dry syringes and 4 mL dispensed into a tube containing K3EDTA 
and the remaining 3 mL dispensed into plain tubes.  Duplicate aliquots (100 μL) of whole 
blood from the K3EDTA tube were rapidly deproteinised in 1000 μL of ice-cold 0.3-
mmol/L perchloric acid, centrifuged (8 min, 14000 rpm, Hettich Microcentrifuge, 
Germany), and frozen for later analysis of lactate using a standard enzymatic method 
(Maughan, 1982) involving fluorimetric detection (Spectramax M2 Microplate Reader, 
Molecular Devices, Inc., US).  The blood in tubes without anticoagulant was allowed to 
coagulate and then centrifuged; the serum collected was used to measure osmolality by 
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freezing-point depression (Micro-osmometer 3300, Vitech Scientific, West Sussex, UK).  
The blood from the K3EDTA tubes was also analyzed for haemoglobin 
(cyanmethemoglobin method) and packed-cell volume (PCV; conventional micro-
haematocrite method).  All blood analyses were carried out in duplicate, with the exception 
of PCV, which was carried out in triplicate.  PV changes were calculated from changes in 
haemoglobin and PCV relative to initial baseline values (Dill & Costill, 1974). 
 
 
Figure 5.2 Illustrations of the lab work data collection. 
 
5.2.4 Data Analysis  
All data are expressed as the mean  SD. All experimental variables (V̇O2, V̇CO2, 
Respiratory exchange ratio (RER), RPE, TC, HR, Tcore) were tested for normality of 
distribution and compared between the two treatments using two-way ANOVA (i.e., pre- 
vs. post-supplementation).  Students paired t-tests were carried out to test difference 
between each time pre- to post-supplementation when difference was detected using 
ANOVA.  Statistical significance was set at P < 0.05 and in cases where significant 
differences were detected between time points pre- to post-supplementation, P-value was 
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corrected using the Sidak adjustment.  Responses at 10 and 35 oC were analysed 
separately.  Student paired t-tests were also used to examine the difference between pre- to 
post-supplementation for the rest of the comparisons.  All statistical analysis was 
completed using the statistical package SPSS, version 15.0 (Statistica 8.0, Statsoft Inc., 
Tulsa, USA). 
The intra-assay C.V. was calculated from the SD of the difference between double or triple 
(PCV) measurements of the sample expressed as a percentage of the total mean sample 
(Table 5.1).   
Table 5.1 Coefficient of variation of blood and serum assays. 
Assay  Method  N  C.V. 
Blood lactate  Maughan 82  14  4.7 
Serum osmolality  Freezing point depression  14  0.2 
Blood Hb  Calorimetric method  14  0.5 
PCV  Microhaematocrit method  14  0.5 
 
5.3 Results 
5.3.1 Subject characteristics  
The 15 male subjects were trained distance runners with V̇O2max being 63.5 ± 5.2 mL·kg-
1·min-1, age, 24 ± 5 yr; height, 180 ± 7 cm; BM, 69.5 ± 5.0 kg (values are presented as the 
mean ± SD). 
5.3.2 Body Mass and Water Compartments  
Supplementation induced significant increase in BM, TBW, ICW and ECW (P < 0.01; 
Figure 5.3).   During supplementation period as well as the preceding week averaged daily 
EI (Pre: 12.8 ± 2.1 MJ·day-1; Post: 11,5 ± 2.4 MJ·day-1) and averaged proportion of energy 
obtained from CHO (Pre: 55 ± 5%; Post:  49 ± 11%), fat (Pre: 33 ± 5% Post: 36 ± 6%), and 
protein (Pre: 13 ± 1%; Post: 14 ± 3%) were not significant different. 
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Figure 5.3 Changes in body mass (BM), total body water (TBW), extracellular water (ECW) 
and intracellular water (ICW) induced by supplementation.  Data presented as mean ± SD.  
*Significant difference between pre- and post-supplementation. 
 
5.3.3 Cardiopulmonary Variables  
Over the duration of running at 10 oC V̇O2, carbon dioxide production (V̇CO2) and RER 
remained constant (Table 5.2).   Over the duration of running at 35 oC V̇O2 and V̇CO2 
increased significantly (P < 0.05, AVOVA, time effect) while the values of RER were 
constant.  No significant differences were detected for V̇O2, V̇CO2 , RER between pre- and 
post-supplementation trials during running at both 10 and 35 oC (Table 5.2).  HR increased 
significantly over the duration of running at 10 and 35 oC (P < 0.05, for both, ANOVA, 
time effect).  During running at 10 oC there was no difference in HR between pre- and 
post-supplementation trials (Figure 5.4).  During running at 35 oC, HR was significantly 
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Table 5.2 Oxygen consumption (V̇O2), carbon dioxide production (V̇CO2), respiratory 
exchange ratio (RER) during 30 min of running at 10 and 35 oC conducted before and after 
supplementation. 
      Exercise time (min) 
Variable Condition 5 10 15 20 25 30 
V̇O2  10 oC  Pre 37.4±2.4 37.6±2.0 37.7±1.8 38.7±2.2 38.8±2.7 38.9±2.8 
(mL·kg-1·min-1) Post 36.4±2.8 37.4±1.5 36.9±1.7 37.7±1.8 37.6±2.2 38.4±3.3 
 35 oC  Prea 37.2±2.4 39.5±2.4 39.5±2.3 40.3±2.6 40.5±4.4 41.2±3.3 
  Posta 36.7±2.4 37.9±2.3 37.4±3.2 38.4±2.6 39.1±2.1 38.5±3.1 
V̇CO2  10 oC  Prea 32.8±1.7 33.7±2.2 33.9±1.4 34.4±2.0 34.7±2.5 34.4±2.5 
(mL·kg-1·min-1) Posta 33.5±3.1 34.6±1.6 34.0±1.7 35.0±1.9 35.1±2.0 35.0±2.3 
 35 oC  Pre 32.3±2.8 34.7±2.3 35.6±2.3 35.3±2.2 35.5±3.2 35.5±3.3 
  Post 32.4±2.5 33.9±2.2 34.4±2.4 35.1±2.3 35.1±2.3 34.5±2.6 
RER 10 oC  Pre 0.87±0.03 0.89±0.03 0.89±0.03 0.88±0.04 0.89±0.04 0.88±0.03 
  Post 0.91±0.05 0.93±0.03 0.92±0.03 0.93±0.03 0.93±0.03 0.92±0.03 
 35 oC  Pre 0.87±0.05 0.88±0.03 0.89±0.03 0.88±0.04 0.88±0.05 0.86±0.05 
    Post 0.88±0.03 0.89±0.03 0.91±0.03 0.91±0.03 0.90±0.03 0.89±0.03 
*Note. Values are presented as the mean ± SD; aSignificant difference over time throughout the trial; P-value was set at 0.05. 
 
 
Figure 5.4 Heart rate (HR) during exercise at 10 and 35 oC before (black circles) and after 
(white circles) supplementation.  Data presented as mean ± SD.  *Significant difference 
between pre- and post-supplementation. 
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5.3.4 Rating of Perceived Exertion (RPE) and Thermal Comfort 
(TC)  
Over the duration of running conducted at both 10 and 35 oC significant (P < 0.05, 
ANOVA, time effect) increases were detected in RPE (Figure 5.5) and TC (Figure 5.6), 
while no significant differences were found between pre- and post-supplementation trials. 
 
Figure 5.5 Rating of perceived exertion (RPE) during exercise at 10 and 35 oC before (black 
circles) and after (white circles) supplementation.  Data presented as mean ± SD. 
 
 
Figure 5.6 Thermal comfort (TC) during exercise at 10 and 35 oC before (black circles) and 
after (white circles) supplementation.  Data presented as mean ± SD. 
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5.3.5 Core Temperature (Tcore)  
Over the duration of running conducted at both 10 and 35 oC Tcore increased significantly 
(P < 0.05, for both, ANOVA, time effect) (Figure 5.7).  During running at 35 oC Tcore was 
significantly lower (P < 0.01, ANOVA, trial effect) in post- than pre- supplementation 








Figure 5.7 Core temperature (Tcore) during exercise at 10 and 35 oC before (black circles) and 
after (white circles) supplementation.  Data presented as mean ± SD.  *Significant difference 
between pre- and post-supplementation. 
 
5.3.6 Urine osmolality  
No significant changes were found in urine osmolality between the pre- (438 ± 306 
mOsm·kg-1) and post-supplementation trials (448 ± 266 mOsm·kg-1). 
5.3.7 Total Sweat Loss 
During running at 10 °C no significant differences between pre- and post-supplementation 
trials were observed in sweat loss (Pre: 0.3 ± 0.1 L; Post: 0.3 ± 0.1 L).  Similarly, during 
running at 35 °C no significant differences between pre- and post-supplementation trials 
were observed in sweat loss (Pre: 0.7 ± 0.2 L; Post: 0.8 ± 0.2 L).  
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5.3.8 Blood Lactate and Plasma Volume (PV) 
During running at both 10 and 35 oC no significant differences were found between pre- 
and post-supplementation trials in resting concentration of blood lactate.  Furthermore, no 
significant increase in blood lactate was observed over duration of exercise.  Additionally, 
during running at both 10 and 35 oC no significant differences were detected between pre- 
and post-supplementation trials in PV changes. 
5.3.9 Osmolality  
Resting serum osmolality did not differ between pre- (268 ± 9 mOsm·kg-1) and post-
supplementation (271 ± 19 mOsm·kg-1) trials.  Additionally, no differences were observed 
between the post 10 and 35 °C bouts and the resting values or between the treatments.  
5.3.10 Side Effects  
In general, subjects tolerated the supplementation protocol well, with only 1 report of 
gastrointestinal distress after supplementation who withdrew from the experimental 
process before completing the post-supplementation trial.  This report is in line with the 
previous study by Easton et al. (2007), where 1 athlete had to also withdraw from the study 
due to similar reasons. 
5.4 Discussion   
The novel finding of this study is that a previously established pre-exercise water loading 
strategy using a combination of hydrating agents such as Cr and Gly that significantly 
increased body water compartments and reduced cardiovascular (Figure 5.4) and 
thermoregulatory (Figure 5.7) responses during running at 35 oC, had no effect on the 
oxygen cost of running at 60% of V̇O2max.  The magnitude of change in BM following 
hyper-hydration was similar to that previously reported in our laboratory (Easton, et al., 
2007) and by Kern et al. (2001).  Somewhat smaller differences in body water 
compartments were observed in the present study (Chapter 5) compared to the previous 
investigation by Easton et al. (2007).  For example, Easton et al (Easton, et al., 2007) 
reported an increase of 0.9 L in TBW and 0.5 L in ICW after 7 days of  supplementation.  
In the present study TBW and ICW were elevated by 0.7 and 0.3 L respectively after 7 
days of supplementation.  These differences could only be attributed to individual 
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responses (i.e., level of “responders” to Cr supplementation as previously demonstrated) 
(Kilduff, et al., 2004; Kilduff et al., 2003) as similar protocols were utilised.  In the present 
study, the retained water was dispersed in both the ICW and ECW.  Despite the significant 
increase in BM and body water compartments and consequently improved 
thermoregulatory responses during exercise, no significant differences in any of the 
respiratory variables were found between the pre- and post-supplementation exercise trials.  
Therefore, the finding that a significant increase in BM did not negatively impact on RE of 
trained runners supports the use of hyper-hydration during endurance running when 
running in hot and humid conditions although confirmatory results are required during 
faster running speeds typical of sporting competition (i.e., > 85% V̇O2max). 
Temperature and cardiovascular regulation during exercise in the heat do appear to be 
critically dependent on hydration status (Gonzalez-Alonso, Mora-Rodriguez, Below, & 
Coyle, 1995; Nadel, Fortney, & Wenger, 1980).  In the present study, combined Cr and 
Gly supplementation induced significant hyper-hydration and substantially attenuated the 
increase in HR at the end of the 30 min run at 35 oC (Figure 5.4).  This attenuation of HR 
during exercise was of similar magnitude to that previous reported by Easton et al. (2007).  
As free water in the form of sweat is primarily lost from plasma and since no differences 
were found in PV changes pre- and post-supplementation despite the increase in TBW, 
ICW and ECW, it can be suggested that the increase in other water compartments resulted 
in water moving towards the plasma due to an osmotic gradient.  This in turn leaves the PV 
unaffected.  It should be also noted that in order for blood volume to be maintained in 
conditions of significant thermal stain and therefore sweating, fluid loss is obtained in 
varying proportions from ECW as well as ICW body water compartments (Sawka, 
Montain, & Latzka, 2001).  Furthermore, as loss of body water increases during exercise in 
the heat as a result of sweating, Tcore also increases (Sawka, et al., 2001).  Therefore, 
increasing body water could potentially result in better maintenance of Tcore during 
exercise in the heat.  Nose et al. (1988) reported a strong association between the loss of 
water in sweat and urine and the decrease in ICW after prolonged exercise in the heat 
(Nose, Mack, Shi, & Nadel, 1988).  In the present study (Chapter 5), Cr and Gly induced 
an increase in ICW and consequently, there was a significant attenuation in the rise of Tcore 
during exercise in the heat (Figure 5.7).  It is possible that this Cr- and Gly-induced 
increase in ICW resulted in an increase of the specific heat capacity of the body (Kilduff, 
et al., 2004).    
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Published studies to date appear to confirm the reduction of Tcore during exercise in the 
heat following Cr supplementation (Easton, et al., 2007; Kern, et al., 2001; Kilduff, et al., 
2004).  Conversely, when Gly was used alone, ICW was increased without significantly 
attenuating the rise in Tcore during the exercise period (Easton, et al., 2007).  The effects of 
Gly ingestion on Tcore and thermoregulation in general during exercise in the heat is 
equivocal, with several studies reporting a reduction in Tcore during exercise (Lyons, et al., 
1990) and numerous other studies finding no such effect (Latzka et al., 1998; Murray, et 
al., 1991).  In addition, several studies concluded that PV expansion has no effect on 
thermoregulatory responses or exercise performance during exercise in the heat (Grant, et 
al., 1997; Watt, Garnham, Febbraio, & Hargreaves, 2000).  These conflicting results and 
assertions provide strong support that the thermoregulatory benefits exhibited with Gly 
ingestion in the present study did not arise from any PV expansion but most likely from an 
increased heat capacity of the body.  Nevertheless, it should also be noted that these 
thermoregulatory benefits were exerted when Gly was co-ingested with Cr. 
Despite the significant increase in TBW and consequently improvement in cardiovascular 
and thermoregulatory responses during exercise, no differences in V̇O2max were observed 
during running at 60% V̇O2max.  Coyle proposed that a reduction in BM induced by 
dehydration would impact on RE during marathon running by reducing the oxygen cost of 
running (Coyle, 2004).  In contrast, hyper-hydration should theoretically increase the 
oxygen cost of running and therefore RE.  However, no such effect was found in the 
present study.  Furthermore, there was no increase in V̇O2 over time during the trial at 10 
°C.  The latter finding indicates that the subjects were working steadily at the calculated 
individual running speed corresponding to 60% of V̇O2max.  It should be noted that this 
relatively low intensity was chosen in order to ensure that the present data would be 
comparable with previous studies conducted under similar conditions (Kern, et al., 2001).  
Furthermore, the relatively low intensity was chosen as to secure that all subjects could 
complete the experiment in the heat while it was high enough to observe possible 
adaptations in cardiopulmonary or thermoregulatory parameters encountered with 
supplementation.  However, V̇O2max was increased during the trial in the heat.  This was 
an expected effect as when exercising in hot environmental conditions, Tcore rises 
accordingly.  It has been shown that with an increase in Tcore, V̇O2 (and therefore RE) also 
increases (MacDougall, Reddan, Layton, & Dempsey, 1974).  Despite this observation, no 
discernable difference in V̇O2 between pre- and post-supplementation trials was reported.  
No other changes in any of the respiratory variables could be observed in the pre- and post-
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supplementation trials.  Similar results have been reported in several other studies using Cr 
as the hyperhydrating agent (Kilduff, et al., 2004) as well as during constant load exercise 
in the study by Easton et al. (2007) where hyper-hydration was induced by Cr and Gly 
(Easton, et al., 2007).  The data from Chapter 5 suggest that an increase in BM of 
approximately 1.4% (average increase in BM in the present study) has no significant effect 
on V̇O2.  Whether such an increase in BM would influence running performance remains 
to be determined.  Furthermore, as HR responses reflect those of V̇O2 (Fudge et al., 2007), 
the finding that HR during exercise was not significantly different between pre- and post-
supplementation trials conducted at 10 °C is further evidence against any detrimental 
metabolic effect of the added BM induced by hyper-hydration on RE. 
5.5 Conclusion  
A hyper-hydration strategy that combines Cr and Gly supplementation for 7 days increased 
BM and TBW and consequently reduced cardiovascular and thermal strain but did not 
significantly affect the oxygen cost of running at 60% of V̇O2max at 35 oC in trained 
runners.  The finding that a significant increase in BM did not negatively impact on RE of 
trained runners, supports the use of effective hyper-hydration strategies during endurance 
running when conditions so dictate (i.e., running in hot and humid conditions).  Further 
studies are necessary however to confirm these findings during faster running speeds 
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6. General Discussion 
 
The primary objectives of the studies described in the previous chapters were: 
1. To compare data extracted from a well-controlled study to previous investigations that 
did not control for primary confounding factors that could have adversely affected the 
results.  This was investigated by examining the effects of a nutritional supplementation 
(GAKIC) on fatigue during high-intensity, repeated cycle sprints in trained cyclists.   
2. To examine the application of established guidelines for food and fluid intake on an elite 
group of endurance runners.  This was achieved by assessing the food and macronutrient 
intake of elite Ethiopian distance runners during a period of high-intensity exercise training 
at altitude and prior to major competition.  The data were also compared to previous 
studies conducted on East African runners. 
3. To describe the drinking behaviours of elite male marathon runners during major city 
marathons.  The results from the current study allowed direct comparison to established 
guidelines on optimal hydration during long distance running. 
4. To investigate the effects of a hyper-hydration strategy that combines Cr and Gly 
supplementation on thermoregulatory responses in hot and cool conditions.  The data 
allowed examination of a possible method that will bring together the established 
guidelines and the data extracted from “real world” studies. 
6.1 Commercial supplements and the industry role 
Chapter 2 examined the issues associated with mixed commercial supplements as well as 
the lack of well-controlled studies conducted on trained subjects while focusing on a 
specific commercial supplement (GAKIC).  Notably, the data from previous investigations 
(Buford & Koch, 2004; Stevens, et al., 2000) suggested that supplementation with GAKIC 
enhances peak power output and attenuates the decline in power output during repeated 
high intensity sprints (Buford & Koch, 2004; Stevens, et al., 2000).  In the initial study, 
(Stevens, et al., 2000), it was demonstrated that GAKIC supplementation increased muscle 
force production by up to 28%, increased total muscle work by at least 12% and improved 
overall performance compared to Pl.  The high intensity experimental protocol of Stevens, 
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et al., (2000), consisted of 35 maximal, isokinetic repetitions at a rate of 90°·s-1 knee 
extensions.  In the later study, Buford & Koch (2004) reported a significant difference in 
mean power output during high intensity exercise consisting of 5 repeated sprints of 10 s 
on a cycle ergometer.  Repeated measures analysis of covariance indicated a significant 
difference between Pl vs. GAKIC in the pattern of change in mean power output over the 
five sprints.  Buford & Koch (2004), using a Post hoc analysis revealed further that the 
decrease in mean power output between sprints 1 and 2 was significantly less with GAKIC 
than with Pl (-1  9 W vs. -47  18 W respectively).  Furthermore, no differences were 
reported in the variables of peak power output or fatigue index between the two treatments.  
Although the experimental designs in the study by Buford and Koch (2004) as well as in 
the investigation presented in Chapter 2 were identical, the outcomes of the two studies 
were different.  For instance, the well-trained male cyclists, who were studied in Chapter 2, 
completed two supra-maximal sprint tests each involving 10 sprints of 10 s separated by 50 
s rest intervals on an electrically braked cycle ergometer.  No differences were found in 
peak power between conditions which declined from the 1st sprint (Pl: 1332  307 W, 
GAKIC: 1367  342 W) to the 10th sprint (Pl: 1091  229 W, GAKIC: 1061  272 W).  
Mean power declined from the 1st sprint (Pl: 892  151 W, GAKIC: 892  153 W) to the 
10th sprint (Pl: 766  120 W, GAKIC: 752  138 W) and did not differ between conditions.  
Fatigue index remained at ~38% throughout the series of sprints and did not differ between 
conditions.  Therefore, GAKIC supplementation did not have an ergogenic effect on 
muscle power output or attenuation of fatigue during repeated sprints in trained cyclists 
and this conclusion is in contrast to previous investigations (Buford & Koch, 2004; 
Stevens, et al., 2000).   
The data presented in Chapter 2 raise two main concerns.  The first and most notable is the 
fact that findings of the previous studies (Buford & Koch, 2004; Stevens, et al., 2000) 
differ from the findings of the current thesis and this could be due to differences existing in 
the experimental design and methodology employed.  The fact that trained athletes were 
employed in the present study (Chapter 2) while non-athletes took part in studies by 
Stevens et al. (2001) and Buford et al. (2004) may account for the existing discrepancies in 
findings.  Indeed, as indicated in Figure 6.1, Buford and Koch (2004) found the smaller 
decline in power output for GAKIC compared with Pl between sprints 1 and 2.  Notably, 
the values in sprint 1 vary between GAKIC and Pl treatments.  This fact may be used as 
indicator regarding the training status of the participants.  In general, the reliability of a 
performance test refers to the consistency or reproducibility of performance when someone 
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performs the test repeatedly (Hopkins, 2000).  The first discrepancy in the methodology is 
the frequent exposure to high-intensity exercise on an almost daily basis, which may 
eliminate performance variability (Hopkins, et al., 2001).  Secondly, physical conditioning 
during the course of a study should not change to the same extent in trained as in non-
trained individuals.  In the study by Buford and Koch (2004) untrained participants were 
utilised.  Therefore, a systematic change (non-random change) in the mean value between 
2 trials that applies to all study participants could be possible.  This systematic change may 
be learning or training effect and is an important issue when volunteers perform a series of 
trials as part of a monitoring programme.  Generally, untrained individuals perform the 
second trial better than the first, because they benefit from the experience of the first trial 
and learn how to do the test (Schabort, Hawley, Hopkins, & Blum, 1999).  In tests of 
human performance, that may depend on effort or motivation, volunteers might also 
perform better in the second trial because they want to improve (Hopkins, 2000).  Thirdly, 
in cases of trained participants, it is likely that the outcome of a human performance test is 
affected by small details an athlete is accustomed to or by practices adopted by each athlete 
(e.g., using customised cycling shoes and pedals, fixed cycling position etc.).  Furthermore, 
the typical error between the experiment and reliability study becomes greater when 
differences in equipment, researchers, environment and characteristics of the volunteers are 
observed (Hopkins, 2000).  Finally, the margin of error widens when non-trained athletes 
are utilized in a study, thus assuming a constant random error in absolute value rather than 
a constant error in percent value contributed by equipment or examiners.  This error will 
have less impact on the overall outcome when expressed as a percentage of the higher 
power output of trained individuals (Hopkins, et al., 2001).  Therefore, studies should 
minimize any learning effects (e.g., by utilizing trained-athletes) as well as get subjects to 
perform practice (or familiarisation) trials to reduce these effects.  Thus, interpretation of 
the effectiveness of a study’s outcome should be taken from tests with high reliability.  In 
the present study (Chapter 2), variability in performance trials between familiarization 
trials was small (i.e., less than 5%) as would be expected from subjects who are well 
accustomed to the exercise protocols employed in the study (Coleman, et al., 2005; 
Hebestreit, et al., 1999; Hopkins, et al., 2001).  The more stringent methodology used in 
the present study ensured that all possible confounding factors were minimised. 
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Figure 6.1 Mean power outputs over five repeated cycling sprints with GAKIC and placebo 
treatments (N = 10, mean   SD).  *Repeated measures ANCOVA indicated an overall 
significant difference (P = 0.039) between GAKIC and Pl over the course of five sprints, with 
a significantly (P = 0.038) smaller decline in power output for GAKIC compared with Pl 
between sprints 1 and 2.  Adapted from Buford and Koch (2004). 
 
As described in Chapter 1, the consumption of supplements is motivated by the pursuit of 
“performance enhancement”.  Athletes are constantly searching for new dietary 
supplements in an attempt to maximize athletic performance, to prevent diseases, to 
compensate for an inadequate diet and/or to overcome their own athletic limits (Alves & 
Lima, 2009).  Consequently, the need to produce novel supplements stimulates the industry 
to manufacture “cocktails” consisting of mixed ingredients in an attempt to maximize the 
potential effect of the product thus making it more attractive to athletes (Green, et al., 
2001).  Additionally, the lack of strict regulations in supplement production can place the 
consumer at significant risk.  DSHEA, which amended the Federal Food, Drug and 
Cosmetic Act, created a new regulatory framework for the safety and labelling of dietary 
supplements.  Under this law, the manufacturer is responsible for determining that the 
dietary supplements it manufactures or distributes are safe (see also Chapter 1).  Notably, 
Green at al. (2001) demonstrated this point clearly.  These authors (Green, et al., 2001) 
analysed 12 brands of supplements by means of high-pressure liquid chromatography to 
identify the true ingredients in each package.  The supplements contained 8 different 
steroids and were randomly selected for purchase in stores that supply nutritional products 
to athletes.  Surprisingly, only 1 brand met the DSHEA labelling requirements (1994).  11 
of 12 brands that did not meet the labelling requirements, contained less than the stated 
dose, 1 brand had 177% of the stated dose, and 2 brands contained none of a stated 
ingredient (Green, et al., 2001).  Moreover, one brand contained 10 mg of testosterone, 
which, is an anabolic steroid, and its use is prohibited in the sporting arena (Green, et al., 
2001).  With the stringent rules adhered to by governing bodies of sports, this type of 
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contaminated supplement could cost the athlete immediate disqualification.  The current 
study by Green et al (2001) verifies the concerns that the labelling of some “sports” 
nutritional supplements does not accurately reflect what is contained in the product.  
Therefore, athletes need to carefully consider even the use of “legal” nutritional 
supplements since manufacturing standards are not the same as pharmaceutical ones 
(Calfee & Fadale, 2006). 
The modern idea of producing nutritional “cocktails” seems to be related with “GAKIC” 
supplementation.  Surprisingly, when the Chapter 2 investigation was sent for review to the 
journal of Medicine and Science in Sports and Exercise, the following comments were 
received and clearly state that there is no rationale for combining the specific compounds 
of GAKIC.  The following comments are notable to the study “To the opinion of this 
referee, there does not seem to be a clear physiological rationale for ingesting these 
specific compounds in combination.  The study conceivably would have been much more 
interesting if the effects of the isolated components had been studied, alone or in 
combination.”  The justification for further investigation was to expand on why this 
specific combination was used in the supplement (with a specific dosage and time), and to 
base the findings on the previous studies.  This interference of the commercial industry in 
the science of nutritional supplementation results in non-established outcomes, which is the 
second important conclusion of the investigation in Chapter 2.  Therefore, it is imperative 
to make a connection between the marketing of supplements by the commercial industry 
and consumption by athletes.  Indeed, it appears that “GAKIC” or “GAKIC HARDCORE” 
or “GAKIC Pro Series” as it is now known in the market (GAKIC, 2010), is the result of 
the industry’s need to produce novel supplements.  It should be noted that in both previous 
studies (which are referenced on the label of the supplement bottle) (Buford & Koch, 2004; 
Stevens, et al., 2000) it was concluded that the specific combination of amino- and keto-
acids contained in GAKIC worked synergistically in order to improve high-intensity 
exercise performance through their relevant metabolic pathway(s).  Nevertheless, both 
studies were unable to report any clear mechanism(s) by which the components of GAKIC 
acted in the way claimed by the manufacturer (individually or synergistically).  
Unfortunately, the supplement is on the market despite the fact that the instantaneous 
ergogenic effects claimed to be yielded by the product do not exist according to current 
evidence found in the investigation presented in Chapter 2.  In the case of GAKIC, athletes 
may choose to consume this specific nutritional “aid” in order to enhance competitive 
performance and promote adaptations to training spending approximately $70  per month 
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(see also Table 1.1 for direct comparison with other nutritional supplements).  
Nevertheless, as mentioned in Chapter 1, before deciding to use a supplement, athletes 
should always consider the issues of efficacy, safety and legality/ethics associated with the 
product (Burke, et al., 2009), and decisions about effectiveness must be extrapolated from 
the best available research.  After controlling the primary cofactors, it seems that GAKIC 
should be placed in the category of “apparently ineffective” supplements (Table 1.2) based 
on the data presented in Chapter 2. 
6.2 Food and fluid intake of elite endurance runners 
Chapters 3-4 provided a rare insight into the lifestyle, training practices, and food and fluid 
intake strategies of some of the most successful endurance runners in the world.  Both 
investigations in these chapters also aimed to assess the food and fluid practices of elite 
endurance runners and compare them to previous studies, as well as to the current 
recommendations for endurance athletes.  A number of studies have reported the dietary 
intake and energy balance status of elite African endurance runners (Christensen, et al., 
2002; Fudge, et al., 2008; Fudge, et al., 2006b; Mukeshi & Thairu, 1993; Onywera, et al., 
2004).  Elite East African runners may be considered as an appropriate target group for 
conducting investigations, because they dominate endurance running (Fudge, et al., 2008; 
Onywera, et al., 2004; Scott & Pitsiladis, 2007).  In the first of these studies, Mukeshi and 
Thairu (Mukeshi & Thairu, 1993) estimated the EI of male, long distance Kenyan runners 
through a combination of questionnaires and direct observation.  Remarkably low EI (9790 
kJ·day-1 on average) was reported, while the average CHO intake was 441 g (8.1 g·kg-1 of 
BM per day) or 75% of TEI.  However, in subsequent studies (Christensen, et al., 2002; 
Fudge, et al., 2008; Fudge, et al., 2006b; Onywera, et al., 2004), substantially higher 
estimates of EI were noted in comparison to the initial data.  For example, Christensen et 
al. (2002) reported an average EI of 13210 kJ·day-1, while the consumption of CHO was 
476 g (8.7 g·kg-1 BM, 71% of TEI).  Similarly, Onywera et al. (2004) reported an average 
EI of 12486 kJ·day-1 (CHO 607 g, 10.4 g·kg-1 BM and 76.5% TEI), while estimated EI in 
two studies by Fudge and colleagues was 13241 kJ·day-1 (CHO 552 g, 9.8 g·kg-1 BM and 
71% TEI) (Fudge, et al., 2006b) and 12300 kJ·day-1 (CHO 580 g, 9.8 g·kg-1 BM, 79% TEI) 
(Fudge, et al., 2008), respectively.  Chapter 3 contains the only investigation which has 
been currently conducted on elite Ethiopian endurance runners.  It was found that the 
athletes studied, met macronutrient dietary recommendations and guidelines for endurance 
athletes (Rodriguez, et al., 2009), but did not meet the guidelines for fluid intake (Sawka, 
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et al., 2007).  For instance, total average EI was 13375 ± 1378 kJ and is in agreement with 
previous studies (Christensen, et al., 2002; Fudge, et al., 2008; Fudge, et al., 2006b; 
Onywera, et al., 2004) (~ 12809 kJ·day-1 on average).  Furthermore, macronutrient intake 
of Ethiopian long distance runners fulfilled recent recommendations (Rodriguez, et al., 
2009).  CHO intake was 64.3% TEI (9.7 g·kg-1 per day) and the daily CHO intake was 545 
± 49 g (Figure 3.2, Figure 3.3), while recommendations for male and female athletes range 
between 6 to 10 g·kg-1 of BM per day (Rodriguez, et al., 2009).  These results are also in 
agreement with previous studies (Christensen, et al., 2002; Fudge, et al., 2008; Fudge, et 
al., 2006b; Mukeshi & Thairu, 1993; Onywera, et al., 2004) when the daily amount of 
CHO was well above 65% of TEI, ranging from 8.1 to 10.4 g·kg-1 BM.  Protein intake was 
12.4% of TEI (Figure 3.2, Figure 3.3) (1.76 g·kg-1 BM per day with a daily intake of 99 ± 
13 g) of which 76% was delivered from vegetable sources (Table 3.3) and well within the 
current recommendations for endurance athletes (1.2 to 1.7 g·kg-1 BM per day) 
(Rodriguez, et al., 2009).  This is also in agreement with the literature (Christensen, et al., 
2002; Fudge, et al., 2008; Fudge, et al., 2006b; Onywera, et al., 2004) where daily protein 
intake ranged from 1.3 to 2.2 g·kg-1 BM.  Although, the values from Chapter 3 (23.3% 
TEI, Figure 3.2) for fat intake were in agreement with the guidelines (Rodriguez, et al., 
2009), they were somewhat higher in comparison to values (6.6 to 17.4% of TEI) observed 
in previous investigations (Christensen, et al., 2002; Fudge, et al., 2008; Fudge, et al., 
2006b; Mukeshi & Thairu, 1993; Onywera, et al., 2004).  Additionally, results from 
Chapter 3 corroborate the findings of previous studies (Christensen, et al., 2002; Fudge, et 
al., 2008; Fudge, et al., 2006b; Mukeshi & Thairu, 1993; Onywera, et al., 2004) regarding 
fluid intake.  In fact, the athletes consumed approximately 1.75 L·day-1 of fluids which 
comprised mainly of water and athletes did not in general consume water before or during 
training; on some occasions small amounts of water were consumed following training.  
Onywera and colleagues (Onywera, et al., 2004) reported a modest fluid consumption (2.3 
L·day-1).  Similar fluid intake (1.8 L·day-1) was observed by Fudge et al. (Fudge, et al., 
2006b) and in a subsequent study by the same research group (2.3 L·day-1) (Fudge, et al., 
2008).  These studies collectively demonstrate that elite East African endurance runners do 
not consume any fluids before or during training, whilst modest amounts of fluids are 
consumed after training and only by a small number of runners (Fudge, et al., 2008; Fudge, 
et al., 2006b; Onywera, et al., 2004).  According to the current recommendations (Sawka, 
et al., 2007) athletes are advised to consume adequate amounts of beverages in order to 
prevent significant dehydration (> 2% BM loss from water deficit) and excessive changes 
in electrolyte balance.  As a consequence, athletes are recommended to consume ~5–7 
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mL.kg-1 BM at least 4 h before the exercise task, while a 0.4 to 0.8 L.h-1 (ad libitum) range 
is suggested during exercise.  ACSM prevailing guidelines (Sawka, et al., 2007) advise 
athletes to drink ~ 1.5 L of fluid for each kg of BM lost.  Therefore, the amount of fluids 
(as dietary water intake) consumed by the subjects of the study presented in Chapter 3 
would be inadequate to maintain the hydration status of the athletes. 
To supplement the investigation of Chapter 3 regarding the drinking behaviours of 
successful elite marathon runners and in the process assess the efficacy of the current fluid 
intake recommendations, a retrospective analysis of the drinking behaviours of 10 male 
athletes during 13 successful city marathons was undertaken using available video footage 
(Chapter 4).  It should be noted that there is almost no information on what the best 
marathoners drink when racing (for a review of the marathon running literature see 
reference (Cheuvront & Haymes, 2001b).  The ambient conditions during the 13 studied 
marathon races were 15.3 ± 8.6 oC (ambient temperature) and 59 ± 17% relative humidity; 
average marathon competition time was 02:06:31 ± 00:01:08 (h:min:s).  In fact, the data of 
the investigation in Chapter 4 demonstrate a wide range of individual rates of fluid 
ingestion by the elite runners during major city marathons (Figure 4.2).  Notably, no 
significant correlations were found between total drink duration, ambient temperature (r < 
0.1, P = 0.77; Figure 6.2) and relative humidity (r < 0.5, P = 0.12; Figure 6.3) of the 
marathon races.  Warmer conditions did not always result in greater total drinking 
durations.  For example, during the London 2006 marathon the winning athlete consumed 
more fluid than during the London 2007 marathon (2290 vs. 1400 mL) even though the 
2006 race was run in cooler conditions (10 vs. 18 °C ) (Table 4.1).  Similarly, the runner in 
the New York 2008 marathon consumed less fluid (73 mL) than did the winner of the 
Fukuoka 2009 marathon (1458 mL) even though both races were run at almost identical 
conditions (6 vs. 7 °C, respectively).  The second significant finding of the study in 
Chapter 4 is that the fluid intake rates of elite runners (0.55 ± 0.34 L.h-1) are within the 
current ad libitum fluid intake recommendations of 0.4 – 0.8 L·h-1 initially proposed by 
IMMDA (Noakes, 2003a) and subsequently adopted by the ACSM (Sawka, et al., 2007).  
However, physical data collected during the Dubai 2009 marathon showed that the athlete, 
who set the previous world marathon record in 2008, finished the race successfully with a 
reduction in BM of 5.7 kg equivalent to a 9.8% BM reduction.  Notably, the fluid intake 
rates (> 0.8 L.h-1) of the runner exceeded the upper limit of the current guidelines, while his 
estimated sweat rate was approximately 3.6 L.h-1.  Many investigations (Muir, et al., 1970; 
Pugh, et al., 1967; Zouhal, et al., 2010) have also reported that BM losses > 3-4% are 
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common in faster finishing competitors.  Additionally, there appears to be a weak inverse 
relationship between BM loss and athletic performance, leading to the conclusion that the 
fastest finishers usually lose the most weight.  Pugh et al. (1967) examined marathon 
runners by measuring their BM and Tcore during a marathon race under mild  enviromental 
conditions (23 °C ambient temperature and 58% relative humidity) and found that the 
winner’s BM loss was 5.2 kg (6.7% BM).  Those authors (Pugh, et al., 1967) also stated 
that a further condition of success seems to be a high tolerance of fluid loss.  Particularly 
notable is the fact that the majority of those who failed to finish the event had lower weight 
losses (Pugh, et al., 1967).  Therefore, as a consequence of these very high sweat rates, 
recommended fluid ingestion rates seem inadequate for the prevention of significant 
sweat/BM loss in order to maintain athlete’s hydration status, during elite marathon 
running. 
 
Figure 6.2 A plot of ambient temperature (°C) of all marathon races against total time 
consuming fluid (in seconds) during the respective marathon. 
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Figure 6.3 A plot of relative humidity (%) of all marathon races against total time consuming 
fluid (in seconds) during the respective marathon. 
 
In Chapter 4 it was concluded that, elite athletes do not seem to maintain their BM during 
successful marathon racing within current recommended ranges of 2 – 3%.  However, a 
number of limitations regarding the aforementioned Chapter should be stated.  The most 
obvious limitation of the data presented in Chapter 4 is the retrospective survey study 
design involving the analysis of video footage in order to estimate fluid consumption of 
elite runners during marathon racing.  Inevitably, this indirect approach resulted in 
incomplete/missing data as the drinking behaviours of the main protagonists (e.g., race 
leaders) were at times not visible in the footage due to technical problems, drinking being 
obscured by other runners in close proximity, or no footage of a drinking station.  As such, 
some 72% (ranging from 33% for Athens 2008 to 100% London 2007) of all drinking was 
observed on the video footage and therefore incomplete/missing data was extrapolated 
from the observed data (Table 4.2).  The indirect approach used in the present study did not 
allow the composition of the athletes’ drink to be determined.  Furthermore, the lack of 
information about pre-race hydration or CHO status is a further limitation in the attempt of 
assessing the hydration status of the runners.  The average flow rate (i.e., 45.2 mL.s-1) for 
standard sport drink bottles used on the present analysis was determined from a 
supplementary laboratory drinking simulation experiment conducted in recreationally 
active individuals and not elite runners.  There is also an increasing amount of evidence 
accumulating questioning the accuracy of using BM losses during exercise as a surrogate 
marker for changes in TBW (Nolte, Noakes, & van Vuuren, 2011).  In the study presented 
in Chapter 4, the change in BM was calculated as the difference between the BM measured 
immediately before and after exercise (i.e., acclimation experiments and the Dubai 




© Lukas Y. Beis (2012) 
marathon).  As such, the delta BM-derived TBW changes are certainly overestimated as 
the production of metabolic water from fuel oxidation and water released from muscle and 
liver glycogen breakdown are not taken into account (Maughan, Shirreffs & Leiper, 2007).  
This portion of released water from glycogen oxidation during exercise varies among 
athletes depending on the glycogen storage.  For instance, a typical East African diet, rich 
in CHO, allows the optimal storage of liver and muscle glycogen.  This is in contrast to 
what appears to be the case for athletes from industrialised countries, where CHO intake 
can fall at the lower end of the range recommended for endurance athletes (e.g., 6.1 g.kg-1 
BM per day; Moses & Manore, 1991), especially when a typically Western diet of 55–58% 
CHO (ACSM, 2000) is consumed.  Interestingly, it has been calculated that an athlete who 
loses 2 kg of BM during a marathon race would be dehydrated as low as approximately 
200 g when allowance is made for the weight lost due to the production of metabolic water 
and by the release of water stored in glycogen complexes in muscle and liver (Pastene, 
Germain, Allevard, Gharib & Lacour, 1996).  Despite the limitation of BM-derived sweat 
loss estimation, similar measurements would have been desirable in all studied elite 
runners but proved impossible.  Similarly, direct measurement of TBW losses using the 
diluted isotope method (e.g., deuterium oxide) was impossible given the study constraints 
and therefore the term “dehydration” with associated ergolytic effects is not used to 
describe the marathoners.  The present analysis is in conjunction with the limited available 
literature (Daries, et al., 2000) provide reasonable evidence that elite marathon runners can 
perform well despite significant BM loss.  Despite these important limitations, the novel 
approaches adopted in this analysis have allowed meaningful conclusions with regard to 
the drinking practices of elite marathoners during competition to be determined.   
The evidence presented in the current thesis (Chapter 3-4) is not the only reason that 
renders the current recommendations questionable.  “Real world” evidence exists that 
contradicts the prevailing guidelines.  For example, Emile Zatopek (1952 Helsinki 
Olympic Marathon), Jim Peters (Multiple World Marathon Records 1952-1954), Abebe 
Bikila (1960 and 1964 Olympic Marathons), Ron Hill (1970 Edinburgh Empire Games) 
are all runners who did not drink during successful marathon races.  Generally, it has been 
shown that athletes who lose the most BM during marathon and ultra-marathon races as 
well as ironman triathlons are usually the most successful (Cheuvront & Haymes, 2001b; 
Muir, et al., 1970; Pugh, et al., 1967; Sharwood, et al., 2004; Wharam, et al., 2006; 
Wyndham & Strydom, 1969; Zouhal, et al., 2010; Zouhal, et al., 2009).  Additionally, 
Zouhal et al. (2010) studied 643 marathon finishers during the 2009 Mont Saint-Michel 
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Marathon in France.  These authors found BM loss during the marathon to be inversely 
related to race finishing time in 643 marathon runners and was > 3% in runners completing 
the race in less than 3 h (Zouhal, et al., 2010).  It should be noted that the degree of BM 
change varied from a loss of 8% to a gain of 5%.  This range of weight change (-8 to +5% 
BM; Figure 6.4) occurred even though all runners received the same pre-race advice and 
had the same access to fluid during the race.  Consequently, the question has been raised as 
to why so many athletes would choose to lose more than 3% BM when enough fluid was 
available to allow some to gain 5% BM (Zouhal, et al., 2010).  The practical 
implementation of the nutritional guidelines has been questioned (Noakes, 2007a, 2007b; 
Zouhal, et al., 2010), because it seems impossible to make recommendations for all 
situations.  Individuals in different climatic conditions with different fluid losses, different 
modes, durations, and intensities of exercise need to be considered.  It is noted that 
dehydration results from all sweat, respiration, urine, and insensible skin losses (Casa, 
Clarkson, & Roberts, 2005).  Additionally, there is no evidence that fluid intake during 
exercise increases sweat rates, stroke volume, or reduces overall cardiovascular strain (i.e., 
increase HR and reduce stroke volume, cardiac output and mean arterial pressure).  
Furthermore, fluid intake during exercise alters skin and muscle blood flow, increases 
oxygen, and substrate delivery to the working muscle (Fudge, et al., 2006a).  Moreover, 
Noakes et al. (1991) support the suggestion that heat stroke can occur in hot conditions 
without dehydration if the heat from muscle work cannot be removed from the body at a 
rate sufficient to prevent a progressive rise in Tcore (Casa, et al., 2005).  This view of the 
drinking behaviours (i.e., ad libitum) of elite endurance runners is corroborated by the 
investigations presented in Chapters 3-4, as in previous studies (Fudge, et al., 2008; Fudge, 
et al., 2006b; Onywera, et al., 2004).   
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Figure 6.4 Distribution of body weight change in 643 competitors in the 2009 Mont Saint 
Michel marathon. Adapted from Zouhal et al. (2010). 
 
The reduction of the energy cost of movement at a sub-maximal velocity by way of 
reducing BM to improve running performance is well known (Cureton & Sparling, 1980; 
Cureton et al., 1978; Marino et al., 2000; Myers & Steudel, 1985).  When humans or 
animals carry extra mass while running or walking, the energy cost per unit distance 
increases in direct proportion to the additional load which is expressed as a percentage of 
the BM according to Taylor et al. (1980).  In fact, Wyndham and Strydom (1969) reported 
no correlation with percent dehydration and Tcore until a 3% weight deficit had occurred.  
Contrastingly, the study by Armstrong et al. (2006) showed that V̇O2 (expressed relative to 
BM) was not significantly influenced by a loss in BM as high as 5.7% (Armstrong, et al., 
2006).  On the other hand, the widely adopted ad libitum strategy during marathon racing 
seems to produce optimal/winning performances.  Supported by this evidence are the 
findings regarding the marathon runner who set the previous world record in 2008 and 
finished a competitive race (Dubai, 2009) with a BM loss of 9.8%.  This evidence would 




© Lukas Y. Beis (2012) 
suggest that there exists a tolerable range for dehydration that may not negatively impact 
running performance.  Other studies (Muir, et al., 1970; Pugh, et al., 1967; Zouhal, et al., 
2010) can also confirm this notion since a range of 3-4% seems to be common in faster 
finishing competitors.  The evidence may even confer an advantage by preventing a 
significant increase in BM due to the “over-consumption” of large volumes of fluid.  Here 
a “drink only when you are thirsty” fluid intake strategy (Chapters 3-4) may yield to a 
balance between drinking enough fluid to maintain an optimal zone of tolerable 
dehydration and reducing the absolute energy cost of movement by reducing the athletes’ 
BM. 
6.3 Hydration and running economy 
In 2007, ACSM replaced their prior Position Stand (Convertino, et al., 1996) with an 
updated one on exercise and fluid replacement (Sawka, et al., 2007) that advocates 
drinking ad libitum (0.4 - 0.8 L·h-1) during exercise (with the lower value for slower, 
lighter individuals competing in cooler environments, and the higher value for faster, larger 
individuals competing in warmer environments) in order to prevent excessive dehydration 
(i.e., < 2% BM loss).  By comparison, when given the data extracted from the investigation 
in Chapter 4 regarding the extremely high values of body water deficit during a race, (i.e., 
~10% BW loss) an alternative hydrating strategy, rather than the widely accepted fluid 
intake method, is warranted in order to bring together the established guidelines and data 
extracted from “real world” studies (e.g., Chapter 4).  The strategy investigated in Chapter 
5 may expand the body’s water compartments, maintain PV, and consequently attenuate 
the rise in Tcore and HR during exercise--especially in hot and humid environments as well 
as being practical and direct in order to be followed by elite athletes.  This alternative 
hydrating strategy was achieved by means of a pre-exercise water loading strategy with use 
of hydrating agents (i.e., Cr and Gly) (Magal, et al., 2003; Riedesel, et al., 1987) in 
combination (Easton, et al., 2007).  
Hydration status appears to be a critical factor for temperature and cardiovascular 
regulation during exercise in the heat (Gonzalez-Alonso, et al., 1995; Nadel, et al., 1980).  
In the investigation presented in Chapter 5, combined Cr and Gly supplementation was 
administered to 15 male endurance runners during a 7-day period.  Exercise trials were 
conducted pre- and post-supplementation at 10 and 35 °C and 70% relative humidity.  BM 
and TBW increased by 0.90 kg and 0.71 L, respectively following supplementation.  
Despite the significant increase in BM, supplementation had no effect on V̇O2 and 
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therefore RE.  Both HR and Tcore were attenuated significantly during exercise after 
supplementation.  Nevertheless, TC and RPE did not significantly differ between pre- and 
post-supplementation.  Similarly, no significant differences were found in PV pre- and 
post-supplementation despite the increase in TBW, ICW and ECW.  Considering the 
aforementioned and the fact that free water in the form of sweat is mainly lost from the 
plasma, it can be suggested that the increase in other water compartments resulted in water 
moving towards the plasma due to an osmotic gradient.  This in turn leaves the PV 
unaffected.  It should also be noted that in order for blood volume to be maintained in 
cases of sweating, fluid loss is obtained in varying proportions from ECW as well as ICW 
compartments of the body (Sawka, et al., 2001; Verbalis, 2003) (Figure 6.5).  Furthermore, 
it would be expected that as body water loss increases through sweating, there would be an 
increase in Tcore during exercise in the heat (Sawka, et al., 2001).  Therefore, increasing the 
body water would result in maintaining Tcore during exercise in the heat.  In the study 
present in Chapter 5, Cr and Gly induced an increase in ICW and consequently there was a 
significant attenuation in the rise of Tcore by 0.28 °C during exercise in the heat (Figure 
5.7).  It is possible that ICW was raised by Cr and Gly supplementation which, as a 
consequence, resulted in an increase of the specific heat capacity of the body (Kilduff, et 
al., 2004). 
 
Figure 6.5 Schematic representation of body fluid compartments in man.  The shaded areas 
depict the approximate size of each compartment as a function of body mass.  The figures 
indicate the relative sizes of the various fluid compartments and the approximate absolute 
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volumes of the compartments (in liters) in a 70-kg adult.  TBW = total body water; ICF = 
intracellular fluid; ECF = extracellular fluid; ISF = interstitial fluid; IVF = intravascular fluid.  
The arrows indicated the direction of fluid shift during sweat loss.  Adapted from Verbalis 
(2003). 
 
Supplementation with combined hydrating agents such as Gly or Cr has consistently 
produced modest fluid retention of 400-800 mL (Kern, et al., 2001; Magal, et al., 2003; 
Riedesel, et al., 1987).  Although the combination of the hyper-hydrating agents previously 
mentioned results in an increase in TBW, and hence in a reduction in certain 
cardiovascular and thermoregulatory responses (Easton, et al., 2007), the increase in 
hydration status due to an increase in BM may be expected to increase RE as previously 
described in Chapter 5.  Nevertheless, the data from the current investigation in Chapter 5 
indicated that this increase in BM had no negative effect on trained endurance runners’ RE 
at 60% V̇O2max, therefore, it would suggest that a pre-exercise hyper-hydration method 
may be ideal for optimal hydration on endurance runners.  The present data suggest that an 
increase in BM of about 1.4% (i.e., average increase in BM in the present study) has no 
detrimental effect on V̇O2 and consequently (at least theoretically) on exercise 
performance.  It was found that a pre-exercise water loading strategy using a combination 
of hydrating agents such as Cr and Gly resulted in a significant increase in body water 
compartments, which reduced cardiovascular (Figure 5.4) and thermoregulatory (Figure 
5.7) responses during running at 35 oC and had no impact on the oxygen cost of running 
and thus the RE of runners at 60% V̇O2max. 
6.4 Future directions  
Chapter 2 demonstrated that a specific combination of amino and keto acids contained in 
GAKIC supplementation did not act as an ergogenic aid.  Nevertheless, a future study of 
the effects of the isolated components, alone or in combination may be interesting for 
further research. 
Chapters 2 and 3 reported that elite endurance runners did not consume the recommended 
amounts of fluids before, during and after training, as well as during running in the most 
prestigious marathon races.  Nevertheless, a deeper insight into the hydration status with 
direct measurements on sweat loss and body water compartments would be beneficial to 
the literature as there is a need for novel data that can be obtained from some of the best 
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athletes in the world in order to assess and possibly improve the applicability of the current 
recommendations to elite athletes. 
Given the association between attainment of a critical Tcore and the development of fatigue 
and taking into consideration that hyper-hydration induced by Cr and Gly supplementation 
attenuated increase in Tcore and had no impact on the oxygen costs of running, it is tempting 
to speculate that the hyper-hydration strategy used in this study may be expected to 
increase exercise performance.  However, this needs to be clarified by future studies, by 
further examining how the positive effects of cardiovascular and thermoregulatory 
responses can impair exercise performance.   
As suggested in Chapter 1, the methodology above (Chapter 5) should be applied to elite 
athletes in “real world” conditions to extract accurate data.  The guidelines for optimal 
hydration status and the practical application of the guidelines have to be researched 
further. 
6.5 General Conclusions 
Chapter 1 explores the factors which affect exercise performance.  Chapter 1 also raises the 
issue of difficulty to establish well acceptable guidelines.  Additionally, it demonstrates the 
need for evidence based data on well-trained and elite athletes.  Therefore Chapter 2 
focuses on a specific nutritional supplement (GAKIC) in order to compare the data with 
previous studies using non-trained athletes as well as to expose potential issues associated 
with the commercial industry and sports enhancing supplements.  Chapter 3 and 4 provide 
a rare insight into the lifestyle, training practices, and food and fluid intake strategies of 
some of the most successful endurance runners in the world.  The results of the research 
allow direct comparison with the established guidelines for food and fluid intake for 
endurance athletes as well as with previous studies conducted on elite runners.  Chapter 5 
provides a possible method that could bring together the established guidelines regarding 
the hydration status during running and the data extracted from “real world” studies.  The 
main findings are as follows:  
1. Chapter 2 reported that GAKIC supplementation does not enhance high intensity 
exercise performance.  After controlling for possible confounding factors that could have 
adversely affected the results, it was found that GAKIC supplementation had no effect on 
peak power, mean power or fatigue index, in contrast to the findings of previous studies 
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(Buford & Koch, 2004; Stevens, et al., 2000).  On the basis of these findings and those of 
previous studies involving the individual components of GAKIC, there appears little 
evidence to support the ergogenic effects of GAKIC during high intensity exercise 
performance when applied to well-trained subjects. 
2. Chapter 3 found that elite Ethiopian runners met dietary recommendations for endurance 
athletes for macronutrient intake but not for fluid intake.  These data are in accordance 
with previous studies conducted on elite Kenyan endurance runners.  
3. Chapter 4 found that the estimated fluid intake rates of the winners during the 13 races 
reported in the investigation (Table 4.2) are broadly within current recommendations 
(Sawka, et al., 2007).  However, these elite runners do not seem to maintain their BM 
during successful marathon racing within current recommended ranges of 2 – 3%.  On the 
other hand, this apparently widely adopted ad libitum strategy during marathon racing 
seems to produce optimal/winning performances.  This evidence and the finding that the 
runner, who set the previous world marathon record in 2008, finished a competitive race 
(Dubai, 2009) with a BM loss of 9.8%, would suggest that there exists a tolerable range for 
dehydration that may not negatively impact on running performance, but may even confer 
an advantage by preventing a significant increase in BM due to the “over - consumption” 
of large volumes of fluid.  This finding is in accordance with a recent meta – analysis 
which suggests that ad libitum drinking produces optimum performance (Goulet & Dugas, 
2010).  
4. Chapter 5 found that supplementation with combined Cr and Gly for 7 days was 
effective in increasing TBW and reducing cardiovascular and thermal strain during 
prolonged exercise in the heat.  Despite the increased hydration resulting in a higher BM 
associated with combined Cr and Gly, there were no changes in runners’ energy demands.  
These results are in accordance with a previous study by Easton et al. (2007).  Hyper-
hydrating before exercise through Cr and Gly seems to be a key for maintaining body 
euhydration for longer.  Finally, no measures were taken that would enable the potential 
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Appendices 
Appendix A: Subject Information Sheet 
University of Glasgow 
Institute of Biomedical and Life Sciences 




Study title: The effects of glycine-arginine-[alpha]-ketoisocaproic acid on fatigue during 
repeated cycle sprints in trained humans.                                
You are being invited to take part in a research study.  Before you decide whether to 
participate, it is important for you to understand why the research is being done and what it 
will involve.  Please take time to read the following information carefully and discuss it 
with friends, relatives and your GP if you wish.  Ask us if there is anything that is not clear 
or if you would like more information.  Take time to decide whether or not you wish to 
take part. 
Thank you for reading this. 
What is the purpose of the study?  We wish to find out whether taking certain previously 
used (by athletes) substances may increase your ability to work hard during cycle sprints, 
by reducing ammonia levels that intense exercise induces.  We will measure your ability to 
perform strenuous exercise lasting approximately 10 s.  The substances you will be 
required to ingest orally are glycine-arginine-[alpha]-ketoisocaproic acid (GAKIC) which 
is commercially available over the counter from most health shops.  This amino-acid 
supplement is popular amongst athletes as it is thought to improve high intensity exercise 
performance especially when repeated bouts of exercise are required (e.g., weight lifting). 
Why have I been chosen?  You have been selected as a possible participant in this 
investigation because you regularly take part in endurance activity and you are in good 
health.  Ten volunteers are being sought. 
Do I have to take part? It is up to you to decide whether or not to take part.  If you decide 
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form.  If you decide to take part you are still free to withdraw at any time and without 
giving a reason. 
What will happen to me if I take part? You will be asked to visit the laboratory on three 
occasions over a three-week period (see Table).  All tests will last approximately 1 h.  You 
will be familiarised to the cycle test during the first visit to the laboratory.  On the first 
experimental cycle test you will consume either 10 g of GAKIC or 10 g of sucrose 45 min 
before the test (to be consumed with fruit juice).  The recommended daily allowance of 
protein and amino acid in the diet is 56 g per day.  For the final week you will take the 
opposite supplement to what you were took initially.  So, if you initially took GAKIC, you 
will then change to the placebo supplement.  You will not know which group you are in, 
until all the tests have been completed.  The protocol for the second supplement is the 
same as the first.  On your first visit to the lab you will be asked to complete two 
confidential questionnaires; the first will allow us to obtain information related to your 
general health; and the second will allow us to quantify your past exercise/activity 
involvement.  
Your heart rate (HR) will be measured throughout exercise using a Polar HR monitor 
strapped round the chest.  During each sprint we will monitor power output throughout.  
Your height, weight and percentage body fat will also be measured on the first visit to the 
lab.  Your percentage body fat will be estimated by a bioelectrical impedance technique, 
which involves placing slightly adhesive small patches (“electrodes”) on your right hand 
and foot and introducing a very small and imperceptible electrical current between these. 
In order to estimate your nutritional intake, we will ask you to record your normal food and 
drink intake for 24-h prior to the test. 
Finally, you will not be able to consume any alcohol 48-h prior to each lab visit.  You will 
be excluded from participating in this study if you take drugs (recreational or performance 
enhancing drugs). 
What are the side effects of taking part? There have been no reported side effects of 
GAKIC ingestion. 
What are the possible disadvantages and risks of taking part?  Exercise has a 
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myocardial ischaemia ("heart attack").  The primary symptom of myocardial ischaemia is 
chest pain on exertion.  If you experience any unusual sensations in your chest during the 
experiment, you should cease exercising immediately.  Some subjects experience mild 
discomfort from prolonged sitting on the seat of the cycle ergometer. 
What are the possible benefits of taking part?  We hope that you will find out more 
about how your body responds to supplementation with GAKIC and subsequent strenuous 
exercise.  This information may help us better understand the mechanisms associated with 
muscle fatigue during strenuous exercise. 
What if something goes wrong?  If you are harmed by taking part in this research project, 
there are no special compensation arrangements.  If you are harmed due to someone's 
negligence, then you may have grounds for a legal action but you may have to pay for it.  
The principal investigators, although not medically qualified are fully trained in Advanced 
Life Support.  In the event of an untoward incident, the principal investigator(s) will 
provide basic life support including chest compressions and ventilation until emergency 
medical staff is on hand.  You may want to consult your GP if you are experiencing any 
side effects from taking part in the study and should also inform the Principal Investigator.  
Will my taking part in this study be kept confidential?  All information about you that 
is collected during the course of the research will be kept strictly confidential 
What will happen to the results of the research study?  Results will be published in a 
peer-reviewed scientific journal once the study is completed.  You will automatically be 
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Table: Schedule of visits and proposed tests. 
 
Visit Test Duration 
(hrs) 
1 Familiarisation and baseline measurements 1 
2 Performance Cycle Test  1 
3 Performance Cycle Test  1 
 
If you wish to find out more about this investigation, you can contact: 
 
Dr Yannis Pitsiladis 
Lecturer, Institute of Biomedical and Life Sciences 
West Medical Building 
University of Glasgow 
Glasgow, G12 8QQ  
Phone: 0141 330 3858 
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Consent Form 
 
I  ...........................................................  give my consent to the research procedures 
which are outlined above, the aim, procedures and possible consequences  of which 
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Appendix B: Subject Information Sheet 
 
University of Glasgow 




Study Title: The effects of hyperhydration on running economy of endurance trained 
runners. 
You are being invited to take part in a research study.  Before you decide whether to 
participate, it is important for you to understand why the research is being done and what it 
will involve.  Please take time to read the following information carefully and discuss it 
with friends, relatives and your GP if you wish.  Ask us if there is anything that is not clear 
or if you would like more information.  Take time to decide whether or not you wish to 
take part.  
Thank you for reading this. 
What is the purpose of the study?  We wish to find out whether taking certain substances 
(previously used by athletes) which increase the volume of water in your body may 
increase the amount of energy you use when running but help you to stay cooler in the 
process.  We will measure your body water, blood volume and weight before and after 
exercise and your heart rate (HR), core temperature (Tcore) and expired gas while running.  
The substances you will be required to ingest orally are creatine (Cr; a food element found 
in high abundance in meat and fish but also made by the body), glycerol (Gly; another 
substance found naturally in the body, which contributes to making energy for exercise).  
Cr in its pure form is commercially available over the counter from most health shops.  
This supplement is popular amongst athletes as it is thought to improve high intensity 
exercise performance especially when repeated bouts of exercise are required (e.g. football, 
rugby). 
Why have I been chosen? You have been selected as a possible participant in this 
investigation because you regularly take part in endurance activity and you are in good 
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Do I have to take part? It is up to you to decide whether or not to take part.  If you decide 
to take part you will be given this information sheet to keep and be asked to sign a consent 
form and fill in a lifestyle questionnaire.  If you decide to take part you are still free to 
withdraw at any time and without giving reason. 
What will happen to me if I take part? You will be asked to visit the laboratory on four 
occasions and a running track once, where a series of assessments will be carried out. All 
experimental trials should last no longer than 2 h.  On your initial visit to the laboratory 
you will be medically examined by a qualified doctor.  The first test will take place in the 
laboratory on a motorised treadmill at a fixed 1% gradient.  During this test you will be 
instructed to run at 10, 11, 12, 13, 14, 15, 16, 17 and 18 kmh-1 (or until volitional 
exhaustion) for 3 minutes at each speed, with a 3-5 min rest interval between each bout 
walking at 4 kmh-1.  The second test is exactly the same, except it is conducted outdoors 
on a 400m running track; an investigator will cycle next to you to monitor and control the 
running speed.  The final four tests will take pace in the laboratory on a motorised 
treadmill; you will be required to run at a constant pace equating to 60% of your maximal 
capacity measured in the first test, for 30 min at 10 oC and 70% humidity. You will then 
receive a 30 min rest period before running again on the treadmill at the same speed as 
before but at 35 oC and 70% humidity.  After the first 5 tests you will consume 2 L of 
experimental drink per day for 6 days and 1 L 5-h before your final test.  The drinks will 
contain 10 g of Cr and Gly (0.75 g·kg-1 BM) dissolved in one litre of warm to hot water 
and flavoured with sugar free fruit juice.  
HR and expired gas will be recorded throughout all tests via a HR monitor and a flexible 
rubber mouthpiece, respectively.  You will also wear an accelerometer whilst running.  In 
addition, you will be required to swallow a harmless recording device (a small pill like 
object) the evening prior to your test.  This will enable the research team to monitor body 
temperature; there is no risk involved in swallowing the pill.  All tests must be conducted 
at approximately the same time of day, and you will be required to wear the same athletic 
clothing/footwear for each test.  During the final four tests we would like to take a small 
amount of blood from an intravenous line in the back of your hand.  Your height, weight 
and percentage body fat will also be measured on each visit to the lab.  Your percentage 
body fat will be estimated by a bioelectrical impedance technique, which involves placing 
slightly adhesive small patches (“electrodes”) on your right hand and foot and introducing 
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In order to estimate your nutritional intake and energy expenditure, we may ask you to 
record your normal food and drink intake for 24-h prior to each test and to keep a diary of 
your physical activity. 
Finally, you will not be able to perform any exercise 24-h prior to testing or consume any 
alcohol 48-h prior to each lab visit.  You will be excluded from participating in this study if 
you take drugs (recreational or performance enhancing drugs). 
What are the side effects of taking part?  Some subjects have previously reported slight 
nausea, gastrointestinal distress (i.e., diarrhoea) and headaches.  The only known 'side 
effect' of oral Cr supplementation that has been reported is a temporary increase in body 
weight.  This increase in body weight is mostly due to an increase in water retention, not 
fat. 
What are the possible disadvantages and risks of taking part?  Exercise has a 
negligible risk in healthy adults, although maximal exercise has a small risk of myocardial 
infarction (“heart attack”).  The primary symptom of myocardial infarction is chest pain on 
exertion. If you experience any unusual sensations in your chest during the experiment, 
you should cease exercising immediately.  Intravenous lines through which blood is 
collected, may cause some bruising and subsequent soreness over the site of puncture and, 
rarely, a small wound (1-2 mm at most), which takes a few days to heal. 
You will breathe through a rubber mouthpiece during the tests, in order for us to collect the 
air you breathe out.  This is similar to the equipment used for snorkelling.  You will also 
wear a nose clip.  You may experience difficulty swallowing while breathing through a 
mouthpiece and wearing a nose clip, due to some pressure in the ears.  In addition some 
subjects experience increased salvation when breathing through a mouthpiece. 
What are the possible benefits of taking part?  We hope to find out more about how 
your body responds to physical exercise after hyper-hydration.  This information will help 
us to decide whether hyper-hydration should be recommended for those participating in 
running training or competition in a hot environment. 
What if something goes wrong?  If you are harmed by taking part in this research project, 
there are no special compensation arrangements.  If you are harmed due to someone’s 
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The principal investigators, although not medically qualified are fully trained in Advanced 
Life Support.  In the event of an untoward incident, the principal investigator(s) will 
provide basic life support including chest compressions and ventilation until emergency 
medical staff is on hand.  You may want to consult your GP if you are experiencing any 
side effects from taking part in the study and should also inform the principal investigator. 
Will my taking part in this study be kept confidential?  All information about you that 
is collected during the course of the research will be kept strictly confidential. 
What will happen to the results of the research study?  Results will be published in a 
peer-reviewed scientific journal once the study is completed.  You will automatically be 
sent a copy of the full publication.  You will not be identified in any publication. 
If you wish to find out more about this investigation, you can contact: 
 
Dr Yannis P. Pitsiladis 
Institute of Biomedical & Life Sciences 
West Medical Building 
University of Glasgow 
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CONSENT 
 







Give my consent to the research procedures which are outlined above, the aim, 
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Appendix C: Ethics Document 
 
UNIVERSITY OF GLASGOW 
FACULTY OF BIOMEDICAL AND LIFE SCIENCES 
 
ETHICS COMMITTEE FOR NON CLINICAL RESEARCH 
INVOLVING HUMAN SUBJECTS, MATERIAL OR DATA 
 





A submission to this Committee does not automatically result in approval. 
Investigators must wait for written approval before commencing data collection. 
Disciplinary measures will be taken if work commences without ethical approval 
being in place. The matter will be referred to the Dean for appropriate action.  
 
THIS APPLICATION FORM SHOULD BE TYPED, NOT HAND WRITTEN. 
 
 
ALL QUESTIONS MUST BE ANSWERED. “NOT APPLICABLE” IS A SATISFACTORY 
ANSWER WHERE APPROPRIATE. 
 
Project Title:  The effects of glycine-arginine-[alpha]-ketoisocaproic acid on fatigue 
during repeated cycle sprints in trained humans.                                
_________________________________________________________________________
__ 
Is this project from a commercial source?   Yes 
 
If yes, give details and ensure that this is stated on the Informed Consent form. 
 
This project is supported  by Iovate Health Sciences Research Inc, Canada. 
 
 



















Address for correspondence relating to this submission: Lab 245, West Medical Building. 














Position held  
 
1. Describe the purposes of the research proposed.  
Dynamic exercise performance can be limited by a reduction in muscular power output 
during high intensity, exhaustive exercise (Lewis & Fulco, 1998).  Numerous dietary 
supplements that potentially limit the reduction in muscle power output during exercise 
have been examined to date, with equivocal results (Williams, 1999).  Lack of 
understanding as to the exact mechanism of fatigue and difficulties in reproducibility and 
objectively measuring high intensity performance are likely to account for these 
differences. 
In vitro experiments and clinical studies have demonstrated that metabolic manipulation of 
nitrogen metabolism using selected ketoacids alone, or in conjunction with certain amino 
acids, can reduce various pathophysiologoical effects of trauma, including clinically 
dysfunctional skeletal muscle (e.g Hirokawa & Walser, 1999; Sandstedt et al. 1992). 
Stevens et al. (2000) have determined that ingestion of a glycine and L-arginine salt of 
[alpha]-ketoisocaproic acid calcium (“GAKIC”) significantly increased resistance to 
fatigue by up to 28% and on average increased total muscle work by approximately 11% 
measured on a computer-controlled isokinetic dynamometer.  Furthermore, Buford & Koch 
(2004) have recently demonstrated that GAKIC is associated with a greater retention of 
mean power measured between the 1st and 2nd sprints during five consecutive sprints on a 
cycle ergometer.  Despite these measured ergogenic effects of GAKIC on resistance to 
skeletal muscle fatigue, the exact mechanism through which GAKIC may have imparted 
these performance gains remains to be determined.  Of further potential interest, is the 
apparent increased peak power produced after GAKIC supplementation during the 5th and 
final sprint.  If GAKIC can increase fatigue resistance then it would be expected that an 
increased cycle-sprint power output would be maintained after 5 sets of sprints.  Therefore 
the aim of the proposed investigation is determine the effects of GAKIC supplementation 
on skeletal muscle power and fatigue measured during 10 consecutive 10 s cycle sprints.  
The study will also provide further information into the potential mechanism underlying 




© Lukas Y. Beis (2012) 
2. Please give a summary of the design and methodology of the project.  Please also 
include in this section details of the proposed sample size, giving indications of the 
calculations used to determine the required sample size, including any assumptions you 
may have made (if in doubt, please obtain statistical advice). 
Methods/Design of investigation 
We propose to study 10 trained male subjects (17-35 yrs) (this sample size is in line with 
the statistical procedures to be used). Subjects will be in good health at the time of testing 
and regularly take part in strenuous exercise.  Eligibility will be assessed by subjects 
undergoing a medical examination (as previously approved by the University Ethics 
Committee).  Subjects will also be required to read and sign the enclosed information 
sheet. 
Protocols 
Subjects will visit the laboratory on three separate occasions.  The first visit will be used to 
explain experimental procedures, collect anthropometric data and record baseline power 
data.  On the second and third session subjects will receive experimental treatments 
(GAKIC or Pl) and will be randomly assigned in a double blind, crossover fashion 
separated by 7 days.  Subjects will be required to complete a 24-h dietary record the day 
prior to each test, which will subsequently be analysed for EI and amino acids. 
Experimental treatments 
Subjects will arrive in the laboratory after an overnight fast before consuming the 
treatment beverage (GAKIC or Pl) in three equal aliquots over a 45 min period.  The 
GAKIC supplement will consist of glycine-L-arginine-[alpha]-ketoisocaproic acid (2.0 g 
glycine plus 6.0 g L-arginine monohydrochloride plus 3.2 g [alpha]-ketoisocaproic acid 
calcium salt) (GAKIC, Iovate Health Sciences International Inc, Mississauga, Canada).  
Based on the 2002/2005 DRI report, the recommended dietary allowance of protein and 
amino acids in the diet is 56 g per day for males aged 19-30 years.   The isocaloric Pl will 
be composed of 9.46 g sucrose.  The GAKIC or Pl will be dissolved in chilled cranberry 
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Exercise trials 
After warm-up subjects will perform a series of ten, 10 s sprints on a Lode-Excalibur sport 
electronically brake cycle ergometer.  Each sprint will be separated by a 50 s rest interval.  
Each sprint will be a modified 10 s Wingate test performed using a resistance of 0.8 N.kg-1.  
Each sprint will be initiated from a dead stop and analysed using computer software for 
power output at each second of the sprint allowing calculation of both 10 second mean 
power and peak power output.  Furthermore, the fatigue index will be determined using the 
following equation: fatigue index % = [(peak power – minimum power)/peak power] x 100 
where minimum power is the lowest power output after the subject achieved peak. 
3. Describe the research procedures as they affect the research subject and any other parties 
involved. 
All experiments will take place in the Laboratory of Human Physiology in the West 
Medical Building.  Dr Yannis Pitsiladis or a qualified (CPR-trained) and experienced 
colleague will be present at all tests.  Dr Pitsiladis is trained in CPR and Advanced Life 
Support. 
Potential participants will be identified either by personal contact or by advertisement.  
They will be asked to meet with the investigators to discuss the project and whether they 
would be suitable as a subject.  All subjects will be healthy individuals without a history of 
any significant medical problem(s).  All subjects will be endurance-trained and therefore 
accustomed to strenuous exercise to exhaustion.  The good health of each subject will be 
established prior to the study by subjects undergoing a medical examination (as previously 
approved by the University Ethics Committee), which is supported by a written assurance 
from the subject.  Subjects with a history of cardiorespiratory or neurological disease will 
be excluded from participation, as will those having an acute upper respiratory tract 
infection.  Subjects who take drugs (recreational or performance enhancing drugs) or who 
have consumed alcohol within 48 h of an experiment will be excluded. 
Close supervision of the subject is ensured at all times by the supervising investigator.   
The well-being of the subject is established at frequent intervals throughout all tests by 
asking the subject "Is everything alright?” Subjects are instructed, prior to the test, to 
respond to this question with a thumbs-up sign if everything is fine, and a thumbs-down 
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questions to establish whether there is a technical problem that could lead to potential 
hazard or whether the subject is feeling unwell.  In either case, the test is immediately 
halted.  All subjects are routinely instructed to cease exercising if they experience any 
discomfort or have any concern for their well-being.  
The risks associated with performing maximal exercise are minimal as long as the subject 
is appropriately instructed and familiarised with the device prior to participation and also is 
appropriately supervised during the experiment.  All exercise bouts are both preceded by a 
5 min "warm-up" and by a 5 min "warm-down".  The latter is of particular importance 
during high-intensity exercise, when the local accumulation of exercise metabolites can 
cause an "expansion" (or vasodilatation) of the blood vessels in the lower limbs, which can 
impair the adequate return of blood to the heart – predisposing to fainting on dismounting 
from the ergometer.  This risk is minimised by having the subject exercise at a mild level 
during recovery to "wash away" these metabolites and therefore to restore the capacity of 
the involved blood vessels to their resting levels. 
4. What in your opinion are the ethical considerations involved in this proposal?  (You may 
wish for example to comment on issues to do with consent, confidentiality, risk to subjects, 
etc.) 
Exercise has negligible risk in healthy adults, although maximal exercise has a small risk 
of inducing myocardial ischaemia. 
The subjects will complete a medical questionnaire and provide their written consent with 
the option to withdraw from training or testing at any point. 
There have been no reported side-effects to GAKIC ingestion using the same 
supplementation dose and frequency as the present study (e.g. Stevens et al. 2000; Buford 
& Koch (2004) and GAKIC is commercially available at select food supplement stores. 
5. Outline the reasons which lead you to be satisfied that the possible benefits to be gained 
from the project justify any risks or discomforts involved. 
It is envisaged that this research will benefit the identification of the physiological 
mechanisms which limit exercise tolerance (i.e., the ability of individuals to perform 
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associated with the above procedures are considered to be worthwhile to gain the 
information required. 
6. Who are the investigators (including assistants) who will conduct the research and what 
are their qualifications and experience? 
Dr Yannis Pitsiladis PhD MMedSci BA, Chris Easton BSc, Mr John Wilson, Mrs Heather 
Collin (Senior Technicians), and 3 BSc Honours Project Students.  The principal 
investigators have wide ranging experience of exercise testing over periods of up to 10 
years without incident.  The principal researchers have carried out Cr supplementation 
studies and exercise to exhaustion studies in relatively extreme environmental conditions 
in the past. 
7. Are arrangements for the provision of clinical facilities to handle emergencies 
necessary?  If so, briefly describe the arrangements made. 
In the event of an emergency, guidelines recently approved by the ethics committee will be 
followed. 
In the event of an untoward incident that is not an emergency, the supervising Principal 
Investigator will administer appropriate first aid, if necessary.  The subject will not be 
permitted to leave the laboratory until he has fully recovered.  The subject will be 
encouraged to contact his local GP.  The subject will be told that one of the Principal 
Investigators will conduct a follow-up by telephone at the end of the same day.  The 
subject will also be provided with 24-h contact numbers for both Principal Investigators. 
8. In cases where subjects will be identified from information held by another party (for 
example, a doctor or hospital) describe the arrangements you intend to make to gain access 
to this information including, where appropriate, which  Multi Centre Research Ethics 
Committee or Local Research Ethics Committee will be applied to. 
N/A 
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Some students may be recruited but will be under no pressure from staff to participate in 
the study. 
10. Specify whether the research will include children or people with mental illness, 
disability or handicap.   If so, please explain the necessity of involving these individuals as 
research subjects. 
N/A 
11. Will payment or any other incentive, such as a gift or free services, be made to any 
research subject?  If so, please  specify and state the level of payment to be made and/or 
the source of the funds/gift/free service to be used.  Please explain the justification for 
offering payment or other incentive. 
No. 
12. Please give details of how consent is to be obtained.  A copy of the proposed consent 
form, along with a separate information sheet, written in simple, non-technical language 
MUST ACCOMPANY THIS PROPOSAL FORM. 
Each subject will be provided with a consent form outlining the testing procedures, which 
asks them for their written consent to participate in the project with the option to withdraw 
at any time (see enclosed copy).  A verbal explanation will also be given and any queries 
answered.  If there is some doubt of the subject's eligibility for the study, the subject will 
be excluded.  Information on GAKIC supplementation and the Pl will be given in the 
Information Sheet. 
13. Comment on any cultural, social or gender-based characteristics of the subject which 
have affected the design of the project or which may affect its conduct. 
All subjects are male.  This constraint is imposed for standardisation purposes 
14.  Please state who will have access to the data and what measures which will be adopted 
to maintain the confidentiality of the research subject and to comply with data protection 




© Lukas Y. Beis (2012) 
The information obtained will be anonymised and individual information will not be 
passed on to anyone outside the study group.  The results of the tests will not be used for 
selection purposes. 
15. Will the intended group of research subjects, to your knowledge, be involved in other 
research?  If so, please justify. 
No 
16. Date on which the project will begin April 2006 and end April 2007 
17. Please state location(s) where the project will be carried out. 
Laboratory of Human Physiology (Lab 245), West Medical Building. 
18. Please state briefly any precautions being taken to protect the health and safety of 
researchers and others associated with the project (as distinct from the research subjects) 
e.g. where blood samples are being taken 
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Appendix D: Advertising leaflet  
 










We are looking for 15 cyclists to take part in a research study into the effects 
of a new amino acid drink on fatigue during repeated cycle sprints. 
 
Subjects should be male cyclists, aged 18 - 45. 
 
Testing will involve four separate cycle sprint sessions lasting 15 minutes on 
an exercise bike located in the University of Glasgow, Human Physiology 
Performance Lab, West Medical building, University Avenue. 
  
Subjects will be provided with a breakdown results of all performance tests. 
If you are interested in taking part or would like further information please 
contact: 
 
LUKAS  BEIS  on 0141 330 3926 (Lab) or 07517477641 (Mobile) 
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Appendix E: Ethics Document 
UNIVERSITY OF GLASGOW 
FACULTY OF BIOMEDICAL AND LIFE SCIENCES 
 
ETHICS COMMITTEE FOR NON CLINICAL RESEARCH 
INVOLVING HUMAN SUBJECTS, MATERIAL OR DATA 
 
APPLICATION FORM FOR ETHICAL APPROVAL 
NOTES: 
 
A submission to this Committee does not automatically result in approval. 
Investigators must wait for written approval before commencing data collection. 
Disciplinary measures will be taken if work commences without ethical approval 
being in place. The matter will be referred to the Dean for appropriate action. 
 
 
THIS APPLICATION FORM SHOULD BE TYPED, NOT HAND WRITTEN. 
 
ALL QUESTIONS MUST BE ANSWERED. “NOT APPLICABLE” IS A SATISFACTORY ANSWER 
WHERE APPROPRIATE. 
 
Project Title:  The effects of hyperhydration on running economy of endurance 
trained runners. 
________________________________________________________________________ 
Is this project from a commercial source?  No 
 
If yes, give details and ensure that this is stated on the Informed Consent form. 
 
 
Date of submission: October 2007 
______________________________________________________________ 
 
Name of all person(s) submitting research proposal: Dr Yannis Pitsiladis  
_________________________________________________________________________
_______ 






Address for correspondence relating to this submission: Lab 245, West Medical Building. 





Name of Principal Researcher (if different from above e.g., Student’s Supervisor): N/A 
1. Describe the purposes of the research proposed.  
The vast majority of the differences in endurance running performance in elite athletes are 
principally accounted for by running economy with maximal aerobic capacity (V̇O2max) 
and % V̇O2max also having a significant impact (Bassett & Howley, 2000; Conley & 
Krahenbuhl, 1980).  Running economy is defined as the rate of oxygen utilization (V̇O2) 
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mass per min (mL·kg-1·min-1) (Bassett & Howley, 2000).  Athletes who maintain a lower 
V̇O2 while running at a given velocity use less energy and therefore are said to have a 
better running economy.  Subsequently, if BM can be reduced and power output 
maintained, athletes should theoretically use less energy and therefore more economical.  
This physiological phenomenon may help explain why despite the reported negative 
impact of dehydration on thermoregulatory and cardiovascular parameters (Montain & 
Coyle, 1992) athletes consistently perform well during competition despite losing between 
4 and 8% BM (Coyle, 2004).  Conversely, hyper-hydrating prior to competing in weight 
bearing sports such as running via ingestion of osmotic agents such as Gly or Cr (Easton et 
al., 2007) may negatively impact performance due to the associated increase in BM 
(Noakes, 2003a).  
However, the only published study to date to examine the effects of hydration status on 
running economy found dehydration of up to 5% BM had no effect on running economy 
and resulted in a significant increase in physiological strain during running in 23 oC 
(Armstrong et al., 2006).  Nevertheless, it is currently unknown whether hyper-hydrating, 
and thus increasing BM would negatively impact on running economy.  Therefore, the 
primary aim of the present study is to examine the effects of combined Cr and Gly hyper-
hydration on running economy, cardiovascular, thermoregulatory and metabolic responses 
to running exercise in both cold (10 oC) and hot (35 oC) conditions in endurance trained 
subjects.  A secondary aim of this study is to determine the accuracy of a breath-by-breath 
portable gas analyser, (K4, COSMED s.r.l., Rome, Italy) for measurement of gas exchange 
variables and running economy in the field. 
2. Please give a summary of the design and methodology of the project.  Please also 
include in this section details of the proposed sample size, giving indications of the 
calculations used to determine the required sample size, including any assumptions you 
may have made. (If in doubt, please obtain statistical advice). 
Methods/Design of investigation 
We propose to study 12 endurance-trained males (mostly runners aged 17-40 yrs).  
Subjects will be in good health at the time of testing and regularly take part in strenuous 
exercise.  Eligibility will be assessed by subjects undergoing a medical examination. 
Subjects will also be required to read and sign the enclosed information sheet and a high 
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committee, e.g., The effects of combined Cr and Gly supplementation on hydration, 
thermoregulation and exercise performance in the heat in endurance-trained subjects). 
Testing will take place in the laboratory of human physiology in the West Medical 
Building.  A series of assessments will be carried out.  These will include (see protocols): 
body composition using standard anthropometric methods; extracellular water and total 
body water measurement using multi-frequency bioelectrical impedance and 6 exercise 
tests.  During the first laboratory visit, a health questionnaire and physical examination will 
be completed, the study and equipment will be explained to the subjects, and the subjects 
V̇O2max will be measured.  The subsequent 5 tests will involve 4 visits to the laboratory 
and 1 to the running track.  Following measurement of V̇O2max, two familiarisation and 1 
baseline exercise trials, subjects will be ingest Cr and Gly for a period of 7 days.  
Each supplement will consist of 11.4 g of Cr H2O (equivalent to 10 g Cr), 75 g of glucose 
polymer and 1g/kg BM Gly made up in 1 L of warm to hot water (x 2 times daily) and 
flavoured with sugar free fruit juice as necessary.  Subjects will ingest the final 
Cr/glucose/Gly drink 5 h before performing a post-supplementation exercise trial and 
further 500 mL water 1 h before the test.  Subjects will be instructed to carry out a weighed 
intake of food and an activity diary in the 24-h preceding each test.  This supplementation 
regiment has previously been approved by the university ethics committee and as 
anticipated, no subjects experienced side-effects.  
Protocols 
Tests 1 and 2: Discontinuous Incremental Maximal Speed Test: will take place both in the 
laboratory and in the field. Subjects will be instructed to run at 10, 11, 12, 13, 14, 15, 16, 
17 and 18 kmh-1 (or until volitional exhaustion) for 3 min at each speed, with a 3-5 min 
rest interval between each bout walking at 4 kmh-1.  The laboratory test will be performed 
on a motorised treadmill, during which, the gradient shall remain at 1% throughout.  
Whereas the field test will take place on a 400m running track; an investigator will cycle 
alongside the subject to control the speed using a GPS system (GPSports SPI 10, 
GPSSports, Fyshwick ACT, Australia).  
Test 3, 4, 5 and 6: Running Economy Tests: will take place in the laboratory on a 
motorised treadmill. Subjects will be required to run at a constant pace of 60% V̇O2max for 
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rest period during which time any fluid lost during exercise will be replaced via ingestion 
of water.  Subjects will then be required to run for a further 30 min at a constant pace of 
60% V̇O2max for 30 min in 35 oC and 70% relative humidity. 
Subjects will be given a warm-up before, and a warm-down after all four tests.  The subject 
will wear a triaxial accelerometer (3dNX, Biotel, Bristol, U.K.) to record the activity 
counts per min.  HR (Suunto t6, Suunto Oy, Vantaa, Finland) and gas exchange variables 
(Douglas bag collection) will be measured throughout exercise.  Each subject will be 
required to swallow a CorTemp Ingestible Temperature Sensor the evening prior to each 
test.  The pill is a small electronic device, which measures Tcore and transmits it through a 
radio wave signal to an external receiver (Rav-Acha et al, 2003). 
Methods/Design of investigation (continued) 
Expired gas values obtained from Douglas bag analysis in experiments 1 and 2 will be 
compared to data previously collected using a K4 metabolic analyser using similar 
experimental protocols.  In exercise tests 3, 4, 5 and 6 a venous cannula will be inserted 
and a 10 mL blood sample taken before and after each bout of exercise 
Bioelectrical impedance:  Extracellular water and total body water will be prior to exercise 
tests 3, 4 and 5 using multi-frequency bioelectrical impedance (Bodystat Multiscan 500).  
This non-invasive method involves placing two current-inducing electrodes and two 
detector electrodes on the dorsal surfaces of the right hand and foot and a small (and 
imperceptible) electrical current (500 Micro-Amps) introduced between these. 
3. Describe the research procedures as they affect the research subject and any other parties 
involved. 
All experiments will take place in the Environmental Chamber in the West Medical 
Building.  Dr Yannis Pitsiladis or a qualified (CPR-trained) and experienced colleague will 
be present at all tests.  Dr Pitsiladis is a certified phlebotomist and trained in CPR and 
Advanced Life Support. 
Some subjects may experience mild discomfort during the placement of and/or sampling of 
blood from a catheter placed in a vein on the dorsum of the heated hand.  In our 
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when the hand has been heated to 44 °C for at least 10 min, allowing a substantial local 
vasodilatation of the superficial blood vessels, which facilitates their cannulation; the 
catheter is indwelling, allowing for multiple sampling; while it is safely secured in place 
with adhesive tape, there is sufficient ‘play’ to allow sampling without ‘pulling’ on the 
vessel (i.e., the catheter can slide easily within the vessel); upon withdrawal of the catheter 
at the end of the experiment, firm pressure is maintained over the site to prevent any 
leakage from the vessel into the surrounding interstitium which could lead to local oedema 
and bruising.  Importantly, if a vessel cannot be readily cannulated or if the subject is 
nonetheless not comfortable with proceeding, the experiment is halted.  No more than 30 
mL of blood will be sampled for each test. 
Potential participants will be identified either by personal contact or by advertisement. 
They will be asked to meet with the investigators to discuss the project and whether they 
would be suitable as a subject.  All subjects will be endurance trained individuals without a 
history of any significant medical problem(s).  The good health of each subject will be 
established prior to the study by subjects undergoing a medical examination by a qualified 
medical practitioner (as previously approved by the University Ethics Committee), which 
is supported by written assurance from the subject in the form of a detailed medical 
questionnaire.  Subjects with a history of cardiorespiratory or neurological disease will be 
excluded from participation, as will those having an acute upper respiratory tract infection. 
Subjects who take drugs (recreational or performance enhancing drugs) or who have 
consumed alcohol within 48 h of an experiment will be excluded. 
Exercise testing: The risks associated with performing maximal exercise are minimal as 
long as the subject is appropriately instructed and familiarised with the device prior to 
participation and also is appropriately supervised during the experiment.  All exercise 
bouts are both preceded by a 5 min "warm-up" and by a 5 min "warm-down".  The latter is 
of particular importance during high-intensity exercise, when the local accumulation of 
exercise metabolites can cause an "expansion" (or vasodilatation) of the blood vessels in 
the lower limbs, which can impair the adequate return of blood to the heart – predisposing 
to fainting on dismounting from the ergometer.  This risk is minimised by having the 
subject exercise at a mild level during recovery to "wash away" these metabolites and 
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Some subjects experience difficulty swallowing while breathing through a mouthpiece and 
wearing a nose clip, due to some transient build-up of pressure in the ears. 
4. What in your opinion are the ethical considerations involved in this proposal?  (You may 
wish for example to comment on issues to do with consent, confidentiality, risk to subjects, 
etc.) 
All procedures described in this application have previously been approved by the 
University Ethics Committee and carried out without incident (e.g. The effects of 
combined Cr and Gly supplementation on hydration, thermoregulation and exercise 
performance in the heat in endurance-trained subjects;  The effects of combined Cr and 
Gly hyper-hydration on cardiovascular responses to postural change;  Estimation of 
aerobic power from accelerometers and HR during walking and running.). 
The subjects will complete a medical questionnaire and provide their written consent with 
the option to withdraw from participation at any point. 
The insertion of a catheter into a vein may rarely cause irritation at the site of insertion, 
venospasm (or constriction of the cannulated vein which may lead to interference with 
blood flow through it) and phlebitis.   These risks are minimized in this investigation by 
the short duration of the test and by the procedures described above. 
Blood will be handled, stored and disposed of according to standard health and safety 
procedures. 
Possible side-effects from the use of similar Gly hyper-hydration strategies include slight 
nausea, gastrointestinal distress (diarrhoea) and headaches.  These problems have been 
reported among some subjects in the many published studies to date (Easton et al., 2007; 
Freund et al., 1995; Lyons et al., 1990). 
The only known 'side effect' of oral Cr supplementation that has been reported is a 
temporary increase in body weight. 
5. Outline the reasons which lead you to be satisfied that the possible benefits to be gained 
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It is envisaged that this research will identify whether an increase in BM induced by hyper-
hydration will negatively affect running economy.  The minimal risk and discomfort 
associated with the above procedures are considered to be worthwhile to gain the 
information required. 
6. Who are the investigators (including assistants) who will conduct the research and what 
are their qualifications and experience? 
Dr Yannis Pitsiladis PhD MMedSci BA, Dr Chris Easton BSc PhD, Mr John Wilson, 
(Senior Technician), and BSc Honours Project and MRes Students.  The principal 
investigators have wide ranging experience of physiological testing over periods of up to 
10 years without incident.  The principal researchers have carried out Cr/Gly 
supplementation studies and exercise to exhaustion studies in relatively extreme 
environmental conditions in the past. 
7. Are arrangements for the provision of clinical facilities to handle emergencies 
necessary?  If so, briefly describe the arrangements made. 
In the event of an emergency, guidelines recently approved by the ethics committee will be 
followed. 
In the event of an untoward incident that is not an emergency, the supervising Principal 
Investigator will administer appropriate first aid, if necessary.  The subject will not be 
permitted to leave the laboratory until he has fully recovered.  The subject will be 
encouraged to contact his local GP.  The subject will be told that one of the Principal 
Investigators will conduct a follow-up by telephone at the end of the same day.  The 
subject will also be provided with 24-h contact numbers for both Principal Investigators. 
8. In cases where subjects will be identified from information held by another party (for 
example, a doctor or hospital) describe the arrangements you intend to make to gain access 
to this information including, where appropriate, which Multi Centre Research Ethics 
Committee or Local Research Ethics Committee will be applied to. 
N/A 
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Some students may be recruited but will be under no pressure from staff to participate in 
the study.  Steps will be taken to avoid the recruitment of students in a dependent 
relationship with the academic involved in the study. 
10. Specify whether the research will include children or people with mental illness, 
disability or handicap.  If so, please explain the necessity of involving these individuals as 
research subjects. 
N/A 
11. Will payment or any other incentive, such as a gift or free services, be made to any 
research subject?  If so, please  specify and state the level of payment to be made and/or 
the source of the funds/gift/free service to be used.  Please explain the justification for 
offering payment or other incentive. 
No 
12. Please give details of how consent is to be obtained.  A copy of the proposed consent 
form, along with a separate information sheet, written in simple, non-technical language 
MUST ACCOMPANY THIS PROPOSAL FORM. 
Each subject will be provided with a consent form outlining the testing procedures, which 
asks them for their written consent to participate in the project with the option to withdraw 
at any time (see enclosed copy).  A verbal explanation will also be given and any queries 
answered.  If there is some doubt of the subject's eligibility for the study, the subject will 
be excluded.  Information on Cr and Gly supplementation will be given in the Information 
Sheet. 
13. Comment on any cultural, social or gender-based characteristics of the subject which 
have affected the design of the project or which may affect its conduct. 
All subjects are male.  This constraint is imposed for standardisation purposes. 
14.  Please state who will have access to the data and what measures which will be adopted 
to maintain the confidentiality of the research subject and to comply with data protection 
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The information obtained will be anonymised and individual information will not be 
passed on to anyone outside the study group.  The results of the tests will not be used for 
selection purposes. 
15. Will the intended group of research subjects, to your knowledge, be involved in other 
research?  If so, please justify. 
No 
16. Date on which the project will begin November 2007 and end May 2008 
17. Please state location(s) where the project will be carried out. 
Laboratory of Human Physiology, West Medical Building. 
Outdoor track (Scotstoun stadium and Bellahouston Park). 
18. Please state briefly any precautions being taken to protect the health and safety of 
researchers and others associated with the project (as distinct from the research subjects) 
e.g., where blood samples are being taken. 
All experiments will be conducted according to the Code of Practice for conducting 
experiments in non-patient human volunteers (including handling and disposal of human 
blood, urine and sputum) previously accepted by the University Ethics Committee. 
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Appendix F: Health Screening and Physical Activity 
Questionnaire 
 
UNIVERSITY OF GLASGOW 
INSTITUTE OF BIOMEDICAL AND LIFE SCIENCES 
 
SUBJECT’S QUESTIONNAIRE AND ASSENT FORM FOR 
HIGH-INTENSITY EXERCISE TESTING 
 
If you feel unwell on the day of a proposed test, or have been feeling poorly over the 
preceding day or two, DO NOT TAKE PART in a high-intensity exercise test. 









a) What kind(s) of exercise do you regularly do (20 + min/session)?  (Please circle) 
 
Number of times per average week 
 
Walking    1 2 3 4 5 
Running    1 2 3 4 5 
Cycling    1 2 3 4 5 
Swimming    1 2 3 4 5 
Skiing                1 2 3          4          5 
Rowing    1 2 3 4 5 
Gymnastics    1 2 3 4 5 
Martial arts    1 2 3 4 5 
Tune Up    1 2 3 4 5 
Popmobility               1 2 3 4 5 
Sweat Session               1 2 3 4 5 
Field athletics               1 2 3 4 5 
Weight training                                   1          2          3          4          5 
Racquet sports               1 2 3 4 5 
Rugby/soccer/hockey              1 2 3 4 5 
 
Other(s) *     1 2 3 4 5 
 
* (Please specify)   ________________________________________ 
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Smoking 
(Please tick one) 
Never smoked  __________ 
Not for > 6 months __________ 
Smoke <10 per day __________ 
Smoke > 10 per day __________ 
 
Illnesses 
Have you ever had …?  (Please circle Yes or No) 
 
Asthma    YES  NO 
Diabetes    YES  NO 
Epilepsy    YES  NO 
Heart Disease   YES  NO 
High Blood Pressure  YES  NO 
 
 
Any other illness that could affect your safety in performing maximal exercise 
 
YES  NO 
 
(If YES, please specify)  ___________________________________________ 
 
Symptoms 
Have you ever had any of the following symptoms to a significant degree? 
i.e., have you had to consult a physician relating to any of the following? 




Breathlessness    YES  NO 
Chest Pain    YES  NO 
Dizzy fits / Fainting  YES  NO 
Heart Murmurs    YES  NO 
Palpitations    YES  NO 
 
Muscle or joint injury 
 
Do you have / or have had any muscle or joint injury which could affect your safety in 
performing maximal exercise or strength testing or strength training? 
 
YES  NO 
 
Medication 
Are you currently taking any medication? YES  NO 
(Please circle Yes or No) 
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Signature ____________________________________________ 
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Email the completed form to: S.Morrison@bio.gla.ac.uk 
 
And send the signed hard copy to: 
 
Stuart Morrison 
Faculty Research Office 
Faculty of Biomedical & Life Sciences 
West Medical Building 
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